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Summary
It has been the clinical impression for many years that certain 
'stressful' pregnancy complications appear to be associated with a 
generally improved neonatal outcome. The reason for this is unclear 
but is has been proposed that a hostile intrauterine environment may, 
perhaps as a result of relative hypoxia, promote the release of 
hormones such as cortisol and catecholamines. These hormones may 
facilitate the maturational processes, particularly in the lung, and 
so help to prepare the fetus for extrauterine life.
Certainly, and despite advances in neonatal care, respiratory 
problems remain the most common cause of death in normally-formed 
live-born babies (Chamberlain et al 1975), being responsible for about 
1500 deaths in England and Wales alone in 1980 (HMSO 1980). Even if 
the baby survives, however, the need for prolonged ventilatory support 
may lead to the development of bronchopulmonary dysplasia and other 
causes of chronic respiratory insufficiency (Levine and Dubowitz 1982, 
Tarrow-Mordi and Wilkinson 1986). Other problems such as 
intraventricular haemorrhage, patent ductus arteriosus and 
pneumothorax are also related to respiratory immaturity (Greenhough 
and Roberton 1985, Whittle et al 1986).
The improvements in neonatal care have resulted in survival rates 
of over 88% for babies weighing greater than 1000 g in some units 
(Greenhough and Roberton 1985). In view of the excellent survival 
rates for the small baby, the obstetrician when faced with a difficult 
management problem not unnaturally has a low threshold for preterm 
delivery often, as is increasingly the trend, without prior assessment 
of fetal lung maturity. With more and more small babies receiving 
assisted ventilation, knowledge of the natural development of the 
respiratory system in the human fetus is essential.
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The aims of this thesis were:
1 To evaluate certain obstetric factors, considered to influence 
fetal lung maturity.
2 To investigate what controls respiratory maturity in the human 
fetus.
3 To evaluate human fetal adrenal cortisol and medullary activity 
from mid-trimester until term.
The basis of the study centres on the concept of fetal stress in 
utero being the interlinking factor between the various obstetric 
problems and fetal lung maturity. However, many of the current ideas 
regarding human fetal lung development have been derived from animal 
experiments, the results of which may not be applicable to the human.
A timetable of events can, however, be defined using a combination of 
animal and human data and a review of the current literature is 
contained in Chapters 2 and 3.
Chapter 2 outlines what is currently known of the normal 
development of the human fetal lung. The anatomical, physiological 
and biochemical development are discussed and the evidence presented 
suggesting an important role for the fetal stress hormones cortisol 
and the catecholamines. A number of animal studies have suggested 
that corticosteroids can cause an induction of the enzymes involved in 
surfactant synthesis and that the catecholamines, especially 
adrenaline, facilitate the release of surfactant (the surface-active 
lung phospholipids) and the clearance of lung fluid at birth, all 
helping to optimise neonatal lung function. These animal expriments \ 
are supported by clinical studies suggesting a reduction in the 
incidence of respiratory problems following treatment of the pregnant 
mother with corticosteroids and various Beta sympathomimetic drugs.
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Various factors, both physiological and pathological, considered 
to influence fetal lung maturity in the human are discussed in Chapter 
3, with regard to both clinical and biochemical lung maturity. In 
addition, the available evidence linking the obstetric factors with 
the human fetal adrenocortical and sympathoadrenal responses is 
presented.
A total of 381 babies were investigated in this study, of which 
189 were born at or prior to 33 weeks’ gestation. Lung maturity was 
assessed clinically by the occurrence of the respiratory distress 
syndrome and the requirement for neonatal ventilation and 
biochemically by measurement of amniotic fluid phospholipids. The 
fetal stress responses were assessed by measuring, in blood sampled 
from the umbilical artery at birth, the cortisol, noradrenaline and 
adrenaline levels and pH. These measurements were also made in 
maternal venous blood at time of delivery. The physiological factors 
investigated were: gestational age, labour and route of delivery and
multiple pregnancy and the pathological factors: the condition of the
baby at birth and the obstetric complications, intrauterine growth 
retardation, premature rupture of the membranes, vaginal bleeding, 
hypertension and preterm labour.
For each of the physiological and pathological factors, the 
clinical and biochemical lung maturity and the fetal adrenocortical 
and sympathoadrenal responses were investigated.
It is generally believed that certain obstetric complications can 
protect the fetus from developing RDS. However, from this study there 
is little evidence to support this, and in addition none of the 
obstetric complications studied had any consistent influence on fetal 
cortisol or catecholamine levels.
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Despite much indirect evidence in the literature this study was 
unable to confirm the proposed effect of stress on fetal lung 
maturity.
The adrenocortical and sympathoadrenal responses have been 
extensively studied in the human fetus at birth from 24 to 41 weeks'
gestation. Although there is a marked increase in UAC levels with
gestation, especially from 34 weeks, the changes in sympathoadrenal
responses are not so clear cut. There was a tendency for the levels
of both NAD and AD to rise with gestation and there is some evidence
to suggest that the ratio of NAD/AD does decrease with increasing
gestation, suggesting an increased AD response to stress in the term 
compared to the preterm fetus.
Interestingly neither the adrenocortical nor the sympathoadrenal 
responses seemed to influence the clinical outcome for the baby.
It cannot be assumed that a fetus under chronic stress will 
necessarily have accelerated fetal lung maturity, a history of
obstetric complications producing stress is often found in babies who
die from RDS. Indeed from this study those babies who developed RDS, 
required ventilation or died were significantly more acidotic than 
those babies who had no respiratory difficulties.
The study therefore does not support the view that stress, either 
the physiological stress of labour or the pathological stress of 
certain obstetric complications accelerates fetal lung maturity. In 
addition to this it does not appear that the stress products cortisol 
or catecholamines have a major role to play in influencing neonatal 
lung function. Gestational age and the condition of the baby at birth 
would seem to be of paramount importance.
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CHAPTER 1
The Importance of Fetal Pulmonary Maturity
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The Importance of Fetal Pulmonary Maturity
Despite advances in neonatal care respiratory problems remain the 
most common cause of death in normally formed live born babies 
(Chamberlain et al 1975), being responsible for about 1500 deaths in 
England and Wales alone in 1980 (HM50, 1980).
The change from placental to pulmonary respiration which occurs 
at birth is the most important adaptation that a fetus makes to 
extrauterine existence. The failure of this normal pulmonary 
adaptation at birth can result from two main causes, although there 
may be some overlap between them. Firstly, delayed clearance of lung 
fluid at birth can result in transient tachypnoea of the newborn 
(Avery et al 1966). Fortunately this tends to be self limiting and 
rarely causes major problems. In contrast, however, a deficiency of 
the lung surfactant which lines the terminal air spaces results in the 
development of the respiratory distress syndrome (RDS) or hyaline 
membrane disease (HMD) (Avery and Mead 1959). Lung surfactant is a 
collection of different phospholipids which coat the alveoli and 
reduce their surface tension, preventing them from collapsing during 
expiration and facilitating air entry during inspiration. When 
surfactant is deficient as in RDS (Adams et al 1965, Boughton et al 
1970), the alveoli collapse during expiration and a high intrathoracic 
pressure is then needed to open the lungs. RDS is a serious disease 
and if surfactant deficiency is severe a deteriorating cycle of events 
occurs - due to collapse of the alveoli the fetus becomes hypoxic and 
acidotic and this in turn reduces pulmonary blood flow, all of which 
will inhibit surfactant production and cause more alveoli to collapse.
Even if the baby survives, the need for prolonged ventilatory 
support may lead to the development of broncho-pulmonary dysplasia and 
other causes of chronic respiratory insufficiency (Levene and
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Dubowitz, 1982). Unfortunately mechanical ventilation is frequently 
associated with complications. Pnuemothorax and pulmonary 
interstitial emphysema, both examples of air leak, occur in 30-50% of 
infants given mechanical ventilation and weighing under 1500 g at 
birth. Around one third of these very small infants develop chronic 
lung disease (Tarrow-Mordi and Wilkinson 1986). Another complication 
of ventilatory support is intraventricular haemorrhage which may lead 
to cerebral dysfunction. In addition behavioural problems may result 
from prolonged enforced separation from the mother.
The development of RDS is related to the stage of fetal lung 
maturation at time of birth, which explains why preterm babies are 
more likely to develop RDS.
In our own experience at the Queen Mother's Hospital during 1979 
(3303 total births), using a clinico-pathological classification, 11 
out of 26 (42%) first week deaths, and 8 out of 13 (62% later neonatal 
deaths (8th to 62nd day), were due primarily to immaturity at birth, 
principally respiratory immaturity; RDS was present in 16 of all the 
babies dying from immaturity.
These deaths, perinatal and late neonatal, constitute the 'tip of 
the iceberg' of prematurity which besides carrying risks of residual 
impairement (Leader BMJ 1979, Leader BMJ 1980, Levene and Dubowitz 
1982, Greenhough and Roberton 1985) poses a very considerable burden 
on both expensive facilities and skilled personnel.
The improvements in neonatal care in recent years have resulted 
in survival rates of over 88 per cent for babies weighing greater than 
1000 g, in some units (Greenhough and Roberton 1985). In view of the 
excellent survival rates for the small baby, the obstetrician when 
faced with a difficult obstetric problem, not unnaturally has a low 
threshold for preterm delivery often, as is increasingly the trend,
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'without prior assessment of fetal lung maturity. Thus as more and 
more babies are being born who require mechanical ventilation, 
knowledge of the natural development of the respiratory system in the 
human fetus is essential. Many of the current ideas regarding fetal 
lung development, however, have been derived from animal experiments, 
the results of which are not necessarily appropriate to the human.
The information which is available in the human has been obtained 
in the face of obstetric pathology making it difficult to evaluate the 
individual influences of stress, drugs, labour and mode of delivery.
It has been the clinical impression for many years that certain 
pregnancy complications appear to be associated with an unusually low 
incidence of neonatal RDS. The reason for this is uncertain. 
However, it has been proposed that a hostile intrauterine environment 
stresses the fetus and in some way accelerates the normal lung 
development.
In this thesis, current ideas on the normal development of the
✓
human fetal lung and how this may be modified by certain obstetric 
factors are discussed. The role that fetal stress, both physiological 
and pathological, plays in the development of fetal, and thus neonatal 
lung development, is investigated.
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CHAPTER 2
The D eve lopm ent o f  F e ta l  Lung M a tu r i t y
This chapter will review the current knowledge regarding the 
anatomical, physiological and biochemical development of the 
fetal respiratory system.
The methods available to assess fetal lung maturity prior to 
birth will also be discussed.
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The D eve lopm ent o f  f e t a l  lu n g  m a tu r i t y
2.1 Anatomical Development (Strang 1977)
2.1.1 Embryonic phase (3-6 weeks) The rudimentary respiratory tract 
first appears about 3-4 weeks after fertilization, arising from the 
ventral portion of the foregut as a single bud, which quickly divides 
into two. These two subdivisions grow rapidly, with further divisions 
pushing into the underlying mesoderm, from which cartilaginous rings, 
lymphatics and capillaries will eventually form. About six weeks 
after fertilization the trachea, main and subsidiary bronchi are well 
developed.
2.1.2 Pseudoglandular phase (7-17 weeks) This is a very active phase 
of development, with further extensive branching of the respiratory 
tree continuing until completion by about the 16th week. Cartilage 
formation, together with the development of a more definitive 
pulmonary vascular system, commences at this time. Microscopically 
the lung appears to comprise glandular tissue, with goblet cells and 
cilia being observed.
2.1.3 The canalicular phase (18-24 weeks) During this time the 
rather tall cells of the preceding phase become more cuboidal and, 
subsequently, the walls of the terminal bronchioles become thinner. A 
capillary plexus begins to develop around the terminal bronchioles to 
form a rudimentary gas-exchange system.
2.1.4 The terminal sac phase (24 weeks to term) The terminal 
bronchioles now begin to subdivide into three or four respiratory 
bronchioles from which develop the clusters of saccules that are a
feature of the fetal lung at about 30-32 weeks. Even earlier in the
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terminal sac phase, the space between capillaries and potential air 
spaces is small enough to enable effective gas exchange in some babies 
born at 24-26 weeks. As the fetus approaches term, minute alveoli 
appear in the terminal saccules - a process which becomes markedly 
accelerated once the baby is born and which continues rapidly until 
about two years of age.
Important epithelial changes also occur during this phase, the 
cells of the terminal air passages thinning out and the specialized 
Type II cells, the pneumocytes, appearing. These latter cells are 
found in the human as early as 24 weeks (Campiche et al 1963) and they
are characterized by their ability to manufacture surfactant which
appears as osmiophilic granules within lamellar bodies in the 
cytoplasm.
2.2 Physiological Development
2.2.1 Fetal Breathing Movements
Breathing movements occur in the human fetus in utero from early 
pregnancy and they have been studied extensively with the introduction 
of real time ultrasound scanning (Lewis & Boylan 1979). The fetal 
breathing movements are not continuous but episodic with periods of 
breathing interspersed with periods of 'apnoea1. In each 24 hour 
period fetal breathing occurs about 30 per cent of the time in the 
human (Patrick et al 1980).
The function of fetal breathing movements in utero is obscure but 
presumably they have the function of preparing the fetus for
extrauterine life. Trudinger (1981) has noted an increase in the
incidence of neonatal respiratory problems amongst later fetuses with 
a rapid irregular breathing pattern. In contrast they found a 
positive relationship between a slow regular breathing pattern,
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considered to be a mature pattern, and a mature L/S ratio.
It has also been found that FBM diminish or cease 24-36 hours 
before the onset of established labour (Boddy et al 1974) and this may 
reduce the flow of fluid known to occur from the trachea (Scarpelli 
1967) and help retain surfactant in the fetal alveoli prior to birth. 
It is interesting that infusion of noradrenaline (NAD), but not 
adrenaline (AD), causes inhibition of FBM in rhesus monkeys (Murata et 
al 1981). NAD is the predominant catecholamine in the human fetus and 
extremely high levels are reached following vaginal delivery (Falconer 
and Lake 1982).
Therefore, although the exact role of FBM is uncertain it would 
seem to have a part to play in the normal development of the fetal 
lung.
2.2.2 Clearance of Lung Fluid
The rapid absorption of fluid from the respiratory tract which 
occurs at the time of the first breath is important in achieving 
optimal lung function.
Clearance of lung fluid is thought, at least partly, to be due to 
the thoracic squeeze which occurs during a normal vaginal delivery 
(Karlberg 1960). Defective clearance of lung fluid will leave the 
neonate with less compliant lungs and therefore increase the work of 
breathing. The thoracic squeeze effect on clearance of lung fluid may 
not be the whole story however. In newborn rabbits the lowest lung 
water content is found following labour, irrespective of mode of 
delivery (Bland et al 1980).
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In the human, neonatal lung volumes have been assessed by the 
crying vital capacity (CVC - expressed as ml/cm of chest 
circumference) and by the more invasive measurements of thoracic gas 
volume.
Chiswick & Milner (1976) and Brice & Walker (1977) have shown 
that neonates born by caesarean section have significantly lower CVC 
than those born vaginally during the first 48 hours after birth. In 
addition Boon et al (1981) noted that babies delivered by emergency 
caesarean section (ie after the onset of labour) formed an 
intermediate group. Milner et al (1978) found significantly higher 
thoracic gas volumes in those babies delivered vaginally compared with 
those delivered by caesarean section. The above studies suggest that 
both labour and passage down the birth canal promote clearance of lung 
fluid.
Exactly how labour itself causes clearance of lung fluid is 
uncertain. However, animal work has suggested that the catecholamines 
especially AD may play an important role.
Intravenous infusion of AD into fetal lambs at concentrations 
similar to those found in labour causes absorption of lung fluid 
(Brown et al 1981, Lawson et al 1978). AD was much more effective 
than NAD in this respect, suggesting that the absorption of fluid is 
moderated via Beta receptors (Walters & Olver 1978). The sensitivity 
of the response to AD seems to increase throughout gestation and is 
maximal at term (Brown et al 1981, Walters & Olver 1978).
Brown et al (1981) using chronically catherised fetal lamb 
preparations noted a correlation between endogenous AD concentration 
and lung liquid absorption during labour. However no such correlation 
of lung liquid absorption was found with NAD and the fact that the 
process is blocked by propranolol is a clear indication that Beta 
receptors are involved.
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Enhorning et al (1977) noted significantly less fetal pulmonary 
fluid in rabbit fetuses infused with a Beta mimetic drug, isoxsuprine 
compared with controls. In the human, data concerning control of 
clearance of lung fluid is sparse. However, Faxelius et al (1983) 
have found a correlation between cord catecholamine levels and 
clearance of lung fluid after vaginal delivery but not after elective 
caesarean section.
It would seem, therefore, that the catecholamines may have an 
important role to play in the clearance of lung fluid, thus helping to 
achieve optimal lung function.
Experiments in goats have suggested that vasopressin, the levels 
of which rise acutely during labour, may induce lung liquid absorption 
(Perks & Cassin (1982). The significance of thses observations is as 
yet not clear.
2.3 Biochemical Development
Avery & Mead (1939) demonstrated that babies suffering from RDS 
(ie where there were no other obvious causes for the baby to have 
respiratory problems) had deficient surfactant in their lungs.
2.3.1 Physical properties of surfactant
Pattle in 1953 noted that surfactant could reduce surface tension 
to very low levels. He found tiny air bubbles from lung tissue did 
not shrink and disappear as rapidly as expected. As early as 1947 
Gruenwald suggested that surface tension and RDS might be related. By
2i
the La Place equation AP = , (where P r difference between air
K
pressure and intrathoracic pressure; T = wall tension in the alveolus; 
R = radius of alveolus), if the surface tension (T) in the alveoli 
were not extremely low, a very high pressure ( P) would be required to 
maintain expansion when the radius of the alveoli (R) has reached its
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minimum at the end of expiration, (ie because the alveolar surface 
tension is low, collapse of the alveolus is prevented as it reduces in 
size).
Clements et al (1961) using a modified Wilhelmy balance and 
Enhorning (1977) using a pulsating bubble technique, concluded that 
normal alveolar stability was due to the ability of pulmonary 
surfactant to cause a change in surface tension as the surface of the 
alveolus (and therefore the radius) changes. On expiration, as the 
alveolus decreases in size the molecules of surfactant are packed 
closer together thus reducing the surface tension as the radius 
decreases and allowing re-expansion of the alveolus at a lower
pressure during inspiration (Harvey & Parkinson 1981). Morley et al
(1978) have suggested that surfactant forms a rigid structure which
holds the lungs open at the end of each breath.
It has further been demonstrated that surfactant may also have a 
role to play in the clearance of lung fluid (Guyton & Moffatt 1981).
2.3.2 Chemical composition of surfactant
Lung surfactant is composed of several phospholipids of varying 
importance in combination with proteins (Table 2.1).
The phospholipid molecule contains a hydrophilic part (the 
phosphatidyl radical) and a hydrophobic part (the long chain fatty 
acids). Many molecules of phopholipids line the alveoli with the * 
hydrophobic end in the air, the alveolar surface then takes on the 
properties of the phospholipid molecule (Harvey & Parkinson 1981).
The major component of lung surfactant phospholipid is dipalmitoyl- 
phosphatidyl choline (lecithin). The next most important phospholipid 
is phosphatidyl glycerol (PG) (Hallman et al 1976) which has been 
shown to be at least as surface active as surfactant lecithin (Pfleger 
et al 1972). Other, and at present state of knowledge, less important
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phospholipids include phosphatidyl inositol (PI), phosphatidyl 
ethanolamine (PE) and phosphatidyl serine (King & Clements 1972, 
Pfleger et al 1972).
2.3.3 Control of surfactant synthesis
The type II alveolar epithelial cells are generally believed to
be responsible for the production of surfactant (Niden 1967).
The phospholipids of lung surfactant appear to recycle between 
lamellar bodies and alveolar spaces (Fig 2.1).
Clements et al (1984) suggest that lamellar body contents when 
secreted from tubular myelin, generate a monolayer at the gas-liquid 
interface. Surfactant molecules from the monolayer may form vesicles, 
and return to the type II cells. The control of the surfactant system 
is as yet uncertain and likely to be more complex then previously 
thought as more information becomes available (Clements et al 1984).
The biosynthesis of phospholipids by the type II pneumocytes has 
been studied in detail by a number of investigators (Gluck et al 1972^ 
Farrell & Avery 1973; Rooney et al 1976).
Two biosynthetic pathways for phosphatidyl choline have been 
described by Gluck, one being active in.the very immature fetus and 
involving progressive methylation of phosphatidyl ethanolamine and the 
other, functioning in the mature fetus involving the incorporation of 
activated choline into diacylglycerol. It is now considered that the
methylation pathway is unimportant in the lung (Van Golde 1976).
Although most early work on surfactant concentrated on 
phosphatidyl choline it became obvious that other components are at
A
least as important. Hallman et al (1976) described two acidic 
phospholipids, phosphatidyl glycerol (PG) and phosphatidyl inositol 
(PI) found in amniotic and tracheal fluid. PG but not PI seemed to be
almost invariably associated with mature fetal lungs. The
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biosynthetic pathways of these two phospholipids appeared to be 
linked, the concentration of PG rising while that of PI fell.
The enzymes involved in catalysing the synthesis of the 
phospholipids may be under the influence of endogenous 
corticosteroids. Doell & Kretchmer (1964) observed that the activity 
of gut invertase could be increased using hydrocortisone. Since lung 
is a gut derivative it seemed possible that its enzymes might also be 
similarly affected and this has been shown to be true by Farrell & 
Zachman (1973) and Rooney et al (1976). A number of animal studies 
have tended to confirm the hypothesis of steroid induction of the lung 
enzymes involved in surfactant synthesis.
a) Animal studies
Liggins (1969), while studying premature delivery of fetal lambs 
infused with corticosteroids, observed partial aeration of lungs at an 
earlier than expected gestation in lambs born vaginally after 
treatment with dexamethasone. He suggested that this may be the 
result of steroid induced accelerated appearance of surfactant 
activity. De Lemos et al (1970) treated one of twin fetal lambs (8 
sets of twins) with hydrocortisone and noted acceleration of lung 
maturation in the steroid treated lambs. Further evidence for 
accelerated appearance of pulmonary surfactant in the fetus was 
provided by Kotas and Avery (1971), where lung maturation in the fetal 
rabbit was assessed by pressure/volume curves, dry weight and surface 
tension properties and by Wang et al (1971), Chiswick et al (1973), 
Motoyama et al (1971), who noted an accelerated appearance of 
osmophilic bodies in fetal lungs following steroid injection. These 
findings are supported by research demonstrating that fetal lungs of 
rabbits, lamb and humans all contain the specific glucocorticoid 
receptor considered necessary for hormonal resposiveness (Ballard &
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Ballard 1972 and 1974).
Clinical and biochemical studies in the human have tended to 
support the animal experiments, however the evidence that 
glucocorticoids have a beneficial effect on lung development in humans 
is by no means clear cut.
b) Human Clinical Studies
Following the observation in animal lungs that corticosteroids 
may cause accelerated appearance of surfactant (Liggins 1969), Liggins 
and Howie (1972) performed a controlled trial of betamethasone therapy 
to mothers threatening preterm labour or those undergoing elective 
preterm delivery in the hope of reducing the incidence of RDS. In 
babies less than 32 weeks’ gestation who had been treated for at least 
24 hours before delivery RDS occurred less often in treated babies 
than in controls. Howie and Liggins (1977) reported the results of a 
larger controlled trial and confirmed that giving antepartum 
betamethasone to mothers threatening preterm labour, reduced the 
incidence of RDS and in addition reduced the incidence of 
intraventricular haemorrhage. However, no benefit was derived from 
treatment if the baby was delivered within 24 hours or more than 7 
days from the start of treatment of if the gestational age was greater 
than 34 weeks. Most subsequent work has tended to confirm the 
findings of Liggins & Howie, (Ballard & Ballard 1976), of the 
beneficial effects of betamethasone (Block et al 1977, Schutte et al 
1980, Kennedy 1974) and also of dexamethasone (Caspi et al 1976) and 
hydrocortisone (Morrison 1978). Unfortunately not all these studies 
were double blind or had adequate controls.
In a prospective randomised study of corticosteroids in the 
management of PROM Garite et al (1981) failed to demonstrate any 
advantage of steroid treatment over conventional expectant management.
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In 1981 a large double blind randomised trial (Collaborative 
Group on Antenatal Steroid Therapy 1981) while confirming the findings 
of Liggins and Howie noted that the reduction in incidence of RDS in 
the treatment group was attributable to differences among singleton 
female infants with no effect observed in males. ' In addition non 
Caucasians seemed to respond but Caucasians did not. The study 
concluded that steroid therapy should be used selectively and with 
caution.
c) Human - Biochemical studies
Surprisingly little work has been carried out on this subject. 
Liggins and Howie (1972 and 1974) could find no consistent change in 
the L/S ratio of amniotic fluid samples taken before and after 
betamethasone treatment. However, Spellacy et al (1973) performed 
amniocentesis at 2 weekly intervals in pregnant women between 28 and 
32 weeks' gestation. One group was given oestrogen therapy, a second 
group corticosteroid and a third group, the controls, no treatment. 
There was a significantly greater rise in L/S ratio in the women 
receiving glucocorticoid treatment.
Although other small studies have tended to confirm a 
corticosteroid induced rise in L/S ratio, the effect seems to occur 
mainly after 32 weeks' gestation (Diedrich et al 1978, Ekelund et al 
1976, Zuspan et al 1977).
d) Placental transfer of cortisol
The proposed influence of exogenous corticosteroids on fetal lung 
maturity raises the possibility that corticosteroids from the mother 
may add to fetal cortisol to influence fetal lung maturity.
Leon and Murphy (1976) showed a significant correlation between 
maternal and umbilical cord venous cortisol concentrations but not
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between maternal venous and umbilical arterial blood concentrations. 
However, there is a dispute concerning an umbilical arterial/venous 
cortisol concentration gradient, which might imply a fetal secretion 
of cortisol. Although several groups of workers (Murphy & Diaz d'Aux 
1972, Leong & Murphy 1976) found higher umbilical arterial than 
umbilical venous cortisol concentrations, Cawson et al (1974) could 
detect no umbilical arterio-venous difference and Smith and Shearman 
(1974 A and B) found higher umbilical venous levels.
More recently Poulakka (1982) noted that the fetal ACTH levels 
tended to be lower in umbilical venous than umbilical arterial blood.
Although there is a concentration gradient across the placenta 
for total cortisol levels, over 90% of maternal cortisol is protein 
bound (Sandberg and Slaunwhite 1959) and not available for transfer. 
There is an increase in corticosteroid binding globulin (CBG) during 
pregnancy and the increased cortisol levels during labour and delivery 
may not exceed this rise in CBG (Slaunwhite and Sandberg 1959).
However even if this did happen, the placenta via the enzyme 11 —B
hydroxysteroid dehydrogenase, metabolises 80-85% of the cortisol 
produced by the mother to inactive cortisone (Murphy et al 1974, 
Levitz et al 1978). This may be a mechanism whereby the fetus is 
protected from maternal cortisol levels at critical stages in its
development, as cortisol is known to be an enzyme inducer (Liggins
1976).
It is likely therefore that most of the free cortisol in the 
fetal circulation originates from the fetal adrenal gland, the 
contribution of maternal cortisol being of lesser importance. It has 
been estimated that at least 75% of the cortisol in fetal plasma at 
term is of fetal origin (Beitins et al 1973). However, it may be that 
due to the large increase in maternal cortisol during labour the 
capacity of the 11 —B hydroxysteroid dehydrogenase responsible for the
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conversion of cortisol to cortisone may be overcome and that a larger 
part of the fetal cortisol is of maternal origin in the later stages 
of labour and delivery.
In addition to the above studies on the effect of exogenous 
corticosteroids on the human fetal lung there is some evidence to 
suggest a corticosteroid deficiency in RDS. Naeye et al (1971) in a 
series of 387 consecutive autopsies on human neonates, demonstrated 
that adrenal glands were 19% lighter in infants with HMD compared with 
those without HMD, the difference being a greater number of adrenal 
cortical cells in those infants who did not develop RDS. These 
workers also showed that anencephalics with little or no adrenal 
cortex had 45% less osmiophilic granules in pulmonary type 11 alveolar 
cells as did 'normal1 controls. Further evidence supporting a 
corticosteroid deficiency in RDS was provided by the measurement of 
cortisol in cord blood at delivery. Murphy (1974 A), Murphy (1974 B), 
Sybulski and Maughan (1976) have shown significantly lower levels of 
cortisol in cord blood in infants who subsequently developed RDS 
compared with unaffected infants of similar gestational age. However, 
the results of these studies were far from being clear cut. Murphy 
(1974 A) omitted clinical details of the infants, eg method of 
delivery, known to affect cortisol levels. In the series reported by 
Murphy (1974 B) one third of the babies with RDS were equal or greater 
than 35 weeks, including 3 at 40 weeks' gestation, calling into 
question the accuracy of the diagnosis of RDS or the gestational 
ageing, or both. Furthermore, when method of delivery was taken into 
account, small numbers were involved (10 with RDS and 8 without), 
although there was still a significant difference in control levels 
(P = 0.05) between the two groups. In addition Sybulski and Maughan 
(1976) concluded that whether or not RDS developed, appeared to depend 
more on the degree of prematurity than upon cortisol levels at
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delivery.
Several groups of investigators have shown that neonates 
suffering from RDS have significantly higher cortisol levels than 
infants of the same gestational age with no RDS (Klein et al 1973, 
Reynolds 1973, Baden et al 1972). In addition Reynolds (1973)
demonstrated that infants with and without RDS were equally responsive 
to ACTH administration by producing elevated corticosteroids, 
suggesting no lessened responsiveness in those with fatal HMD.
Therefore, there is some evidence to suggest an endogenous
corticosteroid deficiency antenatally in babies who subsequently
develop RDS but nothing to suggest that postnatal adrenal hypofunction 
plays a role in the pathogenesis of HMD.
Exogenous corticosteroid treatment antenatally seems to influence 
fetal lung maturity and it might be reasonable to propose that the 
effect of stress on fetal lung maturity is mediated via endogenous 
cortisol production.
In addition to the glucocorticoids, other hormones are thought to 
play a role in surfactant synthesis. Hitchcock (1979) has shown that 
thyroxine can promote lung maturation in fetal rabbit lungs and in 
vitro (Gross & Wilson 1982) and in vivo (Gross et al 1983) studies 
have suggested that the effects of glucocorticoid and thyroxine 
hormones are synergistic. Redding et al (1979) were the first to 
suggest treatment with thyroxine to accelerate lung maturation and the 
results of Mashiach et al (1979) tend to suggest that it may have some 
benefit. Thyroxine, however, does not cross the placenta and 
therefore requires to be given intraamniotically. A way round this 
may be to use TRH which readily crosses the placenta (Rooney et al 
1979).
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It has also been proposed that Prolactin may have a role to play 
in controlling surfactant production (Hauth 1978). Prolactin levels 
were found to be lower in babies developing RDS compared to babies of 
similar gestation with no respiratory problems.
The importance of thyroid hormones and prolactin in the control 
of surfactant synthesis has as yet to be ascertained.
2.3.4 Control of surfactant release
Although the production of surfactant in the type II pneumocyte 
may be controlled, at least partly by fetal adrenocortical hormones, 
it has been suggested that the release of this surface active material 
into the alveolar space may be controlled by a different mechanism 
(Chiswick et al 1973, Mescher et al 1973).
Evidence is now accumulating that the catecholamines may have an 
important role in preparing the fetus for extrauterine existence, 
especially with regard to lung function (Olver 1981). Most of this 
evidence has been obtained directly from animal experimentation and 
indirectly from clinical observation in humans where Beta 
sympathomimetic drugs have been employed in an attempt to arrest 
preterm labour.
The catecholamines are thought to be important in the clearance 
of lung fluid as discussed previously (p 37 ). In addition however to 
dehydrating fetal lungs there is also evidence to suggest that the 
catecholamines may cause an increase in surfactant release (Lawson et 
al 1978, Abdellatif & Hollingsworth 1979).
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a) Animal research
In these experiments exogenous adrenaline was infused into fetal 
sheep and neonatal rabbits with a resulting increase in lung
surfactant secretion. This effect was blocked by propranolol 
(Abdellatif & Hollingsworth 1979) implying that it was mediated via 
Beta receptors. This theory is supported by observations made on 
rabbit fetuses infused with the Beta sympathomimetic drugs isoxsuprine 
and terbutaline. The lungs of fetal rabbits treated with these drugs 
retained more air on deflation (ie were more stable) than those of 
control rabbits (Wyszogrodski et al 1974, Corbet et al 1977, Bergman 
and Hedner 1978). These observations were considered to be due to
enhanced release of surfactant.
Enhorning et al (1977) as well as finding greater surface 
activity and higher L/S ratios in isoxsuprine treated animals compared 
with controls, also noted significantly less fetal pulmonary fluid in 
treated animals. These authors also found a significant decrease in 
lamellar inclusions in type 11 pneumocytes, further evidence of
enhanced surfactant release by Beta adrenergic stimulation.
In vitro studies (Dobbs & Mason 1979) of isolated type 11 cells 
from rat lungs have shown a release of disaturated phosphatidylcholine 
on Beta adrenergic stimulation with Terbutaline. A similar study by 
Kanjanapone et al (1980) found that in addition to increased release 
of surfactant following isoxsuprine treatment there was also an 
increase in choline incorporation into disaturated phosphotidylcholine 
indicating increased surfactant synthesis in the treated group.
There is therefore evidence to suggest that, at least in some 
animal species, exogenous catecholamines cause a decrease in lung 
fluid, and an increase in surfactant synthesis and release.
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b ) Human clinical research
A number of workers have noted a reduced incidence of RDS in 
preterm babies whose mothers were treated with 'B * mimetic drugs in an 
attempt to suppress preterm labour (Kero et al 1973, Boog et al 1975, 
Hastwell 1977, Bergman & Hedner 1978). In two of these studies 
(Boogs et al 1975 and Bergman & Hedner 1978), which were both 
retrospective, a significant reduction in the incidence of RDS was 
found after treatment with a 'B' mimetic, although, in the study by 
Boog et al the difference was only statistically significant for 
infants weighing under 2300 grams.
c) Human biochemical research
Cabero et al (1979) provided some evidence to suggest that the 
same response occurs in humans as in animals after Beta mimetic 
treatment. In their study ritodrine was given orally to pregnant 
women between 33-35 weeks' gestation, following which there was a 70% 
increase in the palmitic acid concentration of amniotic fluid at the 
end of the treatment period. There is therefore some evidence that 
exogenous catecholamines and Beta sympathomimetics can influence lung 
function. However, little work has been done to show that in 
situations of stress endogenous catecholamines can bring about a 
similar improvement in lung function.
In animals, Brown et al (1981), using chronically catheterised 
fetal lamb preparations noted a correlation between endogenous AD 
concentration and lung liquid absorption during labour. However no 
such correlation of lung liquid absorption was found with NAD.
In humans, Woodman et al (1978), noted a significant correlation 
between the ratio of NAD/AD and the L/S ratio, and Artal et al (1982) 
found that mature lung profiles (ie L/S ratio 2.0 + presence of PG) 
correlated significantly with progressively rising metanephrine
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levels.
The ability of exogenous catecholamines to influence fetal lung 
maturity in animal experiments raises the possibility that transfer of 
maternal catecholamines to the fetus in conditions where the 
mother is under stress, eg during vaginal delivery, would help to 
optimise neonatal lung function. Available evidence (see below), 
however, does not lend support to the idea of placental transfer of 
catecholamines from mother to the fetus.
d) Placental transfer of catecholamines
Catecholamines in physiological concentrations do not appear to 
cross the placenta, whereas pharmacologic concentrations of poorly 
metabolised sympathomimetic drugs do have the potential of crossing 
the placenta in significant amounts (Phillipe 1983). Sandler et al 
(1963) in a small study where labelled NAD was injected into mothers 
prior to elective abortion of non viable fetuses, detected small 
amounts in umbilical venous blood but negligible amounts in fetal 
heart blood.
In vitro studies of the human placenta have demonstrated that 
catecholamines cross the placenta in very limited concentrations 
(Morgan et al 1972, Saarikoski 1974). both these studies have 
demonstrated the presence of catechol-o-methyltransferase and 
monoamine oxidase in the placenta which metabolises the catecholamines 
to inactive metabolites. The placenta would seem therefore to act as 
a barrier to the transfer of catecholamines from mother to fetus. The 
demonstration of higher catecholamines in the plasma of the fetus 
compared with the mother (Poulakka et al 1983, Jones and Greiss 1982, 
Messow-Zahn et al 1978, Inglis et al 1981), and in the umbilical 
artery compared with the umbilical vein, further support the idea of 
functional separation of the fetal and maternal sympatho adrenal
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systems.
2.3.5 Amniotic fluid phospholipids and RD5
Helmy and Hack (1962 )  were first to discover lecithin in amniotic 
fluid and a flow of fluid from the fetal lung into the amniotic fluid 
has been demonstrated by several workers (Scarpelli 1967, Dawes et al 
1972, Rethmeier & Egberts 197 5 ) .  Although Graven (1968)  had suggested 
that the amniotic fluid lecithin concentration might be used in the 
prediction of RDS it was Gluck et al (1971)  who made the major advance 
with the introduction of the L/S ratio. They investigated the 
concentrations of the phospholipids, lecithin and sphingomyelin in the 
amniotic fluid, from 18 weeks' gestation until term. Although the 
sphingomyelin concentration remained low and fairly constant 
throughout pregnancy there was a sudden increase in lecithin 
concentration around 35 weeks. They found that the ratio of lecithin 
to sphingomyelin concentration remained low and fairly constant 
throughout pregnancy whereas was a sudden increase in lecithin 
concentration around 35 weeks, which resulted in a rise in the L/S 
ratio. They found that the L/S ratio was a reliable predictor of RDS. 
Since it was introduced the L/S ratio has been used successfully 
throughout the world as a predictor of RDS (Lemons & Jaffe 1973,  
Donald et al 1973, Wagstaff & Bromham 1973,  Gluck & Kulovich 1973,  
Whitfield and Sproule 1 97 4 ) .  Harvey and Parkinson (1981 )  reviewed 42 
papers from the world literature and found that when the L/S ratio 
^ 2 . 0  the incidence of RDS was 1.5?o when L/S ratio < 2 . 0  there was a 
53?o incidence of RDS. (Liquor specimens obtained within 72 hours of 
delivery.)
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Although generally reliable the L/S ratio has certain
disadvantages.
1 A high percentage of false negative results (ie an L/S ratio
below the critical value but no RDS (Harvey & Parkinson 1981, 
Whittle et al 1981^, Whitfield & Sproule 1974, Worthington &
Smith 1978).
2 Occasional false positive results (Ie unpredicted RDS occurring
despite an adequate L/S ratio (Worthington & Smith 1978).
3 It is unreliable when the amniotic fluid has been collected
vaginally (Wagstaff et al 1974, Van Graff & Gunston 1978,
Drombroski et al 1981).
4 It is unreliable when the amniotic fluid is contaminated by 
blood or meconium (Gluck et al 1974, Van Graff & Gunston 1978).
3 Some workers have questioned the reliability of the L/S ratio
when the pregnancy is complicated by diabetes. Whitfield and 
Sproule (1974) noted the association of maternal diabetes with
11 out of 21 cases of RDS occurring despite 'safe' L/S
ratios. Other workers have confirmed the unreliability of the
L/S ratio in predicting lung maturity in diabetic pregnancies 
(Dahlenbrug et al 1977, Mueller-Heubach et al 1978).
In an effort to overcome these limitations of the L/S in 
predicting RDS, Kulovich et al (1979) developed an amniotic fluid 
phospholipid profile. This method employed two dimensional thin layer 
chromatography of the amniotic fluid and in addition to the L/S ratio 
this technique determines the presence of phospotidyl glycerol (PG) 
and phosphotidyl inositol (PI) as well as the less important 
phospholipids, phospotidyl ethanolamine (PE) and phosphotidyl serine
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(PS).
This method has proved reliable in the assessment of fetal lung 
maturity in diabetic pregnancies (Cunningham et al 1978, Kulovich & 
Gluck 1979) and the presence of PG is unaffected by contamination of 
the amniotic fluid (Strassner et al 1980, Hallman & Teramo 1981). PG 
has also shown to be reliable when the liquor was collected vaginally 
at spontaneous rupture of the membranes (Whittle et al 1981, 1982,
Brame & McKenna 1983).
Since the introduction of the amniotic fluid phospholipid profile
p
Whittle et al (1981) have shown that only the L/S ratio and the 
presence or absence of PG are important indicators of the risk of RDS, 
and that this modified profile offers an improvement in the predictive 
accuracy over the L/S ratio alone both in singleton (Whittle et al 
1981^,1982) and in multiple pregnancies (Dobbie et al 1983).
2.4 Factors which control and modify fetal lung maturity
Clearly the maturation of the fetal lungs is a complex process 
involving a number of different systems. The overall control of the 
process is uncertain for a number of reasons. Most information has 
been derived from animal experimentation which may not be necessarily 
applicable to man and the investigation of lung maturation in man is 
made more complex by a number of issues. Firstly should the best 
indicator of fetal/neonatal lung maturity be the presence of adequate 
surfactant levels in amniotic fluid/pharyngeal aspirate or should the 
neonatal respiratory performance be of greater importance? Secondly, 
difficulty in the diagnosis of RDS is often encountered. Thirdly 
other compounding factors such as mode of delivery, condition at birth 
and the vigor of neonatal resuscitation may also influence neonatal 
functional maturity. Finally, attempts to derive a 'normal' timetable
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for fetal lung maturity necessitates the study of prematurely born 
babies who, by definition, are not normal either because of the time 
of their birth or underlying maternal pathology.
The role of the stress products cortisol and the catecholamines 
has a scientific basis in animals but is less clear in the human 
(pp 35-38, 40-50).
For many years obstetricians have had the impression that certain 
pregnancy complications appear to be associated with an unusually low 
incidence of neonatal RDS. Why this should be is unclear but it was 
proposed that 'fetal stress' arising from a hostile intrauterine 
environment was a likely underlying factor.
A possible mechanism whereby stress, both physiological and 
pathological, may influence fetal lung maturity in man is outlined in 
Figure 2.2. The rise in fetal cortisol and catecholamine levels as a 
direct result of fetal stress resulting in increased surfactant 
production and release, and increased absorption of lung fluid leading 
to optimal neonatal lung function.
Chapter 3 will discuss the effect of various physiological and 
pathological factors thought to influence fetal lung maturity and will 
present the evidence for changes in the fetal stress products cortisol 
and the catecholamines as a result of these factors.
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TABLE 2.1 Chemical Composition of Surfactant
The phospholipid % composition of alveolar 
lavage fluid in the mature newborn rabbit
Phosphotidyl choline 79%
Phosphotidyl glycerol 6%
Phosphotidyl inositol 6%
Phosphotidyl ethanolamine 5%
Sphingomyelin 1So
Phosphotidyl serine 1?o
Data from Hallman 1981
Fig. 2.1. Turnover of Lung Surfactant - from Clements et 
al (1984)
Type I 
Cell
Type II 
Cell
Interstitium
E.R. = endoplasmic reticulum 
M = multivesicular body 
V = vesicles 
G = Golgi apparatus
L = Lamellar body
Capillary Lumen
Fi
g.
 
2.
2 
St
re
ss
 
an
d 
Lu
ng
 
Ma
tu
ri
ty
03
03 « 
P 
P o
< 5u <•I p
P o
o w
I— I
03
Chapter 3
Factors Which May Influence Fetal Lung Maturity
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Factors which may influence fetal lung maturity
Much clinical and biochemical evidence has suggested that certain 
obstetric factors predispose to the development of RDS, while others 
somehow cause an acceleration of the normal timing of fetal lung 
maturity (Table 3.1). The evidence, discussed below, has often been 
less than convincing and occasionally even conflicting.
These obstetric factors may influence fetal lung maturity by the 
mechanism outlined in Figure 2.2, whereby the fetal stress products 
cortisol and catecholamines represent the final common pathway 
facilitating optimal neonatal lung function. The evidence available
in the literature supporting changes in the levels of fetal cortisol
and catecholamines as a result of these obstetric factors is 
discussed.
3.1 Physiological Factors 
3.1.1. Gestational Age
a) Clinical Outcome
One of the most important factors associated with the development of 
RDS is preterm delivery. The earlier the gestational age at birth, 
the higher the incidence and severity of the condition. This has been
demonstrated in many studies (Dunn 1963, De Sa 1969, Cohen et al
1960, Usher et al 1971, Jones et al 1975). However, the observation 
that some preterm liveborn babies have mature lungs and survive while 
others of exactly the same gestational age develop RDS and die 
demonstrates clearly that other factors are involved in the
pathogenesis of RDS. This is most dramatically seen in multiple
pregnancies where some siblings develop RDS and die while their 
cosiblings do not (Pender 1972, Lemons & Jaffe 1973, Wilkinson et al
1982, Pritchard & McDonald 1976, Dobbie et al 1983).
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b ) Surfactant
Gluck & Kulovich (1973) observed, in uncomplicated pregnancies, 
that the L/S ratio rose gradually as gestational age advanced, 
reaching mature levels between 34 and 36 weeks. Similar studies have 
reported changes in the concentrations of the other amniotic fluid 
phospholipids with advancing gestational age (Kulovich, Hallman & 
Gluck 1979). Whittle (1984) reported a personal series where the PI/S 
and PG/S ratio was observed in a large group of babies where the 
gestational ages were accurately known. The quantity of PI seemed to 
remain fairly constant after rising from low levels prior to 29 weeks, 
while the concentration of PG rises steadily towards term. However, 
gestational age is not the only determinant of surfactant 
concentration. This is well demonstrated in multiple pregnancies in 
which the babies are of the same gestational age and have been 
subjected to similar obstetric complications. Dobbie et al (1983) 
have shown that the correlation of L/S ratio between pairs of twins is 
poor and, although much improved, is not perfect for PG.
c) Fetal cortisol
1) Adrenal mass
The fetal adrenal cortex occupies 0.5% of total body volume 
compared with mature adult cortex which occupies 0.01% of total body 
volume. There is an increase of relative fetal adrenal mass 
throughout pregnancy. This increase, however, is most marked between 
32-36 weeks (Buster 1980).
2) Umbilical cord plasma cortisol
Smith and Shearman (1974 A & B)) showed a rise in total umbilical 
cord plasma corticosteroids throughout gestation with a surge at 35-37 
weeks, followed by a gradual decline thereafter both with vaginal
57
delivery and with caesarean section. In the caesarean section study, 
however, there were very few cases born less than 35 weeks and 
unusually they found umbilical venous levels to be higher than 
umbilical arterial levels which is in contrast to many studies. 
Gestational age was assessed 'within the usual clinical limits' and 
therefore may not have been very accurate.
Goldkrand et al (1976) studying babies delivered vaginally, found 
significantly higher cord cortisol levels at less than 36 weeks 
gestation compared with greater than 37^ weeks. However, 
Roopnarinesingh et al (1977) found no significant change in mean cord 
plasma cortisol values with advancing gestational age after 33 weeks 
gestation and Pokoly (1973) found that a small group of preterm babies 
delivered by elective caesarean section had similar cortisol levels as 
term babies delivered by caesarean section, and they therefore did not 
demonstrate therefore a rise of fetal cortisol as term approached. 
Murphy (1982) noted a slight fall in cord plasma cortisol from 15 to 
20 weeks and then a rise to 35 weeks followed by a further rise 
between 37 weeks and 40 weeks. These changes occurred in both 
elective caesarean section group and vaginally delivered groups. 
Gestational age was based on last menstrual period in the 'mature' 
babies and on neonatal assessment in the preterm group.
3) Amniotic fluid cortisol
Murphy et al (1975) and Fencl and Tulchinsky (1975) have shown 
that amniotic fluid cortisol rises with gestational age, Murphy et al 
noting a late surge just before term.
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4) Fetal lung cortisol-cortisone metabolism
Murphy (1979) has shown that with advancing gestational age, the 
fetal lung's ability to convert cortisol to cortisone diminishes, 
resulting in increased intracellular cortisol bioavailability. This 
process may be related to maturation of the fetal lung.
The consenses of opinion would seem to indicate that as gestation 
advances there is an increase in fetal corticoids.
d) Fetal catecholamines
In the fetus catecholamines are produced in the adrenal medulla, 
adrenergic nerve endings and in the extra medullary paraaortic 
chromaffin tissue.’ The largest masses of extramedullary chromaffin 
tissue (the origins of Zukerkandl) are situated at the origin of the 
inferior mesenteric artery and have a higher concentration of 
catecholamines than any other major organ, including the brain and 
adrenal medulla (Greenberg & Lind 1961). The extra adrenal chromaffin 
tissue has been shown to be identical developmentally and structurally 
to the phaechromocytes of the adrenal medulla (Coupland 1952).
In a study of the function of the extra adrenal chromaffin tissue 
West et al (1953) noted that by 20-^ 22 weeks the tissue was 
cytologically mature and thereafter underwent no change until they 
begin to fibrose after birth. Pharmacologically the extra adrenal 
chromaffin tissue contains appreciable quantities of NAD, the 
concentration of which increases from 16 weeks until term. The study 
had certain drawbacks. It employed a biological assay for the 
catecholamine measurement and examination of the fetal tissue took 
place 30 hours after death in several cases. Histologic studies by 
Hervonen (1971) have shown an intimate relationship between the 
phaechromocytes of the extramedullary chromaffin tissue and the well 
developed capillary sinusoidal networks of the human fetus,
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emphasizing the resemblance of this tissue to other endocrine glands.
Unlike the adrenal medulla, the extramedullary chromaffin tissues 
are poorly innervated and show no response to splanchnic nerve 
stimulation (Muscholl & Vogt 1964, Hervonen 1971).
Compared to the extramedullary chromaffin tissue, the adrenal 
medulla is much later in attaining structural maturity. Its 
chromaffin tissue being scanty and immature during fetal life. It 
contains much smaller amounts of NAD than the extramedullary 
chromaffin tissue, with AD only appearing in appreciable amounts after 
birth (West et al 1953). After birth the adrenal medulla grows 
rapidly and by the end of the first year, resembles the adult gland.
Niemineva and Pekkarinen (1952) noted that in the adrenals of 
human fetuses (Petal weight range 230-4270 gm), 3/4 of the
catecholamine content was NAD, whereas Greenberg and Lind (1961) found 
equal concentrations of NAD and AD in the adrenals of fetuses weighing 
37-635 grams. Experiments with rabbits (Brundin 1966) and rats 
(Margolis 1966) seem to confirm the finding in humans by West et al 
(1953) that AD only increases near term and early postnatal life.
Although it is generally assumed that a high proportion of NAD in 
the adrenal medulla is indicative of immaturity and that the 
percentage of AD increases slowly with age, there have been few 
studies of the catecholamine content during fetal and neonatal life 
(Comline & Silver 1966).
The maturation of the fetal adrenal appears to involve two main 
factors. Firstly the development of splanchnic innervation to the 
adrenal medulla and secondly the ability of the adrenal cortex to 
secrete corticosteroids (Artal 1980).
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Several histological studies have shown that the adrenal 
medullary cells are richly innervated, from 14 weeks' gestation, with 
preganglionic nerves which synapse with phaechromocytes (Coupland & 
Weakley 1970, Hervonen 1971, Turkel & Itabashi 1974). Neural impulses 
are relayed in centres in the posterior hypothalamus to the adrenal 
medulla via the splanchnic nerves, stimulation of which causes a 
significant release of catecholamines from the adrenal medulla (Artal 
1980). The gestational age at which the adrenal medulla becomes 
sensitive to splanchnic nerve stimulation, in the human, is unknown. 
There does appear to be an interspecies variation in the timing of the 
response. In the fetal lamb the adrenal medulla becomes responsive to 
nerve stimulation at 80-100 days' gestation (equivalent to 24-28 weeks 
in humans), whereas in the fetal calf there is only a slow and small 
increase in the response of the adrenal medulla to nerve stimulation 
throughout gestation. It is felt that the human fetus resembles the 
fetal calf in this respect (Comline & Silver 1966).
The adrenal medulla, situated in close proximity to the cortex is 
exposed to increasing glucocorticoid secretion as gestation advances, 
the glucorticoids are known to regulate the activity of 
phenylethanolamine-N-methyl transferase (PNMT) (Wurtman and Axelrod 
1966). This enzyme is necessary for the n-methylation of NAD thus 
converting it to AD, and is mainly located in the adrenal medulla. 
The extramedullary chromaffin tissue, in contrast, contains only small 
amounts of this enzyme (Gehnser & Studnitz 1969). Therefore, as 
gestation advances the adrenal medulla is exposed to increasing 
concentrations of glucocorticoids encouraging the n-methylation of NAD 
and resulting in increasing concentrations of AD.
There have been few studies measuring catecholamines throughout 
gestation in humans. Studies on amniotic fluid catecholamine 
concentrations have demonstrated increasing amounts of both AD and NAD
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throughout gestation (Phillipe and Ryan 1981, Divers et al 1981 ;^ . 
However, while Phillipe et al found that NAD predominated over AD, 
Divers et al found the opposite to be true. Woodman et al (1978) 
discovered on increase in the NAD/AD ratio in amniotic fluid between 
37 and A3 weeks' gestation and they suggested that in late pregnancy 
the fetus excretes NAD in increasingly greater amounts than AD. 
Lagercrantz and Bistoletti (1973) found that preterm infants had lower 
UA and UV catecholamine levels than term infants after both uneventful 
deliveries and intrauterine asphyxia. However, the percentage of AD 
relative to the total catecholamine concentrations was essentially the 
same in both term and preterm infants. A recent paper (Newnham et al 
1984) measured UA, NAD and AD concentrations in 36 preterm fetuses and 
found significantly greater AD levels in preterm than term fetuses.
3.1.2 Labour and Mode of delivery
a) Clinical outcome
Although Donald et al (1973) and Garbert et al (1973) could find 
no evidence that the mode of delivery had any bearing on the 
subsequent development of RDS, several large retrospective surveys 
have shown that delivery by caesarean section predisposes the neonate 
to RDS and death from hyaline membrane disease (Cohen et al 1960, 
Usher et al 1971) Fedrick and Butler (1972) examined the data of the 
1958 British Perinatal Mortality Survey and found an increased chance 
of dying from hyaline membrane disease (HMD) if the baby was delivered 
by elective caesarean section compared with delivery by caesarean 
section after the onset of labour or vaginal delivery. Unfortunately 
in the other studies quoted above, which link caesarean section with 
an increased incidence of RDS, no distinction was made between 
elective caesarean section and caesarean section performed during
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labour. The evidence presented by Fedrick and Butler was based on the 
necropsy diagnosis of HMD and therefore there could be little 
confusion over diagnosis.
b) Surfactant
Labour has been considered to facilitate the normal adaptation of 
the lungs at birth. This may be achieved by promoting both clearance 
of lung fluid (p 36) and release and increased production of 
surfactant. Cabero et al (1976) and Craven et al (1976) found higher 
L/S ratios and higher lecithin concentrations during labour compared 
with before the onset of labour, suggesting that labour causes a 
significant increase in surfactant. Studies in which serial liquor 
samples were obtained during labour (Whittle et al 1977 and 1981, 
Whittle & Hill 1980) have demonstrated that in some labours the L/S 
ratios rise, in some they stay the same and in some they decrease. 
There was a tendency to short labours in the labours where a rise in 
L/S ratio occurred. Whittle et al (1981) have demonstrated reduced 
fetal heart rate variability in long labours in which the L/S ratio 
fell and postulated that the fetus under stress retained its 
surfactant producing high concentrations in the lung passages, thus 
resulting in optimal lung function.
c) Cortisol
Many studies have shown that in term pregnancies the levels of 
corticosteroids in umbilical cord blood is significantly higher 
following vaginal delivery compared with elective caesarean sections 
(Cawson et al 1974, Weekes et al 1976, Goldkrand et al 1976, Talbert 
et al 1977, Isherwood et al 1981).
Umbilical cord ACTH levels have also been found to be higher 
after vaginal delivery compared with elective caesarean section (Arai
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et al 1976, Poulakka et al 1982, Sybulski & Maughan 1976). Whether 
the high levels of corticosteroids observed are due to the stress of 
labour itself or to the process of initiation of labour in a similar 
manner to the sheep has been the subject of much debate. The finding 
of higher cortisol levels in cord blood after vaginal delivery of 
spontaneous onset compared with induced labour has led some workers to 
favour the initiation of labour theory (Cawson et al 1974, Goldkrand 
et al 1976). However, supportive evidence for higher cord 
corticosteroid levels in spontaneous compared with induced labour has 
not been forthcoming (Isherwood et al 1981, Weekes et al 1976, 
Sybulski & Maughan 1976, Pokoly 1973).
Ohrlander et al (1976), using fetal scalp blood samples found 
that the initial plasma cortisol levels did not differ between 
spontaneous and induced labours but rose equally in both during 
labour.
It would seem more likely therefore that the higher levels of 
cord cortisol observed in vaginal delivery compared with elective 
caesarean section is a result of the stress of labour rather than a 
cause of its initiation.
d) Catecholamines
Several studies of the term human fetus have now demonstrated 
significantly higher cord blood catecholamine levels in those babies 
undergoing the stress of vaginal delivery compared with those 
delivered by elective caesarean section (Inglis et al 1981, Falconer & 
Lake 1982, Poulakka et al 1983, Irestedt et al 1982, Jones and Greiss 
1982). Although not all studies have found this (Eliot et al 1980). 
When vaginal delivery was achieved by instrumental manipulation, eg 
obstetric forceps, this has been associated with significantly higher
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concentration of umbilical arterial NAD than normal vertex deliveries 
(Falconer & Lake 1982). The highest cord catecholamine levels have 
been noted in babies undergoing vaginal breech deliveries (Falconer & 
Lake 1982, Poulakka 1982, Blouquit et al 1979). The high levels of 
circulating catecholamines in the human term fetus after vaginal 
delivery seem to return to normal resting adult levels within 12-48 
hours (Eliot et al 1980,Leonetti et al 1980). In a study of fetal 
catecholamine release in preterm delivery Newnham et al (1984) found 
similar cord catecholamine concentrations in infants delivered 
vaginally and by caesarean section (both elective caesarean section 
and after labour).
3.1.3. Twins
a) Clinical Outcome
RDS appears to be more frequent in twins than in singletons and 
this increase cannot be entirely accounted for by the higher 
prematurity rate of twins over singletons (Myrianthopolous et al 
1971).
The second born of twins appears to be at greater risk than the 
first born for the development of RDS (Farr 1973, Verduzco et al 1976, 
Kenny et al 1977, Neligan et al 1969, Rokos et al 1968). However, 
Usher (1967) and Silverman and Nisihara (1937) found no difference in 
incidence of RDS in first or second born twins.
The higher incidence of RDS in second born twins has been 
attributed to perinatal asphyxia (Rokos et al 1968, Verduzco et al 
1976). However Kenney et al (1977) in a study of premature twins felt 
the role of birth asphyxia in the development of RDS was minor and 
generally overemphasized.
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b) Surfactant
Parkinson et al (1980) noted that twins had significantly lower 
pharyngeal L/S ratio than singletons born between 29 and 35 weeks. 
Obladen and Gluck (1977) have shown that twins with and without RDS 
have markedly different phospholipids, although several reports have 
shown a good correlation of amniotic fluid phospholipids between 
cotwins and no statistical difference between twin one and twin two 
(Spellacy et al 1977, Sims et al 1976, Parkinson et al 1980, Norman et 
al 1983). However, in sporadic reports of individual twin pregnancies 
in which only one twin is affected it seems that the second born 
almost always has the more immature phospholipids and develops RDS 
(Caspi et al 1975, Gluck et al 1974, Dobbie et al 1983). Also there 
appears to be a similar relationship to birth order and lung maturity 
in triplets (Lemons & Jaffe 1973, Pender 1972, Weller et al 1976, 
Dobbie et al 1983), quadruplets, (Weller et al 1976, Wilkinson et al 
1982), and quintuplets (Pritchard & McDonald 1976). The reason for 
this is obscure and is generally attributable to birth asphyxia. 
However, Weller et al (1976) postulated that there may be a link 
between pulmonary maturation of the presenting infant and the onset of 
labour.
c) Cortisol
Goldkrand (1978) found similar cord cortisol levels in three sets 
of twins compared with singletons. Norman et al (1983) found that 
amniotic fluid glucocorticoids were similar in twin one and two before 
labour, but that during labour concentrations of glucocorticoids were 
significantly increased in twin one compared with twin two.
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d) Catecholamines
Poulakka et al (1983) studying 7 sets of twins found a 10-fold 
increase in noradrenaline concentration in twin two compared with twin 
one.
3.1.4 Genetic Factors
a) Clinical outcome
Several workers have now suggested that genetic factors may be 
important in determining which babies develop RDS. Males account for 
a disproportionate number of deaths compared with females (Farrell & 
Wood 1976) and black preterm neonates appear to have a lower incidence 
of fatal HMD/RDS than whites (Fujiwara & Froelick 1966, Farrel & Wood 
1976).
b) Surfactant
In a study of healthy pregnant Nigerian women, Olowe and 
Akinkugbe (1978) found that the L/S ratios were significantly higher 
for a given gestational age than those obtained from a North American 
community. Indeed it is apparently rare to find RDS in Nigerian 
babies.
Myrianthopoulos et al (1971) and Verduzco et al (1976) found a 
significantly higher concordance rate among monozygotic than dizygotic 
twin pairs for the occurrence of RDS. In addition Dobbie et al (1983) 
noted an improved correlation for the L/S, PG/S and PI/S ratios 
between co-twins for monozygotic compared with dizygotic twin pairs, 
again suggesting that genetic factors are of some aetiologic 
importance in the development of RDS.
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c) Cortisol
Although Furuhashi et al (1982) found significantly higher cord 
serum cortisol levels in male compared with female neonates, Murphy 
(1982) and Roopnarinesingh et al (1977) could find no sex differences 
in cord serum cortisol levels.
d) Catecholamines
Padbury et al (1981) provided evidence suggesting that fetal 
catecholamines play a significant role in the sex difference of 
pulmonary maturity. they found significantly more AD in the fetal 
adrenal gland of the female rabbit fetus and the ratio of AD to total 
catecholamine content in the adrenal gland was greater in the female 
fetus. They also found a greater number of adrenergic receptors in 
the fetal lung of the female fetus.
However, in humans Padbury et al (1981) were unable to find any 
sex differences in plasma noradrenaline or adrenaline levels or in 
responsiveness.
3.2 Pathological factors - obstetric complications
3.2.1 Preterm rupture of membranes (PROM)
There is some evidence to suggest that premature rupture of the 
membranes in preterm pregnancy protects against development of RDS in 
the neonate. However, despite considerable research there is no 
general agreement regarding this.
a) Clinical outcome
Mead (1980) in a review of the management of patients with 
premature rupture of the membranes considered that there was 
approximately equal evidence to support or refute the claim that PROM 
accelerates fetal lung maturity.
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Of the retrospective studies supporting a beneficial effect of 
PROM, Alden et al (1972) demonstrated an increased survival rate if 
PROM were present but the incidence of RDS was unaffected. Lee et al
(1976), Yoon & Harper (1973), Chiswick & Burnard (1973), Sell & Harris
(1977) all showed a decreased incidence of RDS with PROM for more than
24 hours. Lee et al (1976) noted the effect to be limited to neonates
weighing between 1500-2300 g and was not beneficial under 1500 g. 
This is in contrast to Miller et al (1978) who found a relationship 
between increased duration of ruptured membranes and a decreased 
incidence of RDS only in the 1000-1500 g weight group and the 
incidence of RDS was unaffected when birth weight was greater than
1500 g. Thibeault & Emmanoulides (1977) found only a decreased
incidence of RDS after 48 hours of ruptured membranes, whereas
Berkowitz et al (1976 & 1978) found a beneficial effect after 16
hours. Berkowitz et al (1976) found a decreased incidence of RDS in 
neonates at equal or less than 32 weeks1 gestation but not between 32- 
36 weeks. This contrasts with Lee et al (1976) and Berkowitz et al
(1978) who found a statistically significant decrease in RDS only in 
neonates of 31 weeks or older gestational age.
In a prospective study of 133 cases Worthington et al (1977) 
found a statistically significant decrease in the incidence of RDS in 
newborn infants of equal or greater than 28 weeks and birth weight 
greater than 1000 g. However, they found no relation between duration 
of ruptured membranes and protection from RDS and suggested that fetal 
lung maturity occurs before membrane rupture. In contrast Richardson 
et al (1974) suggested that the incidence of RDS is inversely 
proportional to the duration of membrane rupture. Another two smaller 
prospective studies, Bauer et al (1974) - 17 cases and Cohen et al 
1976) - 12 cases, support the theory of acceleration of fetal lung
maturity following PROM.
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Although the above retrospective and prospective surveys seem to 
suggest a beneficial effect from PROM this has not been a universal 
finding. Several retrospective surveys - Quirk et al (1979), Dimmick 
et al (1976), Barrada et al (1977), Schreiber & Beneditti (1980), 
Dluholcky et al (1976), including two large studies by Jones et al
(1975) and Bada et al (1976) failed to show benefit from prolonged 
rupture of the membranes in the reduction of HMD.
Similarly prospective studies by Christensen et al (1976) and 
Taeusch et al (1979) failed to show any protective effect of prolonged 
rupture of membranes.
The literature regarding the effect of premature rupture of the 
membranes on the incidence of RDS remains confusing, with
approximately equal evidence on either side. Retrospective studies 
have many disadvantages, eg difficulty in determining the time of 
ruptured membranes, confusion between RDS and respiratory infection 
and inaccuracy in gestational ageing. There are few prospective
studies and most involve small numbers.
b) Surfactant
Biochemical studies involving measurement of the surface active 
phospholipids in the amniotic fluid do give a clearer picture and tend 
to support the idea of a beneficial effect of PROM. Gluck et al 
(1972? and Gluck and Kulovich (1973) noted an earlier appearance of a 
mature amniotic fluid L/S ratio in pregnancies complicated by PROM 
compared with normal pregnancies. Richardson et al (1974) measured 
L/S ratios (liquor obtained by amniocentesis) serially in a number of 
cases with spontaneous PROM and showed an 'acceleration' or increasing 
L/S ratio independent of gestational age, implying an acceleration of 
lung maturity. Kulovich and Gluck (1979), Obladen et al (1979) and
Bustos et al (1979) observed an earlier appearance of PG in
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pregnancies complicated by PROM compared with normal pregnancies. 
Whittle et al (1983) observed the early appearance of PG, prior to a 
mature L/S ratio in complicated pregnancies. The early appearance of 
PG was particularly striking in amniotic fluids obtained after PROM, 
although the duration of membrane rupture before sampling did not 
correlate significantly with the presence of either PG or a mature L/S 
ratio. In a study of vaginal pool phospholipids in the management of 
PROM Brame and MacKenna (1983) found 36 patients in whom PG was 
initially absent and later appeared, (average number of days required 
for PG appearance was 3 to 9). None of these babies developed RDS. 
In addition Rajegowda et al (1973) noted the absence of RDS following 
PROM in one sib of a set of twins in two cases.
c) Cortisol
Preterm rupture of the membranes has been associated both with a 
reduced incidence of RDS and elevated cord blood and amniotic fluid 
cortisol levels (Murphy 1974® Bauer et al 1974, Cohen et al 1976), 
although this has not been a universal finding (Sybulski 1977).
d) Catecholamines
Blouquit and co-workers (1979), in a small series, found 
significantly raised cord catecholamine levels in pregnancies 
complicated by PROM (12 cases) compared with normal pregnancies (20 
cases).
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3.2.2 Hypertension in Pregnancy
a) Clinical outcome
Although some studies have shown a reduced incidence of RDS when 
the mother has hypertension (both toxaemia and essential hypertension) 
Chiswick & Burnard 1973, Lee et al 1976), a large retrospective review 
by Jones et al (1975) failed to show any relationship between toxaemia 
and the occurance of RDS. In addition Lee et al (1976) only found a 
reduced incidence of RDS when the birth weight was greater than 1500 g 
or gestational age greater than 32 weeks.
b) Surfactant
The early appearance of a mature L/S ratio (Gluck & Kulovich 
1973, Aubry et al 1976) or more recently PG (Bustos et al 1979, 
Kulovich & Gluck 1979, Yambao et al 1981), has been proposed as 
evidence of acceleration of fetal lung maturity when hypertension 
complicates pregnancy. However, some studies disagree. Doran et al
(1976) failed to find a mature L/S ratio in advance of normal in 
hypertensive pregnancies and Skjaeraasen (1979) noted a significantly 
delayed surfactant synthesis after 37 weeks' gestation.
c) Cortisol
Raised cortisol levels in umbilical cord blood has been noted in 
pregnancies complicated by hypertension compared with normal 
pregnancies, by some workers (Goldkrand 1978) but not by others 
(Roopnarinesingh et al 1977).
d) Catecholamines
Several workers have measured maternal plasma catecholamines in 
women who developed pregnancy induced hypertension. Some groups found 
higher maternal catecholamines in pregnancy induced hypertension
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compared with normal pregnancies (Sammour et al 1980, Davey & MacNab 
1981, Poland & Lucas 1980). Others, however,, found the opposite 
(Tunbridge & Donnai 1981, Natrajam et al 1982). Sammour et al (1980) 
also found higher cord blood catecholamines in pregnancies complicated 
by preeclampsia compared with normal pregnancies.
3.2.3 Intrauterine Growth Retardation
a) Clinical outcome
It is a commonly held opinion that intrauterine growth retardation 
(IUGR) protects the fetus from developing RDS, chronic intrauterine 
stress in some way enhancing lung maturation, but objective evidence 
for this is scanty.
Procaindy et al (1980) compared 19 small for gestational age 
infants with 19 appropriately grown, matched for gestation, apgars, 
prolonged rupture of the membranes, delivery, survival rate, steroids, 
sex and twinning and found a higher evidence of HMD and 
intraventricular haemorrhage in the appropriately grown infants.
b) Surfactant
Biochemical evidence of acceleration of fetal lung maturity in 
growth retarded fetuses is confusing. Gunston and Davey (1978) 
measuring total amniotic fluid phospolipids, could find no evidence 
that IUGR accelerates pulmonary maturity in the fetus and the finding 
of early pulmonary maturity does not indicate IUGR.
Some workers have found lower L/S ratios in IUGR pregnancies than 
a normal reference group (Doran et al 1976, Skjaeraasen 1979, Dyson et 
al 1973, Dewhurst et al 1973). Others, however, have found higher 
concentrations of phospholipids in the amniotic fluid of IUGR fetuses 
(Fairbrother et al 1973, Sher et al 1981).
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In a retrospective survey of 82 pregnancies resulting in the 
birth of a baby weighing less than 2.7 kg, Gross et al (1981) found a 
significantly higher percentage of PG and L/S ratio in a small for 
gestational age group than an appropriately grown control group. 
However, although there was a similar incidence of maternal 
complications in both groups, the gestational age was significantly 
greater in the small for gestational age group implying that the 
'acceleration of lung maturity' noted was not necessarily due to IUGR.
c) Cortisol
IUGR and meconium stained liquor have both resulted in elevated 
cord cortisol levels compared with normal pregnancies (Sybulski 1977).
Whether elevated cortisol levels in obstetric complications cause 
an acceleration of fetal lung maturity is debatable, as no good 
correlation has been found between the L/S ratio and amniotic fluid or 
cord blood corticosteroids (Sivakumeran et al 1975, Whittle & Hill 
1980), although there is an increasing trend in both amniotic fluid 
corticosteroids and L/S ratio as term approaches (Sivakumaran et al 
1975). Norman et al (1983) made the interesting observation that 
during labour there was a rise in amniotic fluid glucorticoids which 
accompanied a rise in L/S ratio in twin one but not twin two.
There is therefore evidence which suggests that treatment of the 
pregnant woman and hence the fetus with exogenous corticosteroids can 
cause enzymatic induction resulting in elevated lung surfactant and a 
decreased incidence of RDS. Whether conditions which chronically 
stress the fetus can achieve accelerated maturation of the fetal lung 
via endogenous corticosteroids, remains debatable.
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d) Catecholamines
Divers et al (1981) discovered significant elevations of 
catecholamines and catecholamine metabolites in pregnancies resulting 
in IUGR babies compared with normal infants, suggesting an increase in 
adrenergic activity in IUGR as a response to chronic stress in utero.
3.2.4 Antepartum Haemorrhage
The evidence that maternal antepartum haemorrhage causes 
acceleration of fetal lung maturity is unconvincing.
a) Clinical outcome
Rogers and Greenwald (1936) reported an increased incidence of 
antepartum haemorrhage in pregnancies complicated by HMD and in 2 
large retrospective surveys, either maternal bleeding was associated 
with an increased incidence of RDS (Cohen et al 1960) or no 
protective effect of APH could be shown (Jones et al 1975).
b) Surfactant
Although one particular group of research workers (Gluck et al 
1972 B, Gluck & Kulovich 1973, Gould- et al 1977) claimed an 
acceleration of fetal lung maturity in association with chronic 
retroplacental bleeding, only small numbers were involved.
c) Cortisol
No work appears to have been carried out on the fetal cortisol 
response to maternal haemorrhage.
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cl) Catecholamines
Although no work appears to have been carried out in humans on 
the catecholamine response of the fetus to maternal haemorrhage, 
experiments in animal models have given us insight into the possible 
outcome. Artal et al (1979/* using chronically instrumented pregnant 
ewes and their fetuses, found that a maternal blood volume depletion 
of 30?o was needed to induce significant changes in fetal homeostasis. 
This reduction of maternal blood volume resulted in a 21-fold rise in 
NAD and a 150-fold rise in AD in the fetal circulation. The maternal 
catecholamines which were also raised returned rapidly to normal in 
the recovery period in the ewe but remained elevated for much longer 
in the fetus. This may be a reflection of reduced placental perfusion 
or an inability of the fetus to metabolise the high levels of 
catecholamines.
3.2.5 Birth Asphyxia
a) Clinical outcome
Although chronic stress in utero has been linked with 
acceleration of lung maturity in many conditions, acute perinatal 
stress in the form of birth asphyxia is thought to be a risk factor 
leading to or aggravating RDS. Birth asphyxia has been implicated in 
two ways, firstly by causing a decrease in pulmonary vascular 
perfusion leading to ischaemia (Chu et al 1967) and secondly as a 
result of acidosis at cellular level causing a decrease in production 
of phospholipids (Merritt & Farrell 1976).
The incidence of RDS has been shown to be higher among infants 
with abnormal fetal heart rate patterns (Martin et al 1974, Hobel et 
al 1972). Several authors consider that asphyxia plays a central role 
in RDS (James 1959, De Sa 1969, Bruns et al 1961). In addition, Jones 
et al (1975) noted that low apgar scores were associated with an
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increased incidence of RDS.
b) Surfactant
Worthington and Smith (1978) noted that all infants with an L/S 
ratio greater than 2 who developed RDS had evidence of asphyxia. This 
confirmed a previous report by Donald et al (1973). An explanation 
for the effects of acidosis on the RDS was provided by Merritt and 
Farrell (1976) and Smith and Torday (1974). These workers showed that 
in rat and rabbit lung preparations, metabolic acidosis decreased 
lecithin biosynthesis in vitro.
However, recent work by Thibeault et al (1984) suggests that 
acidosis is not such a major factor in the development of RDS as has 
been thought.
c) Cortisol
It has been shown that intrauterine hypoxia and acidosis in the 
full term human fetus results in an increase in endogenous secretion 
of cortisol (Martinsen et al 1982).
d) Catecholamines
Comline et al (1965) studying the factors responsible for 
stimulation of the adrenal medulla during asphyxia in the fetal lamb, 
found that both direct stimulation by hypoxia and indirect stimulation 
via splanchnic nerves caused secretion of catecholamines by the fetal 
chromaffin tissue.
In early gestation the direct response predominated, however, as 
gestation advanced and the fetus matured the indirect response became 
more important and this coincided with the secretion of significant 
amounts of adrenaline. They also found that hypoxia was the main
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stimulator of fetal chromaffin tissue, with acidosis, and hypercarbia 
having little effect on catecholamine secretion during fetal life.
In the human fetus several workers have demonstrated 
significantly raised catecholamine levels in the presence of low apgar 
scores or low cord pH (Nylund et al 1979, Nakai and Yamada 1978, 
Blouquit et al 1979, Bistoletti et al 1983, Padbury et al 1982, 
Messow-Zahn et al 1978, Falconer & Lake 1982). Similar catecholamine 
responses in the preterm human fetus have also been demonstrated 
(Newnham et al 1984).
FHR tracings indicative of fetal distress, eg moderate/severe 
variable decelerations and late decelerations have been associated 
with significantly raised concentrations of catecholamines (Bistoletti 
et al 1983, Padbury et al 1982). Hervonen and Korkala (1972) 
demonstrated that human fetal chromaffin tissue could respond to 
hypoxia. They studied the effect of hypoxia on the catecholamine 
content of human fetal abdominal paraganglia and adrenal medulla using 
extra uterine perfusion techniques on second trimester previable 
fetuses obtained at hysterotomy. They found that the adrenal medulla 
did not respond to hypoxia as clearly as the paraganglia. They 
concluded that in hypoxia release of catecholamines by the paraganglia 
was caused by direct stimulation of the paraganglionic cells as no 
functional nerve endings could be demonstrated at this gestational age 
during fetal life. They considered that the effect of hypoxia on 
medullary chromaffin cells was mediated by the preganglionic 
innervation and it may be that this alternative catecholamine 
secretion mechanism would be dominant at term. However, during the 
second trimester, the direct hormonal regulation of the paraganglia 
seems to be dominant.
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3.2.6 Maternal Diabetes
a) Clinical outcome
Epidemiological studies have shown that babies born to diabetic 
mothers are more prone to develop RDS (De Sa 1969, Farrell & Avery 
1975).
b) Surfactant
Gluck and Kulovich (1973) and Gluck et al, (1972)B were the first 
to report a delay in the normal L/S ratio maturation in diabetic 
pregnancies. Class A, B and C diabetics showed a 1-2 week delay in 
maturation whilst class D and E diabetics showed an accelerated 
maturation. Whitfield et al (1972 and 1973) suggested that the normal 
terminal rise in L/S ratios did not occur in diabetic pregnancies and 
in some cases there was a fall in L/S ratio when serial liquor samples 
were taken. These original observations have been confirmed by other 
workers (Polishuk et al 1973, Aubry et al 1976, Singh et al 1974). 
However, Dahlenburg et al (1977) found a similar rise in L/S ratio in 
class A,B,C diabetics compared with non diabetics and little 
correlation with gestational age and L/S ratio in classes D,F and R 
diabetics, but almost one third of those with an L/S ratio greater 
than 2 developed RDS. The occurrence of RDS in association with an 
L/S ratio equal or greater than 2 has often been reported in diabetic 
pregnancies (Donald et al 1973, Farrell 1976, Gabert et al 1973, Dunn 
et al 1974, Hueller-Heubach et al 1978). Cunningham et al (1978) 
found reduced or absent PG in diabetic amniotic fluids between 34 and 
37 weeks' gestation, RDS occurring in 6 diabetic mothers delivered 
preterm with L/S ratios equal or greater than 2 - PG was absent in 5 
of the cases. Kulovich and Gluck (1979) noted a significant delay in 
the appearance of PG in pregnancy induced (Class A) diabetics. They 
also felt that the appearance of PG marks the 'final' maturation of
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surfactant, and that after the appearance of PG a diabetic pregnancy 
of any class can be safely delivered free of RDS.
Recent studies, however, (James et al 1984) question the
assumption that there is a delay in fetal lung maturation in diabetic 
pregnancies.
c) Cortisol
No significant differences in cord blood or amniotic fluid 
cortisol has been found in diabetic compared with normal pregnancies 
(Sybulski 1977, Goldkrand 1978).
d) Catecholamines
While Stern et al (1968) found a diminished catecholamine 
excretion rate in newborn infants born to diabetic mothers, other 
researchers (Young et al 1979, Artal et al 1982) found higher
umbilical arterial (UA) and umbilical venous (UV) catecholamines in 
diabetic compared with normal mothers indicating an excessive sympatho 
adrenal activity at birth in infants of diabetic mothers. Hertel et 
al (1982) found that while there was no statistically significant 
difference in the UA, NAD and AD levels in infants of diabetic 
compared with normal mothers at birth, by 2 hours post parturn the NAD 
and AD levels were significantly higher in infants of diabetic mothers 
compared with controls.
80
There is therefore evidence in the literature for changes in the 
fetal stress hormones cortisol and catecholamines in each of the 
factors thought to influence fetal lung maturity, (Table 3.1) and this 
lends support to the idea of a final common pathway linking stress and 
lung maturity as outlined in Figure 2.2.
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TABLE 3.1 Factors considered to influence
Factors Enhancing 
Lung Maturity
LABOUR
PROM
HYPERTENSION
IUGR
FEMALE
fetal lung maturity
Factors Predisposing 
To RDS
ELECTIVE CAESAREAN SECTION
BIRTH ASPHYXIA
DIABETES
2nd TWIN
MALE
CHAPTER 4
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Aims o f  th e  S tudy
1 To evaluate the effect of obstetric factors on
neonatal lung maturity.
The factors studied are gestational age (Chapter 6), method 
of delivery (Chapter 7), multiple pregnancy (Chapter 8), 
condition of the infant at birth (Chapter 9) and various 
obstetric complications (Chapter 10).
2 To investigate the control of respiratory maturational
processes (Chapters 11, 12 and 13).
3 To evaluate human fetal adrenal cortical and medullary
activity from mid-trimester until term (Chapters 6 and 7).
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Materials and Methods
5.1 Subjects
A total of 381 babies was investigated in this study. Figure 5.1 
shows the distribution of gestational ages and Figure 5.2 shows the 
birthweights in the study. The study concentrated on the babies most 
likely to develop respiratory difficulties, namely those born prior to 
36 weeks' gestation. A group of 'term' babies (36-41 weeks) was also 
investigated in order to determine more clearly the influence of 
gestational age on the various parameters measured, and also to 
establish an adequate 'normal' data base where some of the parameters, 
namely the fetal catecholamines, had not been adequately assessed.
There were 189 babies in the preterm group (24-35 weeks) - 91 
delivered vaginally, 51 by elective caesarean section and 47 by
caesarean section following the onset of labour.
In the 'term* group there were 192 babies - 118 delivered 
vaginally, 45 by elective caesarean section and 29 by caesarean 
section following the onset of labour.
In the vaginally delivered groups the method of delivery is shown 
In Table 5.1, and the type of anaesthesia employed in Table 5.2
The indications for elective caesarean section are shown in
Tables 5.3 and 5.4 and type of anaesthesia employed in Table 5.5.
The indications for caesarean section following the onset of
labour are shown in Table 5.6 and the type of anaesthesia employed in 
Table 5.7.
Since multiple pregnancies are often complicated by preterm birth 
It is not surprising that the preterm group included 25 sets of twins 
and 3 sets of triplets. The term group included 36 sets of twins for
comparison with the preterm: twins.
Table 5.8 shows the twin pregnancies by gestational age and 
method of delivery.
The 3 sets of triplets were born at 26 weeks (vaginally), 31 
weeks (caesarean section following labour) and 33 weeks (caesarean 
section following labour).
In the investigation of respiratory problems, although the simple 
division of cases into preterm and term appeared adequate, it was 
obvious that the preterm babies required to be further categorised, 
based on the likelihood of them developing respiratory problems.
The groups were established arbitrarily into Group I ( -T? 29
weeks) when functional respiratory immaturity was almost certain; 
Group II (30-33 weeks), when respiratory immaturity was still common 
but associated with fewer problems; and Group III (34-35 weeks) when 
the respiratory maturational processes were clearly active and
respiratory problems unlikely.
So that the numbers were large enough for meaningful statistical
analysis, all of the babies, singletons, twins and triplets have been
grouped together except when a direct comparison between singleton and 
twins was made. Where this was done (Chapter 8) there was little 
difference between singleton and twins in clinical outcome, amniotic 
fluid phospholipids or the fetal stress hormones in the preterm group 
(26-35 weeks) of babies studied.
5.2 Collection of blood and amniotic fluid samples
5.2.1 Umbilical cord blood
Immediately after delivery and before separation of the placenta 
a portion of umbilical cord was isolated between 2 clamps, the baby's 
end of the cord always being clamped first as Padbury et al (1981)A 
have shown in the fetal lamb a rapid increase in both NAD and AD
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subsequent to cord clamping. At least 5 ml of blood was obtained 
first from the umbilical arteries and then the umbilical vein. One ml 
of blood was used for pH and blood gas measurement. The remaining 
blood was spun down under ice using a centrifuge (3,000 revs/min for 3 
minutes). The supernatant was then drawn off and divided into 2 
portions, one for cortisol and one for catecholamine assay, and stored 
at -70 C until assayed (within 6 weeks of collection).
3.2.2 Maternal blood
Immediately after delivery of the baby 3 ml of blood was
withdrawn from an antecubital fossa vein. The blood was again spun
down under ice, separated into 2 portions for cortisol and
catecholamine measurement and stored at -70 °C until assayed.
5.2.3 Amniotic fluid specimens
Amniotic fluid samples were collected within 24 hours of
delivery. Amniotic fluid was obtained by aspiration under direct 
vision from a pool of amniotic fluid high in the vagina if membranes 
had ruptured spontaneously or immediately after artificial rupture of 
the membranes. At caesarean section amniotic fluid was obtained by 
needle aspiration of the intact sacs. If an amniotic fluid sample 
could not be obtained or if it was heavily contaminated with blood a 
gastric aspirate was obtained from the baby immediately after birth.
Before analysis, the amniotic fluid was centrifuged at 3,000 rpm 
for 5 minutes and stored at -20 °C after centrifugation.
5.3 Catecholamine assay
Samples for catecholamine assay were stored at -70 °C, all were 
assayed within 6 weeks of collection.
Plasma noradrenaline (NAD) and adrenaline (AD) levels were 
measured by the radioenzymatic method of Da Prada and Zurcher (1976).
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This assay depends on the methylation of catecholamines by catechol-o- 
methyl transferase (COMT) with the transfer of a labelled methyl group 
from s-adenosyl-l-methionine (SAM) to the catecholamine, ie
NAD + SAM(H3) COMT ^  H 3 NORMETANEPHRINE 
Certain modifications to the method of Da Prada and Zurcher were 
included (Ball et al 1981).
1 Plasma was used without deproteinization but containing
ethyleneglycolbisamino-ethylathertetra acetate (3 n mols/litre).
2 Plasma (100 ) with and without internal standard was added to
incubates containing Tris (1 mol/litre), magnesium chlorate (73 m 
mol/litre) benzyloxamine (dopa decarboxylase inhibitor; 0.5 m 
mol/litre), 20y£ of catechol O-methyltransferase solution and 3.6 Ci 
of s-adenosyl-l-(methyl- H) methionine (5-15 Ci/mmol). The total 
incubation volume was 150 \ii and pH 8.4.
3 The 3-methoxy derivatives were extracted into 1 ml of ether in 
the presence of tetraphenylboron and both extracted into 50 yJl of 
hydrochloric acid (0.1 mol/Litre). This could be applied directly to 
thin layer chromatography and the individual metabolites separated and 
identified under ultraviolet light.
The separated amines are then quantified using estimators of 
radioactivity.
The limit of detection calculated as twice the blank value was 
0.1 n mol/litre for NAD and AD. The intrassay coefficient of 
variation for NAD was 8.6% and AD 11.2%.
This radioenzymatic method for the measurement of catecholamines 
is extremely sensitive and requires a small sample size.
5.4 Cortisol assay
Total cortisol in umbilical cord and maternal venous plasma was 
measured using the commercially available Amerlex Cortisol Radioimmuno 
assay Kit (Amersham International pic, Amersham UK). This assay 
covers the approximate range 0-1700 n mol/litre. Where levels greater 
than 1700 n mol/litre were found, measurement was made following 
dilution of the samples.
5.5 Amniotic fluid analysis
5.5.1 The lung phospholipid profile
The amniotic fluid was centrifuged at 3,000 rpm (about 1100 g) 
for 5 minutes; when analysis was delayed the amniotic fluid was stored 
at -20 C after centrifugation.
The technique of two-dimensional thin-layer chromatography has 
been described (Kulovich et al 1979). The phospholipids are extracted 
from 3-4 ml amniotic fluid, using a chloroform-methanol mixture as in 
the routine L/S ratio technique (Borer & Gluck 1971). Cold acetone is 
used to precipitate the surface-active phospholipids, and this
.precipitate is resuspended in 30 chloroform, 15 of which is 
then injected onto a thin layer of silica. The thin layer is made
from a slurry of silica gel H with 5% ammonium sulphate and spread
onto a 20 x 20 cm borosilicate glass plate. A standard two-
dimensional chromatography technique is used. The first solvent 
system comprises chloroform, methanol, water, glacial acetic acid (65, 
25, 4, 8, v/v/v/v), and the solvent front is allowed to develop to 10
cm from the origin. Theplate is removed from the chromatography 
tank, dried at 70 C for 5 minutes, turned at right-angles and placed 
in the second solvent system of tetrahydrofuran, methylal, methanol, 
2N ammonium hydroxide (40, 28.5, 7.8, 4.2, v/v/v/v).This new solvent
front is also allowed to develop for 10 cm; the plate is removed,
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dried at 100 °C and then charred at 250 °C. Figure 5.3 shows the 
separation of the phospholipids. The L/S ratios,
phosphatidylglycerol/sphingomyelin (PG/S) ratios, and phosphatidyl- 
inositol/sphingomyelin (PI/S) ratios were estimated using densitometry 
(Kulovich et al 1979).
5.5.2 The lecithin and phosphatidylglycerol concentrations
The lecithin and phospatidylglycerol concentrations were 
determined by a phosphate analysis technique following 2 dimensional 
thin layer chromatography (TLC).
The phosphate assay was based on the technique of Kankara et al 
(1971) and is described below.
a) Recovery of phospholipids from TLC
The phospholipids were scraped from the plate into clean tubes 
ready for digestion, and the gel blank was made from an area of silica 
gel scraped off from below the origin, where both solvents had been in 
contact with the gel but not with the lipid extract (Figure 5.4). The 
concentration of phosphorus in the gel blank is directly proportional 
to the area of silica removed, regardless' of the presence of 
phospholipid, therefore a constant area of silica gel is removed for 
each phospholipid spot and for the blank. This area is equivalent to 
the area of the largest phospholipid spot present which is usually 
lecithin.
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b) Digestion
2 ml 5M H2So4 was added to each tube. The digestion was carried 
out at 180 °C for 2 hours. The tubes were cooled. 0.1 ml of 30%
H2So4 was added to each tube, and digestion continued at 180 °C for a 
further 2 hours.The volume in each tube by the end of the digestion 
was only 0.3ml.
c) Colour Development
9.5 ml double-distilled water was added to each tube and a set of 
standards, containing from 0 to 0.3 moles of inorganic phosphate in 
10 ml of 1M H2So4, prepared.
2 ml of freshly prepared mixture of equal volumes of 5% w/v 
ammonium molybdate and Fiske-Subba Row Reagent were added to each 
tube.
The contents of each tube were mixed using a vortex mixer. The 
tubes were placed in a boiling water bath for 7 minutes. The tubes 
were then centrifuged for 2 minutes at 370g to precipitate the silica 
gel. A spectrophotometer (Pye Unicam, SP600) was used and the optical 
density determined at 830 nm in standard 3 ml cuvettes. Reagent 
blanks, the gel blank, and the eluted lipids were assayed 
simultaneously.
A typical standard curve is shown in Figure 5.5. The phosphate 
content was determined for each lipid from such a curve after 
allowance had been made for the amount of silica gel containing the 
lipid.
5.6 Blood and gases
Measurements of pH and Po2 on umbilical arterial, umbilical 
venous and maternal venous blood were performed on . a Corning 178
pH/Blood Gas Analyzer. Utilizing its microprocessor the '178'
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calculates bicarbonate ion concentration, total Co2 and base excess. 
The Corning 178 automatically calibrates itself.
5.7 Gestational Age
Gestational age, determined from the menstrual history and 
clinical assessment of the uterine size at the first antenatal clinic 
in all cases was confirmed by an early ultrasound scan ( <20 weeks)
in 95% of cases.
5.8 Respiratory Distress Syndrome
Evaluation of the newborn was by the paediatric staff, the 
diagnosis of RDS being based on the clinical features (tachypnoea, 
grunting, sternal recession and rib retraction) present for at least 
24 hours and the radiological appearance of the lung field (diffuse 
granularity with a superimposed air bronchogram).
On the basis of the ventilatory support required to maintain 
satisfactory oxygenation, RDS was assessed as mild when only enriched 
ambient oxygen was required, moderate when constant positive airways 
pressure (CPAP) was needed, and severe when intermittant positive- 
pressure ventilation (IPPV) had to be used.
5.9 Method of anaesthesia
For elective caesarean section under general anaesthesia, 
Ranitidine 150 mg orally is given the night before and morning of 
operation.
Prior to induction of anaesthesia, left lateral tilt is employed, 
and oxygen 3 litres min via a Hudson mask for 3 minutes if given. 
Induction of anaesthesia is achieved with Atropine 0.5 mg IV, 
Thiopentone 3-4 mg/kg and Suxamethonium.1.5' mg/kg. Anaesthesia is
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maintained with 50% nitrous oxide and oxygen plus 0.5% Halothane until 
delivery.
At emergency caesarean section Cimetidine 200 mg IM is given at 
time of decision to operate.
Epidural anaesthesia was induced via an epidural catheter 
inserted into the epidural space at L3-L4. For elective epidural 
caesarean section 13-23 ml of 0.5% plain Bupivicaine is used to obtain 
an anaesthetic level of T5. For emergency epidural caesarean section 
20-30 ml of 2% Lignocaine and Adrenaline (0.2 ml 1:1000 in 20 ml) is 
used.
For labour analgesia 6-10 ml of 0.25% plain Bupivicaine is used 
to obtain an anaesthetic level of T10.
5.10 Statistical Methods
Note, in the Probability Plots described below;
* represents 1 observation
+ represents 10 observations
a number represents the number of observations at that 
point.
5.10.1 Catecholamines
Neither the fetal nor the maternal catecholamine levels were
normally distributed. Figures 5.6, 5.7 and 5.8 show the distribution
and probability plots for umbilical arterial NAD, AD and NAD/AD 
ratios, and Figures 5.9, 5.10 and 5.11 show the maternal NAD, AD and
NAD/AD ratios. Figures 5.12-5.17 show the distribution and 
probability plots following logarithmic transformation of the 
catecholamine levels.
Comparison of catecholamine levels between various groups were 
made using Student's T test following logarithmic transformation of
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the catecholamine levels, where a normal distribution was obtained 
Log UA NAD, AD and NAD/AD ratios (Figures 5.12, 4.13 and 5.14). Where 
there was still doubt regarding the normality of the distribution 
maternal NAD and AD and NAD/AD ratios (Figures 5.15, 5.16, and 5.17),
a Mann Whitney test was used).
5.10.2 Cortisol
Figures 5.18 and 5.19 show the distribution and probability plots 
for umbilical arterial and maternal venous cortisol levels.
Comparisons of cortisol levels between groups was made using 
Student’s T test for maternal venous cortisol levels. However, the UA 
cortisol data showed a slightly skewed distribution and a Mann Whitney 
test was used.
5.10.3 Amniotic Fluid Phospholipids
The distribution and probability plots for the L/S and PG/S 
ratios are described in Figures 5.20 and 5.21. Neither the L/S, nor 
PG/S ratios were normally distributed and comparisons of ratios 
between groups were made using the Mann-Whitney test.
The distribution and probability plots for the lecithin 
concentrations and phophatidylglycerol concentrations are shown in 
Figures 5.22 and 5.23.
Comparisons of levels between groups were made using Student's T
test.
5.10.4 Clinical parameters
Comparison of the occurrence of clinical parameters (eg 
occurrence of RDS, death etc) between groups was made using the method 
of Chi- square ( x2)> except when the numbers concerned made this test
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inappropriate. In this circumstance Fisher's test of exact 
probability was used.
Statistical analysis was performed on the Glasgow University main 
frame computer, employing a Minitab statistical package.
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T a b le  5 .1  V a g in a l ly  D e liv e re d  Group -  Method o f  D e l iv e r y
Term (36-41 weeks) 
SVD
Forceps
Rotational Forceps 
Breech
Preterm (24-35 weeks) 
SVD
Forceps
Rotational Forceps 
Breech
Number
78
13
10
17
118
48
28
4
11
91
T a b le  5 .2  V a g in a l ly  D e liv e re d  -  Type o f  A n a e s th e s ia
Number of Babies 
Term Preterm
Pethidine Alone 30 15
Pudendal Block 6 8
Epidural Block 57 40
Nil 25 28
118 91
T a b le  5 .3  In d ic a t io n s  f o r  E le c t iv e  Caesarean S e c t io n
Term (36 -41  weeks) Group
Number of Babies 
Breech Presentation 15
Placenta Praevia 8
Suspected Cephalopelvic Disproportion 2
Suspected Intrauterine Growth Retardation 1
Previous Caesarean Section 13
Maternal Disease 2
Other 3
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T a b le  5 .4  I n d ic a t io n s  f o r  E le c t iv e  Caesarean S e c t io n
P re te rm  (2 4 -3 5  weeks) Group
Number of Babies
Fetal Distress 4
Placenta Praevia 1
Suspected IUGR 11
Severe Maternal Hypertension 25
Rhesus Sensitized 7
Other 3
51
Table 5.5 Type of Anaesthesia for Elective Caesarean Section
Term (36-41 weeks)
Epidural
General Anaesthesia
Preterm (24-35 weeks)
Epidural 16
General Anaesthesia 35
Number of Babies
36
9
T a b le  5 .6  In d ic a t io n s  f o r  C aesarean S e c t io n  F o llo w in g  th e
Onset o f  Labour
Number o f  B ab ies
Term (36-41 weeks) Group
Failure to Progress in Labour 6
Fetal Distress 11
Suspected Cephalo Pelvic Disproportion 8
Other 4
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Preterm (24-35 weeks) Group
Failure to Progress in Labour 2
Fetal Distress 3
Preterm Breech in Labour 15
APH 2
Abruption 6
Placets Praevia 4
Intra Partum Bleeding 3
Severe Maternal Hypertension 2
Previous Caesarean Section 2
Rhesus Sensitized 1
Intrauterine Infection 1
Multiple Pregnancy 6
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Table >.7 Type o f  A n a e s th e s ia  f o r  Caesarean S e c t io n
F o llo w in g  th e  Onset o f  Labour
Number of Babies
Term (36-41 weeks) Group
Epidural 17
General Anaesthesia 12
Preterm (24-35 weeks) Group
Epidural
General Anaesthesia
12
35
Table 5.8 Twin Pregnancy by Gestational Age and
Method of Delivery
Delivery Gestation (Weeks)
28-29 30-33 34-35 36-3S
Vaginal 4 5 4 28
Elective C/S 0 1 3 3
Emergency C/S 1 2 4 5
— — -- --
5 8 11* 36
* + One twin pregnancy where first twin delivered 
vaginally but second delivered by emergency C/S.
TOTAL 61 sets of twins
Figure 5.1
Gestational Age (Weeks) Distribution
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Figure 5 .3  Phospholipid profile after two-dimensional thin-layer 
chromatography. L  =  Lecithin. S=.Sphingomyelin. PI =  
Phosphatidylinositol. PS=Phosphatidylserine. P E = P h os-  
phatidylethanolamine. PG=Phosphatidylglycerol.
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Figure 5 .4  Recovery of Phospholipids from TLC !
Removal of the Gel Blank
The gel blank was made from an area of silica gel scraped off from 
below the origin, where both solvents had been in contact with gel but 
not with the lipid extract.
The hatched area represents the silica gel in contact with both solvents 
and not with the lipid extract.
Figure 5.5 A Typical standard Curve
The phosphate content was determined for each lipid from, 
such a standard curve.
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CHAPTER 6
In f lu e n c e  o f  G e s ta t io n a l Age
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Influence of Gestational Age
6.1  In t r o d u c t io n
The earlier the gestational age at birth, the higher the 
incidence and severity of neonatal respiratory problems. This has 
been demonstrated in many studies (p 56 ). Amniotic fluid
surfactant also appears to increase with gestational age (p 57 ).
However, gestational age per se is not the sole factor determining 
functional lung maturity, as some babies may have adequate surfactant 
levels and have no respiratory problems, while others of a similar 
birthweight and gestational age have deficient lung surfactant and 
develop severe respiratory problems requiring artificial ventilation.
In the investigation of the control of fetal lung maturity, as 
outlined in Figure 2.2, knowledge of the effect of gestational age on 
the fetal stress products cortisol and catecholamines is important. 
Fetal cortisol appears to increase with gestation in the human fetus 
(p 57 ), however the influence of gestation on the levels of
catecholamines in the human fetus is sparse and conflicting (p 61 ).
Animal experiments have suggested that AD is much more important 
than NAD in enabling the fetus to adapt to an extrauterine existence 
(p 37 ) and that the conversion of NAD to AD in the fetal adrenal, 
possibly under the control of rising corticosteroid levels, increases 
as the gestation advances.
This chapter will investigate the influence of gestational age on
1 Cliical outcome, amniotic fluid phospholipids and the fetal 
stress hormone levels.
2 The relationship between fetal NAD and AD levels.
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3 The relationship between fetal NAD and AD and fetal cortisol.
In addition, the possibility that maternal levels of cortisol and 
catecholamines may be able to influence fetal levels of the stress 
hormones is also investigated.
6.2 Results
6.2.1 Influence of Gestational Age on Clinical outcome
Table 6.1 illustrates that neonatal mortality drops dramatically 
as gestation increases.
The incidence of respiratory problems was about 78% in babies at 
or less than 29 weeks, about 38% for babies born between 30 and 33 
weeks, but only 16% and 1% for those at 34 to 35 and 36 to 41 weeks 
respectively. The frequency of other morbid events such as patent 
ductus arteriosus, intracranial haemorrhage (as diagnosed by 
ultrasound) and apnoeic attacks also fall as gestation advances.
6.2.2 Influence of Gestation on Amniotic Fluid Phospholipids
There is a gradual increase in L/S ratio (Figure 6.1) and 
lecithin concentration (Figure 6.2) with increasing gestational age. 
The PG/S ratio (Figure 6.3) and PG concentration (Figure 6.4) rise 
after 36 weeks. Only those cases where PG was present were included 
in Figures 6.3 and 6.4.
6.2.3 Influence of Gestation on Umbilical Arterial Cortisol
There is a marked increase in umbilical arterial cortisol (UAC) 
with gestational age from around 34 weeks (Figure 6.5).
A similar increase in UAC is found after correcting for method of 
delivery (Figures 6.6, 6.7 and 6.8).
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In contrast to UAC there appears to be no increase with 
gestational age in maternal venous cortisol levels at delivery (Figure 
6.9).
The UAC levels in the term (36-41 weeks) and preterm (24-33 
weeks) groups are directly compared in Table 6.2 and demonstrate 
significantly higher UAC levels in term compared with the preterm 
baby, for all methods of delivery.
6.2.4 Source of Cortisol in Umbilical Cord Blood
Current evidence suggests that fetal cortisol levels are largely 
uninfluenced by maternal levels (p44- )• This section describes the 
relationship between maternal and fetal cortisol levels for those 
babies delivered vaginally and those delivered by elective caesarean 
section.
a) Maternal-Fetal Concentration Gradients
There was a significant maternal-fetal concentration gradient in 
the term (36-41 weeks) and preterm (24-33 weeks) groups in both 
methods of delivery (Tables 6.3 and 6.4).
The maternal venous cortisol (MVC) levels were significantly 
higher after the stress of vaginal delivery compared with elective 
caesarean section in both the term and preterm groups.
b) The Correlation between Maternal Venous and Umbilical Cord Cortisol
In the vaginally delivered group MVC levels correlated 
significantly with umbilical venous (UVC) levels at each gestational 
age group except between 36-37 weeks (Table 6.5).
The MVC and UAC levels correlated prior to 34 weeks. There was 
no correlation in the 34-35 week groups and a weak correlation in the 
38-41 week group which surprisingly reached statistical significance
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(T a b le  6 . 5 ) .
In the elective caesarean section group there was no correlation 
between MVC and UAC or UVC levels at any gestational age group (Table 
6.6).
c) Umbilical Arterio-Venous Concentration Gradient
In the vaginally delivered group, a significant umbilical
arterio-venous difference only occurred from 34 weeks' gestation
(Table 6.7).
In contrast, in the elective caesarean section groups, there was 
a significant umbilical arterio-venous concentration difference at all 
gestations, except the small group (6 cases) at ^ 29 weeks (Table 
6.8).
d) The Correlation between Umbilical Arterial and Umbilical Venous 
Cortisol
There is an excellent correlation between UAC and UVC regardless
of gestational age or mode of delivery (Table 6.9).
e) Placental Clearance of Cortisol
The clearance of cortisol (  ^^00^ different gestational
age groups is shown in Table 6.10, and demonstrates an increased 
clearance of cortisol after 34-35 weeks' gestation.
6.2.5 Influence of gestational age on umbilical arterial 
catecholamines
a) Umbilical arterial NAD
The mean (SD) for Log1Q UA NAD at each week of gestational age
from 25 to 41 weeks is shown in Figure 6.10. There appears to be an
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increase of umbilical arterial NAD with gestation.
The mean (SD) for umbilical arterial NAD at each week of 
gestation is shown in Figure 6.11 for those babies delivered 
vaginally, Figure 6.12 for those born by elective caesarean section 
and Figure 6.13 for those delivered by caesarean section following the 
onset of labour. There appears to be a trend to increasing NAD levels 
with advancing gestational age in those babies delivered vaginally. 
However, there is no apparent change in the mean umbilical arterial 
NAD concentration in those babies delivered by elective caesarean 
section or by caesarean section following the onset of labour.
The mean umbilical arterial NAD concentration is compared between 
the term group (36-41 weeks) and the preterm group of babies (24-33 
weeks) for each of the three methods of delivery (Table 6.11).
The preterm group delivered vaginally had significantly lower 
mean umbilical arterial NAD concentrations than the term group. 
Following delivery by elective caesarean section or by caesarean 
section after the onset of labour, there was no significant difference 
in mean umbilical arterial NAD between term and preterm babies.
b) Umbilical Arterial AD
The UAAD levels, shown in Figure 6.14 are seen to rise around 34 
weeks’ gestation. Figures 6.13, 6.16 and 6.17 demonstrate that this
rise in UAAD levels is confined to those babies delivered vaginally. 
There is no apparent change in mean UAAD concentration as gestation 
advances in those delivered by caesarean section.
The mean umbilical arterial AD concentration of the term and 
preterm groups of babies for the 3 methods of delivery is shown in 
Table 6.12. In the preterm group those babies delivered vaginally had 
a significantly lower mean umbilical arterial AD concentration than
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those babies born in the term group. In contrast there was no 
significant difference in the mean umbilical arterial AD concentration 
between the term and preterm groups of babies who were delivered by 
elective caesarean section or by caesarean section following labour.
There was no change with gestation in mean maternal venous NAD 
or AD at delivery (Figures 6.18 and 6.19).
c) Influence of gestational age on the relationship between
noradrenaline and adrenaline
The relationship between umbilical arterial AD and NAD for the 
term (36-41 weeks) and preterm (24-33 weeks) groups of babies is shown 
in Figure 6.20. A linear relationship is demonstrated for both the 
term and preterm groups.
The slopes of the regression lines indicate that the NAD/AD ratio 
increases with increasing NAD levels. The regression lines for the 
term and preterm babies are statistically significantly different 
(p <.05 using F test of Equality of Regression). This indicates that 
as the NAD level increases the ratio of NAD/AD would be greater in the 
preterm than the term babies.
The babies are further divided into gestational age groups and 
their respective regression lines shown in Figure 6.21. The babies 
born between 34-35 weeks have a regression line almost identical to 
that at 36-41 weeks. However, the regression lines of those babies 
born between 30-33 weeks and 25-29 weeks again suggest that for a 
given NAD level the ratio of NAD/AD is highest in the preterm baby.
The mean (SD) umbilical arterial NAD/AD ratio at each 
gestational age from 25 to 41 weeks is shown in Figure 6.22. There is 
no obvious trend with gestational age. There is a much wider 
variation in NAD/AD levels in the babies born prior to 35 weeks 
compared to those born after this gestation.
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The mean (SD) umbilical arterial log NAD/AD ratio in term (36-41 
weeks) and preterm (24-33 weeks) groups of babies for the 3 different 
methods of delivery are shown in Table 6.13. There was no significant 
statistical difference in the NAD/AD ratios between the term and 
preterm groups.
d) The Influence of gestational age on the relationship between UAC 
and the UA NAD/AD ratio
The relationship between UAC levels and the UA NAD/AD ratio is 
shown in Figure 6.23 and shows that there is no correlation between 
the two. However, when the babies were divided into a preterm group 
(25-35 weeks) and a term group (36-41 weeks), those babies with the 
lowest UAC levels in conjunction with the highest NAD/AD ratios were 
found in the preterm group (Figure 6.24). There was no correlation 
between UAC and UA NAD or UA AD levels (Table 6.14).
6.2.6 Source of catecholamines in umbilical cord blood
Current evidence suggests that the fetal catecholamines are 
largely uninfluenced by maternal levels. This section describes the 
relationship between maternal and fetal ' levels for those babies 
delivered vaginally and those delivered by caesarean section.
a) Maternal-fetal concentration gradients
There was a significant maternal-fetal concentration gradient for 
both NAD and AD, the highest levels being in the fetus. This was true 
for both the term and preterm groups of babies irrespective of method 
of delivery (Tables 6.15, 6.16, 6.17, 6.18).
The mean UA NAD/AD ratio was significantly higher than the mean 
MV NAD/AD ratio (Table 6.19).
The MV NAD and AD levels found after vaginal delivery were not
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significantly different to those observed following elective caesarean 
section (Tables 6.15, 6.16, 6.17, 6.18).
b) The correlation between maternal venous and umbilical cord 
catecholamines
There was no correlation between MV catecholamines and umbilical 
cord catecholamines, except a weak correlation between MV aned UV AD 
in term vaginal delivered group and between MV and UA AD in the 
preterm group (Table 6.20).
c) Umbilical Arterio-venous concentration gradients
There was a significant umbilical arterio-venous concentration 
gradient for both NAD and AD, in the term and preterm groups for both
methods of delivery (Tables 6.15, 6.16, 6.17, 6.18).
d) The correlation between umbilical arterial and umbilical venous 
catecholamines
There was a significant umbilical arterio-venous correlation for 
NAD and AD in the term and preterm groups of babies for both methods 
of delivery (Table 6.21).
e) Placental clearance of catecholamines
The placental clearance ( x ^or an<^  ^  ^y
gestational age is shown in Table 6.22.
The placental clearance for NAD was similar throughout gestation, 
however clearance of AD seemed to rise as gestational age advanced.
A linear relationship was demonstrated between the arterio-venous 
concentration difference and the umbilical arterial concentration of 
NAD in both the term and preterm groups (Figure 6.25), the slopes of
the lines being almost identical.
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A linear relationship was also demonstrated between the arterio­
venous AD concentration difference and the umbilical arterial 
concentration of AD in both the term and preterm groups (Figure 6.25). 
Again the slopes of the lines were almost identical.
Figures 6.25 and 6.26 demonstrate that the clearance of NAD and 
AD was directly proportional to their respective umbilical arterial 
concentrations and over the concentration ranges found in this study 
the process was non-saturable.
6.3 Discussion
Effect of gestational age on clinical and biochemical lung maturity 
and fetal stress hormones
Gestational age has a pronounced effect not only on mortality and 
morbidity but also on amniotic fluid phospholipids and umbilical 
arterial cortisol levels. The neonatal mortality and incidence of RDS 
falls as the amniotic fluid phospholipids and umbilical arterial 
cortisol levels rise. The rise in UAC, which occurs irrespective of 
method of delivery, parallels the rise in amniotic fluid 
phospholipids. In, addition the incidence of RDS falls dramatically 
after 34-35 weeks, the time of the main UAC surge. It is therefore 
not unreasonable to postulate that endogenous cortisol secretion may 
play a role in the synthesis of fetal lung phospholipids.
The catecholamines however did not demonstrate such clear cut 
changes with gestational age. Figures 6.10 and 6.14 (all cases) and 
Figures 6.11 and 6.15 (all vaginal deliveries) suggest an increase in 
umbilical arterial NAD and AD with increasing gestational age. In 
contrast there seemed no evidence to suggest such a trend when the 
babies were delivered by elective caesarean section or caesarean 
section following labour. However, the relatively small numbers at 
each week of gestation age, especially prior to 30 weeks, makes
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interpretation difficult. Separating the babies into a preterm (24-35 
weeks) and a term (36-41 weeks) group, (Tables 6.11 and 6.12) the mean 
umbilical arterial NAD and AD levels were significantly lower in the 
preterm compared with the term babies who were delivered vaginally. 
No such differences were seen when the babies were delivered by 
caesarean section either electively or following labour.
These findings are in broad agreement with Lagercrantz and 
Bistoletti (1973) who, in a small series of 9 preterm babies and 
employing a fluorometric method for catecholamine measurement reported 
lower catecholamine values in preterm than term infants at birth. In 
contrast, Newnham et al (1984) observed significantly greater mean 
arterial plasma AD concentration in preterm than term fetuses, with 
NAD similar in the 2 groups.
The reason for the discrepancy when comparing the catecholamine 
levels in the preterm and term babies between this study and the work 
of Newnham et al is not immediately obvious. However, the study by 
Newnham et al(l984) involved a much smaller series (36 preterm babies) 
and this combined with the wide range of catecholamine levels found in 
the human fetus may account for this discrepancy.
It is generally assumed that a high proportion of NAD in the 
adrenal medulla is indicative of immaturity and that the percentage of 
AD increases slowly with age (Comline & Silver 1966). However no 
obvious trend in the NAD/AD ratio with gestational age could be
demonstrated, (Figure 6.22) and there was no significant difference in 
the mean NAD/AD ratio between the term and preterm babies (Table
6.13). In babies born prior to 35 weeks there was a much wider
scatter of NAD/AD values and it would appear that the higher NAD/AD
ratios occurred prior to this gestation.
Figures 6.21 and 6.22 demonstrate that as the umbilical arterial 
NAD concentration increases the ratio of NAD/AD increases and that for
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a given NAD concentration the preterm baby tends to have a relatively 
lower AD concentration than at term. This may reflect a poorer AD 
response to stress in the preterm baby.
AD would seem to be relatively more important than NAD in the 
adaptation of the fetus to an extrauterine environment. It is thought 
to play a major role in lung maturation - both the release of 
surfactant and the absorption of lung fluid, cardiovascular changes 
and glucose homeostasis. The preterm neonate with a relatively poorer 
'AD response' would be placed at a disadvantage in adjusting to 
extrauterine life.
As gestation advances the adrenal medulla is exposed to 
increasing levels of glucocorticoids which encourages the 'N' 
methylation of NAD and AD. However, there was no correlation between 
the umbilical arterial cortisol and the NAD/AD ratio (Figure 6.23). 
Nevertheless the highest NAD/AD ratios and the lowest UAC 
concentrations were found in those babies born prior to 35 weeks 
(Figure 6.24). It may be that those babies with a high NAD/AD ratio 
and a low UAC are biochemically immature and may be placed at a 
disadvantage when attempting to adapt to an extrauterine environment.
Source of fetal cortisol
The large maternal-fetal concentration gradient across the 
placenta would suggest that maternal cortisol levels could influence 
cord levels, especially with the high maternal levels associated with 
vaginal delivery.
However, more than 90?o of maternal cortisol is bound to 
corticosteroid binding globulin (CBG) and therefore unavailable for 
transfer (Sandberg & Slaunwhite 1959). This CBG is elevated during 
pregnancy (Slaunwhite & Sandberg 1959). In addition to this the 
placental 'barrier' to the transfer of cortisol is re-inforced by the
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presence of 11B-hydroxysteroid dehydrogenase in the placenta and fetal 
membranes which promotes oxidation of maternally transferred free 
cortisol to cortisone (Murphy et al 1974).
It is possible, however, that the high levels of maternal 
cortisol noted during vaginal delivery could overcome the 'placental 
barrier' and thereby influence fetal cord levels. In this regard it is 
interesting that there is no correlation between maternal venous 
cortisol levels and umbilical cord levels at elective caesarean 
section, when the maternal venous cortisol levels are relatively low. 
In contrast during vaginal delivery there was a significant 
correlation of maternal venous and umbilical venous cortisol in all 
gestational groups except between 36-37 weeks.
The strongest correlation between maternal venous and umbilical 
cord cortisol levels were found in the preterm group of babies. This 
may help to explain the lack of umbilical arterio-venous cortisol 
gradient in the preterm babies born vaginally prior to 34 weeks. 
There is a significant umbilical arterio-venous cortisol gradient only 
after 33 weeks and this arterio-venous gradient increases with 
gestation (Table 6.7). This may reflect not only an increase in 
endogenous fetal secretion of cortisol but also an increase in 
corticosteroid binding globulin and in placental 11B oxidoreductase as 
gestation advances.
The maternal venous cortisol levels were significantly lower in 
the elective caesarean section group compared with those mothers 
delivered vaginally (Table 6.3 and 6.4). These lower cortisol levels 
may explain the lack of correlation between maternal venous and 
umbilical cord cortisol levels, in contrast to the vaginally delivered 
group (Table 6.5, 6.6). The relative lack of maternal influence on
cord cortisol levels in the elective caesarean section group may also 
be reflected in the significant umbilical arterio-venous cortisol
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levels found in all but one of the gestational age groups. In this 
group, however, there were only 6 cases (Table 6.8). In the vaginally 
delivered babies the lack of an arterio-venous cortisol gradient in 
those born prior to 34 weeks (Table 6.7)and the correlations between 
maternal venous and umbilical cord cortisol levels (Table 6.5) suggest 
that maternal cortisol levels can influence fetal cord blood levels 
especially in the preterm baby.
Source of fetal catecholamines
In contrast to plasma cortisol the plasma catecholamine levels in 
the fetus were significantly higher than those in maternal venous 
blood (Tables 6.15, 6.16, 6.17 and 6.18). The significantly higher
catecholamine levels in the umbilical artery than in the umbilical 
vein (Tables 6.15, 6.16, 6.17 and 6.18), the significant correlations
between umbilical arterial and umbilical venous catecholamines (Table 
6.21) and the lack of correlation between maternal venous and cord 
blood catecholamine levels (Table 6.20) all suggest that the fetus is 
the predominant source of cord blood catecholamines. In vitro studies 
have demonstrated the presence of catechol-o-methyltransferase and 
monoamine oxidase in the human placenta which metabolise the 
catecholamines into inactive metabolites (Morgan et al 1972). It 
would seem likely therefore that there is functional separation 
between the fetal and maternal sympathoadrenal systems.
Falconer et al (1982) have shown that the clearance of NAD by the 
term placenta was directly proportional to the umbilical arterial NAD 
concentration and that over ^he concentration range which they 
encountered the process was non-saturable. This has been confirmed 
and has also been shown to be true for the preterm placenta (Figure 
6.25).
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It would also appear that there is a substantial placental 
clearance for AD (Figure 6.26). This substantial clearance and 
inactivation of catecholamines by the placenta may help protect the 
fetus from the high circulating levels of NAD and AD.
6.4 Conclusions
1 Gestational age has a marked influence on
a) Neonatal lung function - the incidence of RDS and mortality 
increases with decreasing gestation age below 34-35 weeks.
b) Lung surfactant - the important surface active 
phospholipids lecithin and PG increase with gestational 
age.
c) UAC increases with gestational age, especially after 
34 weeks
2 Gestational age appears to have some effect on fetal 
catecholamine levels.
Fetal NAD and AD seems to increase with gestation but 
only in those babies delivered vaginally.
The higher NAD/AD ratios were found in preterm babies.
3 There was no obvious relationship between UAC and UA NAD/AD
ratios.
4 The maternal and fetal sympathoadrenal systems appear to
function independently.
5 Fetal cortisol levels may be influenced by the high MVC levels
associated with vaginal delivery, especially in the preterm
baby.
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T a b le  6 .2
Umbilical Arterial Cortisol (nmol/ft) 
Term compared with Preterm Delivery
Delivery Term (SD) Preterm (SD) Significance
(36-42 weeks.) (24-35 weeks)
314 (180) p < .0000
(n = 63)
239 (116) p < .0002
(n = 43)
235 (149) p < .0003
(n = 37)
Vaginal 533 (185)
(n = 74)
Elective 353 (134)
Caesarean Section (n = 35)
Labour and 474 (250)
Caesarean Section (n = 22)
T a b le  6 .3
M a te rn a l Venous v e rsu s  U m b il ic a l C o r t is o l  (n m o l/J l)
Vaginal
Delivery
Elective
Caesarean
Section
Term Group (36-41 weeks)
(Mean)
Cortisol (SD)*
Maternal Venous (n = 83) 1572 (502) |
p < .0000
Umbilical Artery (n = 74) 533 (180) p <
p <.0000
Umbilical Vein (n = 95) 396 (135) J
Maternal Venous (n = 34) 1179 (431)
Umbilical Vein
1
p <.0000
Umbilical Artery (n = 35) 353 (134) J p *
p < .007
(n = 37) 276 ( 95) J
.0000
p <.0001
.  J
.0000
*  (SD = S ta n d a rd  D e v ia t io n )
T a b le  6 .4
Maternal Venous versus Umbilical Cord Cortisol (nmol/&) 
Preterm Group (24-35 weeks)
(Mean)
Cortisol (SD)*
Maternal Venous (n = 68)
Vaginal
Delivery Umbilical Artery (n = 63)
Umbilical Vein (n = 73)
1681 (638)
313
1
p< .0000
(185) J  p<.0000 
NS
287 (162) J
p < .0000
Maternal Venous (n = 45)
Elective
Caesarean Umbilical Artery (n = 43) 
Section
Umbilical Vein (n = 44)
1067
239
(397) “]
p < .0000
(116) _ -J p < .0000
202 ( 80)
NS~fj
*  (SD = S ta n d a rd  D e v ia t io n )
T ab le  6 .5
Correlation between Maternal Venous and Umbilical 
Cord Cortisol
Vaginal Deliveries
Gestation MVC v UAC MVC v UVC
(weeks) r p r p
,< 29 0.568 < .01 0.646 < .01
(n = 21) (n = 21)
30-33 0.52 < .05 0.59 < .01
(n = 18) (n = 22)
34-35 0.43 NS 0.674 < .001
(n = 20) (n = 22)
36-37 -0.03 NS -0.22 NS
(n = 24) (n = 29)
38-41 0.4 <.02 0.54 < .001
Cn =41) (n = 50)
r  = c o r r e la t io n  c o e f f i c ie n t
T a b le  6 .6
Correlations between Maternal Venous and Umbilical
Cord Cortisol
Elective Caesarean Section
Gestation MVC v UAC MVC v UVC
(weeks) r p r p
0.384 NS
(n = 3)
0.435 NS
(n = 19)
0.06 NS
E N T  D A T A
0.12 NS
(n = 29)
r  = c o r r e la t io n  c o e f f i c ie n t
<29 -0.67 NS
(n = 5)
30-33 0.3 NS
(n = 19)
34-35 -0.15 NS
36-37 I N S U F F I C I
38-41 0.14 NS
(n = 28)
T ab le  6 .7
The Influence of Gestational Age on 
Umbilical Arterio-Venous Cortisol Difference
Vaginal Deliveries
Gestation
(weeks)
UA
mean (SD)
UV
mean (SD)
£ 29: (n = 20) 225 (134) 242 (150) NS
30-33 (n = 22) 286 (182) 260 (156) NS
34-35 (n = 20) 440 (174) 369 (157) <.0006
36-37 (n = 24) 482 (173) 347 (347) <.0000
38-41 (n = 50) 558 (180) 419 (145) <.0000
*p Paired 'T1 Test
T a b le  6 .8
The Influence of Gestational Age on 
Umbilical Arterio-Venous Cortisol Difference
Elective Caesarean Section
Gestation UA UV *p
(weeks) mean (SD) mean (SD)
x 29 (n = 6) 220 (83) 201 (59) NS
30-33 (n = 19) 205 (87) 175 (64) < .007
34-35 (n = 18) 280 (142) 230 (95) < .005
36-37 I N S U F F I C I E N T  D A T A
38-41 (n = 33) 351 (138) 272 (94) < .0000
*p Paired 1T1 Test
T a b le  6 .9
Umbilical Arterio-Venous Cortisol Correlation 
by Gestational Age and Method of Delivery
Gestation
(Weeks)
Vaginal Elective Caesarean 
Section
r P r P
<< 29 0.9
(n = 20)
<.001 0.38 
(n = 6)
NS
30-33 0.88 
(n = 22)
<.001 0.88 
(n = 19)
ooV
34-33 0.86 
(n = 20)
<.001 0.9
(n = 18)
A O o
36-37 0.7
(n = 25)
<.001 INSUFFICIENT DATA .
38-41 0.6
(n = 49
<.001 0.86 
(n = 33)
<.001
T ab le  6 .1 0
Influence of Gestational Age on 
Placental Clearance of Cortisol 
UA-UV
UA X All Vaginal Deliveries
Gestation (weeks) Cortisol Clearance 
^ 29 8%
30-33 5?o
34-33 18?o
36-37 26?o
38-41 24?^
T a b le  6 .11
Umbilical Arterial Noradrenaline (nmol/il)
Term (36-41 weeks) compared with Preterm (24-35 weeks) Delivery
Delivery Term 
mean (SD)
Preterm 
mean (SD)
Significance*
Vaginal 35.8 (38) 
(n = 104)
17.4 (24) 
(n = 66)
<.0002
Elective
Caesarean Section
13.8 (22) 
(n = 42)
10.6 (15) 
(n = 44)
NS
Emergency 11 (10) 
(n = 28)
24 (54) 
(n = 40)
NS
*  1T 1 T e s t p e rfo rm e d  u s in g  lo g a r i th m ic  trans fo rm ed  v a lu e s  o f  NAD
T a b le  6 .1 2
Umbilical Arterial Adrenaline (nmol/&)
Term (36-41 weeks) compared with Preterm (24-35 weeks) Delivery
Delivery Term 
mean (SD)
Preterm 
mean (SD)
Significance*
Vaginal 4.5 (3.7) 
(n = 96)
2.5 
(n =
(2.5)
66)
<.0000
Elective
Caesarean
Section
2.0 (1.7) 
(n = 37)
1.9 
(n =
(2.2)
44)
NS
Emergency 1.9 (1.7) 2.5 (4.9) NS
Caesarean (n = 27) (n = 39)
Section
*  ’ T ' T e s t p e rfo rm e d  u s in g  lo g a r i th m ic  tra n s fo rm e d  v a lu e s  o f  AD
T a b le  6 .1 3
Umbilical Arterial Noradrenaline/Adrenaline Ratio 
Term (36-41 weeks) compared with Preterm (24—35 weeks) Delivery
Delivery Term 
mean (SD)
Preterm 
mean (SD)
Significance *
Vaginal 8.6 (7.7) 9.4 (15.1) NS
(n = 96) (n = 66)
Elective 3.9 (3.3) 10.7 (21) NS
Caesarean (n = 37) (n = 44)
Section
Labour and 7.5 (7.4) 13.3 (21) NS
Caesarean Section (n = 27) (n = 39
*  * T f T e s t p e rfo rm e d  u s in g  lo g a r i th m ic  tra n s fo rm e d  v a lu e s
T ab le  6 .1 4
Correlation of Umbilical Arterial Cortisol and 
Umbilical Arterial Noradrenaline and Adrenaline
r
UAC v NAD 0.264 NS
UAC v AD 0.3 NS
T ab le  6 .1 5
The Relationship between Maternal Venous and Cord NAD (nmol/&) Levels
Term (36-41 weeks) Deliveries
NAD (mean (SD))
MV (n = 96) 1.83 (0.6) 1
p <.0000 i
Vaginal UA (n = 104) 35.8 (38.9) _1 p <.0000
Delivery p <.0000 1
UV (n = 110) 9.12 (8.9) J — 1
MV (n = 40) 1.69 (0.75) 1
p <.0000 1
Elective UA (n = 42) 13.8 (22.1) =1 p <.001
Caesarean Section p <.0000 I
UV (n = 44) 3.26 (2.39) J J
T a b le  6 .1 6
The Relationship between Maternal Venous and Cord NAD Levels (nmol/il)
Vaginal Delivery
Elective
Caesarean Section
Preterm (24-35 weeks) Group
MV (n = 66)
NAD (mean (SD)) 
1.48 (0.7) i  1
UA (n = 66) 17.36 (24)
p <.0000 1
rj p < .0000
UV (n = 72) 6.77 (10.8)
p<.0000 I
J J
MV (n = 38) 1.82 (0.9) 1
p <.0000 1
UA (n = 46) 10.18 (13)
_1
—I
p < .0000
NS
1
UV (n = 43) 3.82 (8.2) J A
T a b le  6 .1 7
The Relationship between Maternal Venous and Cord AD Levels (nmol/&)
Term Group (36-41 weeks)
AD (mean (5D))
MV (n = 84) 0.66 (0.4) "1 “1
p< .0000 I
Vaginal Delivery UA (n = 96) 4.37 (3.74) —t p< .0000
p< .0000 J
UV (n = 100) 1.48 (1.16) J
Elective
Caesarean Section
MV (n = 33) 0.66
UA (n = 37) 1.97
UV (n = 39) 0.83
(0.47) “I
p< .0000
(1.65) d  NS
p< .odoo 
(0.75) J
T ab le  6 .1 8
The R e la t io n s h ip  between M a te rn a l Venous and Cord AD L e v e ls  (n m o l/& )
Preterm Group (24-35 weeks)
AD (mean (SD))
MV (n = 66) 0.57 (0.3) “I
Vaginal Delivery UA (n = 66) 2.49
P
(2.52)
<.0000 
—J 
—1
UV (n = 72) 1.22
P
(1.5)
<.0004
J
MV (n = 35) 0.83 (0.85) n
Elective UA (n = 44) 1.86
P
(2.2)
<.006 
—|
Caesarean Section
UV (n = 43) 1.01
P
(1.5)
<.01
J
1
p <.0002
J
1
NS
J
T a b le  6 .1 9
Comparison of the NAD/AD Ratio in Umbilical Arterial 
and Maternal Venous Blood
(mean) 
NAD/AD Ratio
Maternal Venous 4.49
(n = 285)
Umbilical Arterial 9.25
(n = 309)
SD
6.72
13.9
1
p <.0000
J
* 'T' Test using logarithmic transformed values
Tab le .20
Plasma Catecholamines 
Maternal Venous - Umbilical Cord Correlations
Term Group (36-41 weeks)
Vaginal Delivery r_ £
MV NAD V UA NAD -.07 NS
MV NAD V UV NAD .18 NS
MV AD V UA AD .13 NS
MV AD V UV AD .A3 < .001
Elective Caesarean Section
MV NAD V UA NAD .12 NS
MV NAD V UA NAD .18 NS
MV AD V UA AD .19 NS
MV AD V UV AD .31 NS
Preterm Group (24-35 weeks)
Vaginal Delivery
MV NAD V UA NAD -.02 NS
MV NAD V UV NAD .04 NS
MV AD V UA Ad .07 NS
MV AD V UV AD .18 NS
Elective Caesarean Section
MV NAD V UA NAD -.08 NS
MV NAD V UV NAD - . 2 NS
MV AD V UA AD -.47 < .01
MV AD V UV AD -.31 NS
T ab le  6 .21
Plasma Catecholamines 
Umbilical Arterial-Venous Correlations
Term Group (36-41 weeks) 
Vaginal Delivery
L  P
UA NAD v UV NAD 0.75 <.001
UA AD v UV AD 0.64 <.001
Elective Caesarean Section
UA NAD v UV NAD 0.77 <.001
UA AD v UV AD 0.59 <.001
Preterm Group (24-35 weeks) 
Vaginal Delivery
UA NAD v UV NAD 0.74 <.001
UA AD v UV AD 0.45 <.001
Elective Caesarean Section
UA NAD v UV NAD
UA AD v UV AD
0.82 <.001
0.6 <.001
T a b le j.22
Placental Clearance of Catecholamines 
by Gestational Age
NAD AD
All Cases 71% 62%
(n = 326) (n = 322)
^ 29 weeks 61% 44%
(n = 33) (n = 32)
30-33 weeks 64% 51%
(n = 63) (n = 63)
34-35 weeks 64% 66%
(n = 54) (n = 54)
36-41 weeks 75% 65%
(n = 174) (n = 160)
F ig u re  6 .1
LSR 
9*0 +
Influence of Gestational Age on the L/S Ratio 
(Mean (SD) at Each Week of Gestation)
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F ig u re  6 .2
Influence of Gestational Age on Amniotic Fluid 
Lecithin Concentration
(Mean (SD) at each week of gestation)
Lecithin
Concentration (ymol/Jl)
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X
X
50 ♦ + X
X
X
X
40 ♦ + i
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I •
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X * X
X I X
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F ig u re  6 .3
Influence of Gestational Age on the PG/S Ratio 
(Mean (5D) at each week of gestation)
PG/S Ratio 
3*60 +
X
X
2.70 +
X
i
X «
X
1*80+ X X  X
X •
X X *
• •
X • • • •  X X
0*90+ • 8
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F ig u re  6 .4
Influence of Gestational Age on the 
Amniotic Fluid PG Concentration 
(Mean (SD) at each week of gestation)
PG Concentration 
(ymol/jO
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U m b il ic a l  A r t e r i a l  C o r t is o l  ((n .m o l/& ) a g a in s t
G e s ta t io n a l Age in  Weeks A l l  Cases Mean (SD)
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U m b il ic a l  A r t e r i a l  C o r t is o l  (pm ol/JO  a g a in s t
G e s ta t io n a l Age in  Weeks A l l  V a g in a l D e l iv e r ie s  Mean (SD)
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F ig u re  6 .7
Umbilical Arterial Cortisol (pmol/fl,) against 
Gestational Age in Weeks Elective Caesarean Section Mean (SD)
UAC 
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U m b il ic a l A r t e r i a l  C o r t is o l  (n m o l/& ) a g a in s t
G e s ta t io n a l Age in  Weeks Labour and Caesarean S e c tio n  Mean (SD)
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M a te rn a l Venous C o r t is o l  (n m o l/ j l)  a g a in s t
G e s ta t io n a l Age Mean (SD)
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F ig u re  6 .1 0
Umbilical Arterial Logm Noradrenaline (nmol/il) against
Gestational Age in Weeks All Cases Mean (SD)
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M a te rn a l Venous L o g m A d re n a lin e  (n m o l/& ) a g a in s t
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Relationship between UA AD & UA NAD for term (36-41 weeks) 
& preterm (25-35 weeks)
2
36-41 wks r=0.83 (N=160)
25-35 wks r=0.66 (N=151)1
  Term y=-0.48 + 0.73x
  Preterm y=-0.386 + 0.57x
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Fig. 6.21
Relationship between UA NAD & UA AD by gestational age groups
2
36-41 wks r=0.83 (N=160) 
34-35 wks r=0.72 (N=54)
30-33 wks r=0.64 (N=63)1
'24-29 wks r=0.584 (N=32)
0
30 21
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U m b il ic a l  A r t e r i a l  NAD/AD R a tio  a g a in s t
G e s ta t io n a l Age in  Weeks A l l  Cases Mean (5D)
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F ig u re  6 .2 3
The Relationship between the Umbilical Arterial NAD/AD Ratio 
and Umbilical Arterial Cortisol Cnmol/il) All Cases
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Placental clearance of NAD
Term (36-41 weeks) & Preterm (24-35 weeks)
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Labour and Route of Delivery
7.1  In t r o d u c t io n
Fedrick and Butler (1972) found that babies delivered by elective 
caesarean section were at greater risk of dying from RDS than those 
babies delivered either vaginally or even by caesarean section if this 
was preceded by labour. This observation seemed to imply that labour 
may. protect the baby from RDS, although the mechanisms responsible 
remain to be elucidated. However (as discussed in Chapter 2) it is 
possible that the increase in cortisol and/or catecholamine levels 
associated with labour promotes both clearance of fluid from lung and 
increases production and release of surfactant.
In this chapter the effect of labour and mode of delivery on 
neonatal outcome, amniotic fluid phospholipids and umbilical arterial 
cortisol and catecholamines in those babies born v- 35 week's 
gestation, will be assessed. Because of the substantial effect of 
gestational age on these parameters (Chapter 5) the babies were also 
divided into gestational age groups as discussed in Chapter 5, 
depending on the likely occurrence of RDS.
As the term group of babies (36-41 weeks) had a very low 
incidence of respiratory problems, study of neonatal outcome and A.F. 
phospholipids was confined to those babies born 35 weeks. However 
the effect of mode of delivery on UAC and UA catecholamines was 
studied in the term babies and their response compared with the 
preterm group.
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7.2 Results
7.2.1 Clinical outcome
In order to reduce confusion over the diagnosis of RDS and to 
make it easier to detect differences between babies with and without 
respiratory problems, only those babies with moderate and severe RDS 
(ie requiring artificial ventilation - CPAP or IPPV) were included in 
the RDS groups.
24-35 weeks (Table 7.1)
Although there were no significant differences between the 
birthweights and gestational ages of the babies by route of delivery 
(Table 7 . 1 ) ,  Figures 7.1 and 7 . 2  illustrate that more of the smaller 
and younger babies were delivered vaginally (11?o were < 28 weeks in 
the vaginally delivered group compared with 6?o in elective caesarean 
section group).
Neonatal death was less common in the labour plus caesarean 
section group although this was not statistically significant. 
However, the incidence of RDS in this group was statistically lower 
than when the baby was delivered by elective caesarean section.
^ 29weeks, 30-33weeks, 34-35 weeks (Tables 7.2, 7.3 and 7.4)
Although neonatal death and RDS were more common in those babies 
delivered by elective caesarean section, there were no statistically 
significant differences between the different routes of delivery 
after allowance for gestational age.
7.2.2 Amniotic fluid phospholipids 
24-35 weeks (Table 7.5)
There were no statistically significant differences in mean L/S
ratio, PG/S, ratio, lecithin concentration, PG concentration and in
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the percentage of babies with PG present in their amniotic fluid, 
between the 3 different routes of delivery.
24-29 weeks, 30-33 weeks, 34-33 weeks (Tables 7.6, 7.7 and 7.8)
There were no significant differences • in amniotic fluid 
phospholipids between the 3 modes of delivery after allowance for 
gestation age.
7.2.3 Umbilical arterial cortisol
a) Method of delivery 
24-33 weeks (Table 7.9)
The mean UAC levels were statistically significantly higher 
following vaginal delivery compared with delivery by caesarean 
section.
The babies delivered by elective caesarean section had a 
significantly lower mean UApH compared to those delivered vaginally.
A similar picture of higher UAC levels in vaginal delivery 
compared to caesarean section was also found in the term group of 
babies (Table 7.10).
24-29 weeks, 30-33 weeks, 34-33 weeks (Tables 7.11, 7.12 and 7.13)
Except in the 24-29 weeks group when the numbers were small, 
those babies born vaginally had higher UAC levels than those born by 
elective caesarean section, after allowance for gestational age.
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b) Type of vaginal delivery
The effect of type of vaginal delivery on UAC levels for the 24- 
33 week group is shown in Table 7.14. There was no significant 
difference in mean UAC between the 3 types of vaginal delivery.
In the term group of babies the spontaneous vaginal group had 
significantly raised mean UAC compared with the vaginal breech group 
(Table 7.15).
c) Duration of labour
There was no correlation between UAC levels and the duration of 
labour in the preterm (34-35 weeks) (Table 7.17) or the term (36-41 
weeks) group of babies (Figure 7.3 and Table 7.16) delivered by SVD.
d) Type of anaesthesia employed
In the vaginally delivered group, 78 babies were born by 
spontaneous vertex delivery between 36-41 weeks and 48 between 24-35 
weeks. The type of analgesia employed is shown in Table 7.18 and 
7.19.
In those babies delivered by elective caesarean section, 45 were 
born between 36-41 weeks and 51 between 24-35 weeks. The type of 
anaesthesia employed is shown in Table 7.20 and 7.21.
In those babies delivered by caesarean section following the 
onset of labour, 29 were born between 36-41 weeks and 47 between 24-35 
weeks. The type of anaesthesia employed is shown in Table 7.22 and 
7.23.
Apart from a significantly lower mean UAC concentration in those 
preterm babies delivered spontaneously from mothers given pethidine 
compared with those given no analgesia in labour, the type of 
anaesthesia employed did not affect the UAC levels in the preterm or
term babies after either vaginal delivery (Tables 7.18, 7.19) or after
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caesarean s e c t io n  (T a b le s  7 .2 0 , 7 .2 1 , 7 .22  and 7 . 2 3 ) .
7.2.4 Umbilical arterial catecholamines
a) Method of delivery 
24-33 weeks (Table 7.9)
In this group of babies the only significant difference in 
catecholamine levels in the different delivery groups was a 
significantly raised UANAD level in those babies delivered vaginally 
compared with those delivered by elective caesarean section.
This is in contrast to the term group of babies (36-41 weeks) 
(Table 7.10) where the catecholamine levels were significantly raised 
following vaginal delivery compared with either elective or emergency 
caesarean section.
24-29 weeks, 30-33 weeks, 34-33 weeks (Tables 7.11, 7.12 and 7.13)
Method of delivery had little influence on cord catecholamines 
prior to 34 weeks. However the 34-35 week group showed a similar 
response to the term group (36-41 weeks) with significantly higher UA 
NAD and AD levels following vaginal delivery compared with caesarean 
section.
b) Type of vaginal delivery
The effect of the type of vaginal delivery on UA catecholamine 
levels for the 24-35 week group is shown in Table 7.14.
Those babies born by vaginal breech delivery tended to have lower 
catecholamine levels than those delivered by forceps or spontaneous 
vaginal delivery. However the babies born by the breech had 
significantly lower mean gestational age and mean birth weights than 
the forceps or spontaneous delivery group.
116
In contrast the mean UA AD level in those babies delivered by the 
breech at term (Table 7.13) was significantly raised compared with the 
level for the forceps or spontaneous vertex groups.
c) Duration of labour
There was no correlation between UA catecholamine levels and the 
duration of labour in the preterm (24-35 weeks) (Table 7.17) or the 
the- term group (Figure 7.3) of babies delivered by spontaneous vertex 
delivery.
d) Type of anaesthesia/analgesia employed
In those babies undergoing spontaneous vertex delivery there were 
no significant differences in UA catecholamines or pH between the 3 
methods of analgesia (Tables 7.18 and 7.19).
The effect of type of anaesthesia on those babies delivered by 
elective caesarean section is shown in Table 7.20 for the preterm 
group and Table 7.21 for the term group of babies. In the preterm 
group the only statistical significant difference was a higher mean UA 
AD concentration in the epidural compared with the general anaesthetic 
group. In the term group there was no significant difference in UA 
catecholamines between those babies delivered under general 
anaesthesia or under epidural blockade.
The effect of type of anaesthesia on the UA catecholamines of 
those babies delivered by caesarean section after the onset of labour 
is shown in Table 7.22 for the preterm group and Table 7.23 for the 
term group. In the preterm group the fetal catecholamines were 
significantly lower in those babies whose mothers were given a 
general anaesthetic. In the term group there were no significant 
differences in the UA catecholamine levels between those babies 
delivered under general anaesthesia compared with those born under 
epidural block.
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7.3 Discussion
The reported lower incidence of hyaline membrane disease (Fedrick 
& Butler 1972), higher thoracic gas volumes following vaginal delivery 
compared with elective caesarean section (Milner et al 1978) and the 
increase in phospholipid content of amniotic fluid collected serially 
in labour (Cabero et al 1976, Craven et al 1976, Whittle et al 1977), 
all strongly suggest that labour produced optimal conditions for 
neonatal respiratory function. The mechanism whereby this adaptation 
to extrauterine existence occurs is uncertain. However animal 
evidence suggests that endogenous cortisol and catecholamines, 
elevated by the stress of labour may cause increased synthesis and 
release of phospholipids and promote clearance of lung fluid. The 
baby delivered by elective caesarean section, especially if born prior 
to term may therefore be placed at a disadvantage.
In the preterm group of babies (24-33 weeks) those delivered 
vaginally had a similar incidence of respiratory problems as those
born by elective caesarean section. However significantly more babies 
developed RDS in the elective caesarean section group compared with 
the group delivered by caesarean section following labour (Table 7.1). 
These groups were not stricly comparable however, as although the mean 
gestational ages and mean birthweights showed no significant 
difference, the distribution of birthweights and gestational ages were 
different between delivery groups (Figure 7.1 and 7.2). The lower
birthweights and earlier gestational ages occurring in the elective 
caesarean section group.
In general labour did not appear to confer any particular 
advantage with respect to respiratory function, the incidence of
problems being similar in babies born following either labour or
elective caesarean section. However, although the numbers are small, 
babies delivered by caesarean section following the onset of labour at
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429 weeks or 30-33 weeks had half the incidence of respiratory 
complications of those delivered vaginally or by elective caesarean 
section.
Measurement of the amniotic fluid phospholipids, did not explain 
the variability in clinical outcome since there were no differences in 
amniotic fluid phospholipids between the method of delivery in any of 
the gestational age groups.
The differences seen in the cortisol and catecholamine levels 
between the different routes of delivery in the term group of babies 
(Table 7.10) were not so obvious in the preterm groups 24-29 weeks and 
30-33 weeks (Table 7.11 and 7.12). This may be due to the smaller 
numbers involved but more likely it reflects that whereas those babies 
delivered by elective caesarean section at term were, as a group, 
relatively uncomplicated, those delivered preterm by this route came 
from high risk pregnancies. This latter group although not subjected 
to the physiological stress of labour were under a more severe 
pathological stress, as reflected by the significantly lower mean 
umbilical arterial pH in the elective caesarean section group compared 
with those delivered vaginally between 30 and 33 weeks. Thus, 
although there was no difference in amniotic fluid phospholipids 
between the elective caesarean section and the vaginally delivered 
groups (at 30-33 weeks), hypoxia in the elective caesarean section 
group may have interfered with surfactant activity either because of 
decreased surfactant production or extrasavation of fluid into the 
interstitial space of the fetal lung thus interfering with surfactant 
activity (Strang 1976). This may explain why twice as many babies in 
the elective caesarean section group developed RDS than in the 
vaginally delivered group.
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In the term neonate (Table 7.10) the significantly higher 
cortisol levels in vaginally delivered babies and in those delivered 
by caesarean section following the onset of labour compared with those 
delivered by elective caesarean section indicate that both labour and 
vaginal delivery cause cortisol levels to rise.
In contrast there was no significant difference in the mean NAD 
or AD levels between those babies delivered by elective caesarean 
section and those by caesarean section after the start of labour 
(Table 7.10). Vaginal delivery, however, caused a significant 
increase in mean NAD and AD levels compared with either method of 
caesarean section, suggesting that it was the passage down the birth 
canal which stimulated catecholamine release rather than the stress of 
labour itself. Vaginal delivery therefore should be advantageous if 
endogenous fetal cortisol and/or catecholamines are important elements 
in assuring optimal lung funtion.
However, vaginal delivery in the preterm group of babies did not 
appear to convey any great advantage, either in terms of clinical 
outcome or in the maturity of the lung phospholipids.
Whether the fetal endocrine responses to the stress of delivery 
can be modified by the type of anaesthesia has been investigated. 
Tables 7.20 to 7.23 demonstrate that there was no significant 
difference in mean fetal cortisol levels between those babies 
delivered by caesarean section (both elective and after onset of 
labour) under epidural block or under general anaesthesia. This was 
true for both the term and preterm groups of babies. This finding is 
in agreement with Namba et al (1980) who also found that method of 
anaesthesia does not influence the fetal cortisol responses.
The literature regarding the fetal catecholamine response to the 
type of anaesthesia employed at caesarean section is rather 
conflicting. Falconer and Lake (1982) and Newham et al (1984) found
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no difference in fetal mean catecholamine levels at caesarean section 
between epidural block and general anaesthesia, while Jones et al 
(1985) noted that the 'lowest levels' were found after caesarean 
section under epidural. These conclusions, however, were based on 
small numbers of cases. Irestedt et al (1982) with a large series 
found significantly higher fetal NAD and AD levels in epidural 
caesarean sections compared with caesarean section performed under GA. 
Tables 7.21 and 7.23 show that, in the term group, there was no 
significant difference in mean catecholamine levels between those 
babies delivered by caesarean section (both elective and following the 
onset of labour) performed under general anaesthesia and those under 
epidural block. In the preterm group of babies, however, (Tables 7.20 
and 7.22) the fetal catecholamines tended to be higher in those 
babies delivered by caesarean section under epidural block than those 
delivered by caesarean section under general anaesthesia. The reason 
for these differences in the preterm but not the term group of babies 
is difficult to explain. The two preterm caesarean section groups of 
general anaesthesia and epidural block may not be strictly comparable 
as the distribution of gestational ages and birth weights were not 
similar in the two groups , the younger and smaller babies 
predominating in the general anaesthesia group. In addition to this, 
those babies delivered by caesarean section prior to 36 weeks were a 
very heterogenous group (see Table 5.4 and Table 5.6).
With vaginal delivery the type of anaesthesia would appear to 
have little effect on fetal catecholamines (Falconer & Lake 1982, 
Bistoletti et al 1983). This would be in agreement with Tables 7.18 
and 7.19 which show no significant differences in the biochemical 
parameters between those babies whose mothers were given either 
pethidine alone or an epidural block. Overall, therefore, it would
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appear that the type of maternal analgesia or anaesthesia has little
effect on fetal stress products at delivery.
7.4 Conclusions
1 Route of delivery had little effect on incidence of RDS or
neonatal survival in the group of babies studied.
2 Route of delivery had little influence on lung surfactant as
reflected by amniotic fluid phospholipids.
3 Route of delivery had a marked influence on UAC levels. Those 
babies born vaginally had significantly raised mean UAC compared 
with those delivered by caesarean section.
4 Route of delivery had a marked influence on UA catecholamine
levels in the term (36-41 weeks) babies, those born vaginally 
having significantly raised mean UANAD and AD levels compared 
with those delivered by caesarean section.
In the preterm babies ( >6 33 weeks) the effect of route of 
delivery on UA catecholamine levels was not so clear cut.
3 The type of maternal analgesia/anaesthesia had little effect on
UA cortisol or catecholamine levels.
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UAC v 2nd Stage .013
Log UA NAD v 2nd Stage .097
y 10
Log UA AD v 2nd Stage .09
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Relationship between Duration of Labour and Biochemical 
Aspects of the Neonate
Preterm Group (24-33 weeks)
r
UAC v Duration of Labour -0.26 NS
Log1QUA NAD v Duration of Labour -0.26 NS
Log1QUA AD v Duration of Labour -0.34 NS
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Effect of Anaesthesia on Biochemical Aspects of the Neonate 
Preterm (24-35 weeks)___________ Elective Caesarean Section
Arterial Cord Values - Mean (SD)
GA (n = 35) Epidural (n = 16) 
Cortisol (nmolA) 254 (122) 202 (96) NS
NAD (nmol/il) 8.1 (10.6) 15.3 (21) NS
AD (nmol/5,) 1.4 (1.7) 2.8 (2.8) p<.04
pH 7.22 (0.1) 7.21 (0.1) NS
T a b le  7 .21
E f fe c t  o f  A n a e s th e s ia  on B io c h e m ic a l A spects  o f  th e  Neonate
Term (36-41 weeks)___________ Elective Caesarean Section
Arterial Cord Values - Mean (SD)
GA (n = 9) Epidural (n = 36) 
Cortisol (nmol/5,) 311 (180 360 (128) NS
NAD (nmol/5,) 10.7 (11.8) 14.5 (24.2) NS
AD (nmol/5,) 1.9 (1.5) 2.8 (1.7) NS
pH 7.31 (0.07) 7.28 (.05) NS
T a b le  7 .22
E f fe c t  o f  A n a e s th e s ia  on th e  B io ch e m ica l A spects  o f  th e  Neonate
Preterm (24-35 weeks)___________ Labour and Caesarean Section
Arterial Cord Values - Mean (SD)
GA (n = 35 Epidural (n = 12) 
Cortisol (nmol/S) 238 (165) 225 (99) NS
NAD (nmol/5,) 12(15) 53.3(88) p< .005
AD (nmol/5,) 2.3 (5.6) 5 (8) p< .01
pH 7.29 (.05) 7.23 (0.1) NS
Tab le  7 .2 3
E f fe c t  o f  A n a e s th e s ia  on th e  B io c h e m ic a l A spects  o f  th e  Neonate
Term (36-41 weeks) Labour and Caesarean Section
Arterial Cord Values - Mean (SD)
GA (n = 12) Epidural (n = 17)
Cortisol (nmol/it) 474 (296) 473 (208) NS
NAD (nmol/^) 7.1 (4.9) 14.1 (12.3) NS
AD (nmol/&) 1.9 (1.78) 1.8 (1.6) NS
pH 7.22 (0.1 7.28 (0.05) NS
F ig u re  7 .1
D is t r ib u t io n  o f  B ir th w e ig h ts  (2 4 -35  weeks)
Vaginal Delivery 
MIDDLE OF NUMBER OF 
INTERVAL OBSERVATIONS
0.4 1 X
0.6 3 X X X
0.8 3 X X X
1.0 8 j K X X X X X X X
1.2 6 xxxxxx
1.4 10 xxxxxxxxxx
1.6 11 xxxxxxxxxxx
1.8 10 xxxxxxxxxx
2.0 14 xxxxxxxxxxxxxx
n nMm ♦ Mm 13 xxxxxxxxxxxxx
2.4 5 xxxxx
2.6 3 X X X
2.8 0
3.0 3 X X X
Labour and Caesarean Section 
BW
MIDDLE OF NUMBER OF 
INTERVAL OBSERVATIONS
1.0 3 X X X
1.2 3 X X X
1.4 7 xxxxxxx
1.6 3 X X X
1.8 7 xxxxxxx
2.0 7 xxxxxxx
2.2 10 xxxxxxxxxx
2.4 3 X X X
2.6 3 X X X
2.8 0
3.0 1 X
Elective Caesarean Section
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MIDDLE OF NUMBER OF
INTERVAL OBSERVATIONS
0.4 Z X X
0.8 7 xxxxxxx
1.2 14 xxxxxxxxxxxxxx
1.6 8 xxxxxxxx
2.0 8 xxxxxxxx
2.4 8 xxxxxxxx
2.8 3 X X X
3.2 1 X
F ig u re  7 .2
D is t r ib u t io n  o f  G e s ta t io n a l Ages (24 -35  weeks)
Vaginal Delivery 
EE5T
MIDDLE OF NUMBER OF 
INTERVAL OBSERVATIONS
24. 1 X
25. 3 X X X
26. 4 xxxx
27. nMm X X
23. 7 xxxxxxx
29. 12 xxxxxxxxxxxx
30 . 8 xxxxxxxx
31. 5 xxxxx
32. 9 xxxxxxxxx
33. 10 xxxxxxxxxx
34. 17 xxxxxxxxxxxxxxxxx
35. 13 xxxxxxxxxxxxx
Labour and Caesarean Section 
■GES1------------------------
MIDDLE OF NUMBER OF 
INTERVAL OBSERVATIONS
26. 1 X
27. 0
28. 2 X X
29. 4 xxxx
30. 2 X X
31. 4 xxxx
32. 5 xxxxx
33. 10 xxxxxxxxxx
34.' 11 xxxxxxxxxxx
35. 8 xxxxxxxx
Elective Caesarean Section 
XGEST
MIDDLE OF NUMBER OF 
INTERVAL OBSERVATIONS
26. 1 X
27. 2 X X
29. 2 X X
29. 5 xxxxx
30. . 3 X X X
31. 8 xxxxxxxx
32. sJ xxxxx
33. C"U xxxxx
34. 8 xxxxxxxx
35. 12 xxxxxxxxxxxx
F ig u re  7 .3
C o r t is o l
Influence of Duration of Labour on Umbilical Cortisol 
NAD and AD (nmol/£)
u a c  SVD'S 36-41 weeks
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CHAPTER 8
Multiple Pregnancy
8.1 In t r o d u c t io n
Multiple Pregnancy
RDS appears to be more frequent in twins than in singletons and 
this increase cannot entirely be accounted for by the higher 
prematurity rate in twins over singletons (Myrianthropulous et al 
1971). In addition, as discussed in Chapter 3, there is some evidence 
to suggest that twins have lower surfactant levels than singletons at 
similar gestational ages. Twin II appears to be at particular risk 
of developing RDS and this has generally been attributed to increased 
perinatal asphyxia.
In this Chapter, twins are compared firstly to singletons and 
secondly twin I is compared to twin II with respect to clinical and 
biochemical lung maturity and the levels of stress hormones cortisol 
and the catecholamines.
Some authors have described a similar relationship to birth order 
and lung maturity in triplets, quadruplets and quintuplets (p 66 )
and in this Chapter the clinical and biochemical lung maturity and 
fetal stress hormones are described in 3 sets of triplets.
8.2 Results
8.2.1 Comparison of Twins and Singletons
A total of 61 sets of twins was studied (Table 8.1). As there 
were no twin pregnancies delivered prior to 28 weeks or after 39 
weeks, the gestational age groups considered in this section were 28- 
29, 30-3, 34-33 and 36-39 weeks. Clinical outcome was considered only 
in babies born prior to 36 weeks.
Lack of numbers did not permit correction for method of delivery 
except for the babies born after 33 weeks, when only vaginal 
deliveries were investigated.
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Only from 34 weeks' gestation was there a significant difference 
in mean birthweight between singletons and twins (Table 8.2).
a) Clinical outcome
The babies born from twin pregnancies seemed to do at least as 
well as singletons at each gestational age group studied (Tables 8.3- 
8.3).
b) Amniotic fluid phospholipids
There were few differences in amniotic fluid phospholipids 
between singletons and twins (Tables 8.6-8.9). However the mean PG/S 
ratio and mean PG concentration were significantly higher in 
singletons than twins at 30-33 weeks (Table 8.7) and the mean PG/S 
ratio significantly higher in singletons than twins in 30-33 and 36-39 
week groups (Tables 8.7 and 8.9).
c) Umbilical arterial cortisol
Table 8.10 shows that from 34 weeks' gestation the mean UAC level 
was significantly higher in singletons than in twins.
d) Umbilical arterial catecholamines
There was no significant difference in mean UA NAD or AD levels 
between singletons and twins at any gestational age (Table 8.11 and 
8.12).
e) Condition of infant at birth
There was no significant difference in mean UA pH between 
singletons and twins prior to 36 weeks. However, after this gestation 
the twins were significantly more acidotic as a group compared to 
singletons (Table 8.13).
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8.2.2 Comparison of Twin I and Twin II
In this section the first and second born twins were compared
with regard to clinical outcome, amniotic fluid phospholipids,
umbilical arterial cortisol and catecholamines.
a) Clinical outcome
(Clinical outcome was only considered in those babies born less 
than 36 weeks).
The clinical outcome for twins I and II is shown in Table 8.14.
Although the incidence of RDS and requirement for ventilation was
similar, more deaths occurred in Twin II.
b) Amniotic fluid phospholipids
In the preterm group of babies (28-35 weeks) twin I had
significantly higher mean lecithin concentration compared with twin II 
(Table 8.15). This, however, was the only observation to suggest a 
deficiency in surfactant in the second twin. There were no significant 
differences in amniotic fluid phospholipids betweeen twin I and twin 
II when all twins in study were considered together (Table 8.16) or 
when only those born >. 36 weeks were studied (Table 8.17).
The correlation between co-twins for amniotic fluid phospholipids 
is shown in Table 8.18. Only the PG concentration showed a 
significant correlation in the term group (36-39 weeks) or in the
study as a whole.
The correlations were much improved in the preterm group ( -$ 35
weeks). The statistically significant correlations are shown in
Figures 8.1-8.5. However, in the one twin pregnancy in the study,
where one baby (twin II) developed RDS and its co-twin did not PG was 
absent in twin II (Table 8.19).
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e) Umbilical arterial cortisol
The mean UAC level was significantly higher in twin I compared to 
twin II when all twins were considered together or when only those 
born after 35 weeks were considered (Table 8.20). Interestingly, when 
only one twin developed RDS (Table 8.19) the twin developing RDS had a 
much higher UAC level).
There was a significant correlation between co-twins for UAC 
(Table 8.21) (Figures 8.6, 8.7 and 8.8).
d) Umbilical arterial catecholamines
There were no significant differences in mean UA 
between co-twins (Tables 8.22 and 8.23) but an excellent 
between twin I and twin II (Table 8.21) (Figures 8.9, 8.10
e) Umbilical arterial pH
There were no significant differences in mean UA pH between twin 
I and twin II (Table 8.24) and no significant correlation between co­
twins (Table 8.21).
8.2.3. Triplets
There were 3 sets of triplets included in the study (Table 8.25). 
The triplets born at 26 weeks were grossly immature and all 3 
developed severe RDS.
..Interestingly in one set of triplets at 31 weeks the first two 
babies delivered were monozygotic, both had PG and neither developed 
RDS while the third - a genetically different baby, had no PG and 
developed RDS. Zygosity was established using 8 blood group systems - 
ABO, Rh, MNS, PI, KELL, LUTHERAN, DUFFY and KIDD - when twins had the 
same sex and dichorionic placentation (Corney & Robson 1975). All 3 
babies had intact amniotic sacs and were delivered by caesarean
NAD or AD 
correlation 
and 8.11).
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section in a similar condition, as shown by their UA pH values. 
Despite the similar condition at birth the cord cortisol and
catecholamine levels varied considerably, with no obvious relationship 
to lung maturity.
8.3 Discussion 
Twins versus Singletons
RDS appears to be more frequent in twins than in singletons and
this increase cannot apparently be entirely accounted for by the
higher prematurity rate of twins over singletons (Myrianthopolous et 
al 1971). In this small study no increase in the incidence of RDS in 
twins compared with singletons could be demonstrated (Tables 8.21— 
8.23). However the mean amniotic fluid PG/S ratio and mean PG
concentration were significantly lower in twins than in singletons at 
30-33 weeks' gestation. There was also a lower percentage occurrence 
of amniotic fluid PG in twins conmpared with singletons at 30-33 weeks 
and 28-29 weeks, although these differences were not statistically 
significant. This suggestion of a 'poorer' surfactant in twins 
compared with singletons is - consistent with the findings of Parkinson 
et al (1980) who noted that twins had significantly lower pharyngeal 
L/S ratio than singletons when born between 29-35 weeks. This may 
indicate that with large numbers more significant differences between 
singletons and twins would become apparant.
There were no significant differences in mean UA NAD, AD or pH 
between singletons and twins in the gestational age-'groups considered, 
however there was a significantly raised mean UAC in singletons 
compared with twins. This difference may reflect the differences in 
mean birthweight between singletons and twins but may also have some 
bearing on differences in surfactant noted between the 2 groups.
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Twin I versus Twin II
In the study of fetal lung maturity, multiple pregnancies provide 
an interesting model, the babies acting as their own controls 
especially with regard to gestational age and intrauterine 
environment. The second born twin is reported to have double the risk 
of RDS than the first born (Rokos et al 1968, Farr 1975) and this has 
mainly been attributed to perinatal asphyxia, (Rokos et al 1968, 
Verduzco et al 1976). In sporadic reports of individual twin 
pregnancies where only one twin is affected, it seems that the second 
born almost always has the more immature surfactant and develops RDS 
(Caspie et al 1975, Gluck et al 1974, Dobbie et al 1983).
Although in this study more second twins died, the incidence of 
other complications, including RDS was similar between twin I and twin 
II. In addition little difference was found in amniotic fluid 
phospholipids between co-twins (Tables 8.32-8.34) although the 
lecithin concentration was significantly lower in twin I between 30-33 
weeks' gestation.
Measurement of stress related products in cord blood demonstrated 
excellent correlation for UAC NAD and 40 but not pH between co-twins 
with no differences in arterial catecholamine or pH levels noted 
between twins. However the UAC level was significantly higher in 
twin I compared with twin II (after 35 weeks) and this is in agreement 
with the findings of Norman et al (1983) who found that during labour 
glucocorticoids increased significantly in the amniotic fluid of 
twin I compared with twin II.
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8.4 Conclusions
Singletons compared to twins
In the group of babies studied:-
1 There was no difference in incidence of respiratory complication.
2 Apart from a lower mean PG/S ratio and mean PG concentration in 
twins compared to singletons at 30-33 weeks’ gestation, there 
were no other significant differences in lung surfactant.
3 The mean UA cortisol was significantly raised in singletons 
compared to twins only after 34 weeks’ gestation.
4 There was no difference in mean UA NAD, AD or pH.
Twin I compared to twin II
1 No difference in clinical or biochemical lung maturity.
2 Significantly higher mean UA cortisol in twin I only after 33 
weeks.
3 No difference in mean UA NAD, AD or pH.
4 Excellent correlations between co-twins for UA NAD, AD and 
cortisol but not pH.
130
T ab le  8 .1
Tw in Pregnancy by G e s ta t io n a l Age and Method o f  D e liv e ry
Delivery Gestation (weeks)
28-29 30-33 34-33 36-39
Vaginal 4 5 4 28
Elective C / S O  1 3 3
Emergency C/S 1 2  4 5
5 8 11* 36
* + One twin pregnancy where first twin delivered 
vaginally but second delivered by emergency C/S.
TOTAL 61 sets of twins
T ab le  8 .2
Singleton v Twin Pregnancy 
Birthweight (kg) Mean (SD)
Gestation (weeks) Singleton Twin
28-29 1.24 (0.3) 1.12 (0.3)
(n = 22)
30-33 1.74 (0.4) 1.77 (0.6)
(n = 52) (n = 16)
34-33 2.23 (0.45) 1.98 (0.28)
(n = 45) (n = 24)
36-39 3.02 (0.55) 2.64 (0.43)
(Vaginal delivery only) (n = 29 (n = 56
NS 
NS 
p <.004 
p <.009
T a b le  8 .3
Singleton v Twin Pregnancy 
Clinical Outcome 
28-29 weeks
Singleton Twin
(n - 22) (n = 20)
Died 36% (8/22) 30% (3/10) NS
RDS 59% (13/22) 70% (7/10) NS
Ventilation 59% (13/22)
oCD (8/10) NS
T ab le  8 .4
Singleton v Twin Pregnancy 
Clinical Outcome 
30-33 weeks
Died 
RDS
Ventilation
Fishers Exact Test 
* p <0.078 NS 
0 p <.004
Singleton
(n = 52) (i
10% (5/52) 13%
35% * (18/52) 13%
44% 0 (23/52) 6%
Twin 
= 16)
(2/16) NS
* (2/16) NS
0 (1/16)
T a b le  8 .5
Singleton v Twin Pregnancy 
Clinical Outcome 
34-35 weeks
Singleton Twin
(n = 45) (n = 24)
Died (2/45) 4K (1/24)
RDS m (5/45) 0%
Ventilation 1655 (7/45) 4?o (1/24)
T a b le  8 .
Singleton v Twin Pregnancy 
Amniotic Fluid Phospholipids 
28-29 weeks
Singleton Twin
(n = 22) (n = 10)
Mean (SD) Mean (SD)
L/S Ratio 1.4 (0.6) 1.5 (0.3) NS
PG/S Ratio 0.7 (0.3) 0.9 (0.05) NS
AFPG (7/13) m 2/10 20?o NS
Lecithin
Concentration* 13.3 (2.2)
PG
Concentration* 4.6 (1.3)
INSUFFICIENT DATA
INSUFFICIENT DATA
* (ymol/&)
T a b le  8 .7
L/S Ratio 
PG/S Ratio 
AFPG
Lecithin
Concentration*
PG
Concentration*
Singleton v Twin Pregnancy 
Amniotic Fluid Phospholipids 
30-33 weeks
Singleton Twin
(n = 32) (n = 16)
Mean (SD) Mean (SD)
1.94 (0.97) 1.78 (0.76) NS
1.03 (0.6) 0.47 (0.4) P <
64% (35/52) 44% (7/16) NS
19.9 (8) 21.9 (7.8) NS
5 (2.4) 3 (0.5) P <
*  (y m o l/ i l)
T ab le  8 .8
L/S Ratio
PG/S Ratio
AFPG
Lecithin
Concentration*
PG
Concentration*
Singleton v Twin Pregnancy
Amniotic Fluid Phospholipids 
34-35 weeks
Singleton Twin
(n = 45) (n = 24)
Mean (SD) Mean (SD)
2.5 (1.2) 3 (1.8)
0.9 (0.4) 1.6 (1.9)
00 (35/45) 88?o (21/24)
32.7 (19) 29.8 (10.6)
5.7 (1.7) 7 (2.4)
(No significant differences) 
* (ymol/Jl)
T ab le  8 .9
L/S Ratio 
PG/S Ratio 
AFPG
Lecithin
Concentration*
PG
Concentration*
Singleton v Twin Pregnancy 
Amniotic Fluid Phospholipids
1 weeks_____ Vaginal Delivery Only
Singleton Twin
(n = 29) (n = 56)
Mean (SD) Mean (SD)
3.5 (1.6) 3.5 (2.3) NS
1.7 (0.9) 1.0 (0.8) P<
66% (19/29) 91 % (51/54) NS
32 (8.3) 38 (16) NS
7.4 (3) 8.1 (5) NS
* (ymol/&)
T ab le  8 .1 0
Singleton v Twin Pregnancy 
Umbilical Arterial Cortisol (nmol/&)_____ Mean (SD)
Gestation (Weeks) Singleton Twin
28-29 228 (142) 192 (63) NS
(n = 22) (n = 10)
30-33 216 (124) 271 (203) NS
(n = 52) (n = 16)
34-35 388 (171) 248 (116) p <
(n = 45) (n = 24)
36-39 * 594 (165) 469 (185) p <
(n = 29) (n = 56)
.002
.01
*  V a g in a l d e l iv e r ie s  o n ly
T a b le  8 .11
Singleton v Twin Pregnancy 
Umbilical Arterial Noradrenaline (nmol/&)
Mean (SD)
Gestation (Weeks) Singleton Twin
28-29 14.2 (15) 2.6 (0.9) NS
(n = 22) (n = 4)
30-33 14.6 (26) 12.1 (7) NS
(n = 52) (n = 16)
34-35 13.3 (16.7) 17.7 (18) NS
(n = 45) (n = 24)
36-39 * 36.9 (34) 36.2 (42) NS
(n = 29) (n = 56)
*  V a g in a l d e l iv e r ie s  o n ly
T a b le  8 .1 2
Singleton v Twin Pregnancy 
Umbilical Arterial Adrenaline (nmol/l,) 
Mean (SD)
Gestation (Weeks) Singleton Twin
28-29 1.3 (1.5) 0.5 (0.15) NS
(n = 22) (n = 4)
30-33 2.6 (3)
(n = 52)
1.7 (0.9) NS
(n = 16)
34-35 2.2 (1.9)
(n = 45)
4.1 (7.9)
(n = 24)
NS
36-39 * 4.1 (2.9)
(n = 29
5.4 (4.5)
(n = 56)
NS
*  V a g in a l d e l iv e r ie s  o n ly
T a b le  8 .1 3
Singleton v Twin Pregnancy 
Condition of Infant at Birth
Umbilical Arterial pH Mean (SD)
Gestation (Weeks) Singleton Twin
28-29 7.21 (0.13) 7.19 (0.12) NS
(n'= 22) (n = 10)
30-33 7.26 (0.08) 7.27 (0.1) NS
(n = 32) (n = 16)
34-33 7.25 (0.09) 7.22 (0.1) NS
(n = 45) (n = 24)
36-39 * 7.3 (0.05) 7.2 (0.06) p <
(n = 29) (n = 56)
.0000
*  V a g in a l d e l iv e r ie s  o n ly
T a b le  8 .1 4
Twin I v Twin II 
Clinical Outcome 28-35 Weeks
Twin I Twin II
Birthweight (kg) 1.8 (0.5) 1.7 (0.5) NS
Mean (SD)
RDS 4/25 (165S) 5/25 (20%) NS
Ventilation
Requirements 4/25 (16%) 6/25 (24%) NS
Died 1/25 (4%) 5/25 (20%) p <.0000 *
* Fishers Exact Test
T a b le  8 .1 5
L/S Ratio 
PG/S Ratio 
AFPG
Lecithin 
Concentration *
PG
Concentration *
Twin I  v Twin I I
Amniotic Fluid Phospholipids 
28-35 Weeks______(n = 25)
Twin I Twin II
Mean (SD) Mean (SD)
2.25 (1.1) 2.5 (1.8) NS
1.39 (1) 1.4 (2.2) NS
64% (16/25) 56% (14/25) NS
30.8 (12) 23 (6.8) p <.01
6.3 (3.3) 5.9 (2.2) NS
* (ymol/&)
T a b le  8 .1 6
Twin I  v Twin I I
Amniotic Fluid Phospholipids 
28-39 Weeks (n = 61)
L/S Ratio 
PG/S Ratio 
AFPG
Lecithin 
Concentration *
PG
Concentration *
* (ymol/£)
Twin I Twin II
Mean (SD) Mean (SD)
3 (1.9) 2.9 (2) NS
1.3 (0.9) 1.12 (1.4) NS
79?o (48/61) 74?o (45/61) NS
36 (14) 35 (16) NS
6.8 (3) 8.3 (5.3) NS
No s ig n i f i c a n t  d if fe re n c e s
T a b le  8 .1 7
L/S Ratio
PG/S Ratio
AF PG
Lecithin 
Concentration *
PG
Concentration *
Twin I  v Twin I I
Amniotic Fluid Phospholipids 
36-39 Weeks (n = 36)
Twin I Twin II
Mean (SD) Mean (SD)
3.5 (2.1) 3.2 (2.1) NS
1.2 (0.8) 0.99 (0.68) NS
89?o (32/36) 86% (31/36) NS
37.6 (14.6) 38.8 (16) NS
(3) (5.7) NS
* (ymol/il)
No s ig n i f i c a n t  d if fe re n c e s
T a b le  8 .1 8
Correlation between Co-twins 
Amniotic Fluid Phospholipids
All Twins Term
(28-29 weeks) (36-39 weeks )
r_ t_
LSR 0.1 NS 0.07 NS
PGSR 0.37 NS 0.34 NS
Lecithin
Concentration * 0.33 NS 0.2 NS
PG
Concentration * 0.67 p <.001 0.67 p <.001
Preterm 
(28-33 weeks)
T_
0.46 p <.03 
0.45 NS
0.89 p <.001
0.9 p <.01
*  (p m o lA )
T ab le  8 .1 9
Twin Pregnancy (33 weeks) Emergency Caesarean Section (Epidural)
Ruptured Membranes
Weight pH L/S PG Cortisol1 AD1 NAD1 RDS
(kg) (UA) Ratio
I 2.10 7.28 1 Present 190 1.7 8.6 No
II 2.02 7.27 1.97 Absent 330 1.3 5.4 Yes
(Dizygotic twin pregnancy) 
1 (nmol/5,)
T a b le  8 .2 0
Twin I  v Twin I I
Umbilical Arterial Cortisol (nmol/&)
Mean (SD)
Twin I Twin II
28-3:9 weeks 383 (199) 332 (176) p<.02*
(n = 61)
36-39 weeks 432 (199) 386 (161) p<.01*
(n = 36)
28-33 weeks 260 (132) 225 (160) NS
(n = 25)
* Paired ’ T1 Test
T a b le  8 .21
Correlation between Co-twins
UAC
Log UA NAD
Log UA AD
UA pH
Cord Blood
All Twins
(28-39 weeks)
r_
0.69 p <.001
0.63 p <.001
0.73 p <.001
0.16 NS
Biochemistry
Term 
(36-39 weeks)
r
0.38 p <.01
0.58 p <.01
0.58 p <.01
0.14 NS
Preterm 
(28-35 weeks)
r_
0.83 p <.001
0.82 p <.001
0.9 p <.001
0.34 NS
T a b le  8 .2 2
Twin I v Twin II
Umbilical Arterial Noradrenaline (nmol/g,) 
Mean (SD)
28-29 weeks 
(n = 61)
36-39 weeks 
(n = 36)
28-33 weeks 
(n = 25)
Twin I Twin II
20 (30) 29 (37) NS
23.4 (35) 35 (42) NS
13.1 (13) 14 (15.8) NS
T ab le  8 .2 3
28-29 weeks 
(n = 61)
36-39 weeks 
(n = 36)
Twin I  v Twin I I
Umbilical Arterial Adrenaline (nmol/1,)
Mean (SD)
Twin I Twin II
3.1 (2.7) 4.7 (6.3) NS
3.7 (2.8) 3.2 (3.3) NS
28-33 weeks 
(n = 25)
1.8 (1.7) 3.8 (8.2) NS
T ab le  8 .2 4
28-39 weeks 
(n = 61)
36-39 weeks 
(n = 36)
Twin I  v Twin I I
Umbilical Arterial pH 
Mean (SD)
Twin I Twin II
7.23 (.08) 7.21 (.1) NS
7.22 (.09) 7.22 (.07) NS
28-33 weeks 7.27 (.03) 7.20 (.15) NS
(n = 25)
T a b le  8 .2 5
TRIPLETS
C l in ic a l  and B io ch e m ica l Lung M a tu r ity  and S tre s s  Hormones
I Triplet Pregnancy (26 weeks) Vaginal Delivery
Weight
(kg)
pH
(UA)
L/S
Ratio
PG Cortisol' AD' NAD' RDS
I 0.94 7.33 1.0 Absent 87 2.6 21.7 Yes
II 0.88 7.26 0.85 Absent 182 3.8 38.6 Yes
III 0.90 7.36 0.70 Absent 78 5.0 40.2 Yes
2 Triplet Pregnancy (31 weeks) Emergency C/S (GA)
Membranes Intact
Weight pH L/S PG Cortisol' AD' NAD' RDS
(kg) (UA) Ratio
I 0.92 7.19 3.54 Present 430 0.8 38.6 No
II 1.32 7.16 4.22 Present 0.1 1.8 No
III 1.5 7.17 1.83 Present 135 0.31 20.9 Yes
3 Triplet Pregnancy (33 weeks) Emergency C/S
Weight pH L/S PG Cortisol' AD' NAD' RDS
(kg) (UA) Ratio
I 1.62 . 2.11 Present 138 3.0 293.6 No
II 1.75 - 1.67 Present 150 0.73 21.6 No
III 1.38 _ 5.74 Present 140 3.3 192.4 No
1 (nmol/il)
/F ig u re  8 .1
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CHAPTER 9
C o n d it io n  o f  th e  In fa n t  a t B i r t h
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Condition of the Infant at Birth
9.1 Introduction
The incidence of RDS has been shown to be higher among infants 
with low apgar scores (Jones et al 1975) and abnormal fetal heart rate 
patterns (Martin et al 1974, Hobel et al 1972), and several workers 
(De Sa 1969, Bruns et al 1961) consider that asphyxia plays a central 
role in the development of RDS.
The possible mechanisms whereby asphyxia may result in RDS was 
investigated by establishing the relationship between fetal acidosis 
and clinical outcome, amniotic fluid phospholipids, umbilical arterial 
cortisol and umbilical arterial catecholamines.
The babies were again divided into gestational age groups:- 24-29 
weeks, 30-33 weeks and 34-35 weeks as described in Chapter 4 
(Materials and Methods Section).
9.2 Results
9.2.1 Clinical outcome
From 30 weeks onwards, those babies who developed RDS, required 
ventilation or died were significantly more acidotic than those babies 
who had no respiratory difficulties (Tables 9.1, 9.2 and 9.3).
9.2.2 Amniotic fluid phospholipids
a) 'Mature* versus 'Immature' amniotic fluid phospholipid profile 
At each gestational age group (ie S 29 weeks, 30-33 weeks, 34-35 
weeks) a mature lung phospholipid profile (L/S £.2.0 + PG) was
compared to an immature profile (L/S <2.0 no PG) with respect to UApH 
(Table 9.4).
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In addition to the phospholipid profile, the L/S ratio alone and 
PG alone were also considered at each gestational age group (Tables 
9.5 and 9.6).
There were no significant differences in mean UApH between those 
babies with 'mature' compared with 'immature' amniotic fluid 
phospholipids.
b) Correlation between UApH and Amniotic fluid phospholipids
There was no significant correlation between UApH and the L/S 
ratio PG/S ratio, LECITHIN concentration or PG concentration (Table 
9.7).
9.2.3 Umbilical arterial cortisol
There is no obvious relationship between UApH and UAC levels in 
all cases studied (Figure 9.1) or after allowance for gestational age 
and method of delivery (Figures 9.2 and 9.3).
9.2.4 Umbilical arterial catecholamines
a) UA NAD
There was no obvious relationship between UApH and UANAD levels 
in the study as a whole (Figure 9.4). After correction for 
gestational age and method of delivery (Figure 9.5 and 9.6), only 
those babies delivered vaginally (SVD's) between 36-41 weeks 
demonstrated any significant correlation.
b) UA AD
There was no obvious relationship between UApH and UAAD levels 
(Figure 9.7) even after correction for gestational age and method of 
delivery (Figure 9.8 and 9.9).
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9.3 Discussion
The condition of the baby at birth, as indicated by the UApH had 
a significant effect on the occurrence of RDS, the requirement for 
ventilation and the ultimate survival of the infant. However, the 
study did not confirm previous work that acidosis causes a decrease in 
the production of phospholipids (Merritt & Farrell 1976, Smith & 
Torday 1974) as no significant differences in mean UApH were observed 
between those babies with 'mature' and those with 'immature' 
phospholipids.
In addition there was no correlation between UAph and L/S ratio 
PG/S ratio, lecithin or PG concentrations.
However, exudation of plasma proteins from the injured lung, 
secondary to hypoxia, may interfere with surfactant function and lead 
to RDS. In addition asphyxia may cause central depression and 
therefore interfere with the infant's respiratory efforts which result 
in initial lung expansion. This lung expansion normally helps to 
clear lung fluid resulting in an abrupt fall in pulmonary vascular 
resistance.
The lack of correlation between UApH and UAC is in agreement with 
Farquarson et al (1983) but in contrast to the findings of Martinsen 
et al (1982) who in a study of 108 full term neonates delivered 
vaginally, found a significant correlation between cord cortisol 
levels and UAph. In this latter study, however, in the UApH range in 
which most babies are born (7.20-7.30) there was a wide variation in 
UAC levels. The correlation depended on those babies having highest 
UAC levels when pH was < 7.20, suggesting a threshold response. No 
such UApH threshold for release of cortisol was found in this present 
study. Only those babies undergoing spontaneous vertex delivery in 
the term (36-41 weeks) group showed a significant correlation to UApH.
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Several other studies, however, have demonstrated a significant, 
correlation between cord blood NAD and pH in the term (Padbury et al 
1982, Falconer & Lake 1982) and in the preterm human fetus (Newham et 
al 1985). Bistoletti et al (1983) demonstrated a significant 
difference in mean cord NAD levels between babies with an UApH < 7.25 
compared to those with an UApH > 7.26.
In the study by Padbury et al (1982) the relationship between
UApH and UANAD became much less obvious when babies with UApH < 7.20
were omitted, again suggesting a threshold response.
Similarly no obvious relationship could be demonstrated between 
UApH and UAAD. This is in agreement with Bistoletti et al (1983) who, 
in term vaginal deliveries demonstrated no difference in UAAD levels 
between babies whose pH was less than 7.26 compared to those whose pH
was greater than 7.25. In contrast, however, Padbury et al (1982) in 
the term fetus demonstrated a significant correlation between UAAD and 
UApH which no longer held true when babies whose UApH was less than 
7.20 were omitted, again suggesting a threshold response. A 
significant correlation between UApH and UAAD was also demonstrated in 
the preterm neonate by Newham et al (1985).
It would seem, therefore, that there is evidence from the 
literature, although not substantially supported by the present study, 
to suggest that fetal catecholamine and cortisol levels are influenced 
by fetal acidosis to some extent. However, in the range of pH values 
in which most babies are born (ie > 7.20) there is a very wide
scatter of catecholamine and cortisol values and that it is only when 
the pH drops to below 7.20 that a significant relationship between pH 
and fetal stress products occur in most studies.
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9.4 Conclusions
The condition of the baby at birth, as reflected by the UA pH
had:
1 a pronounced effect on the occurrence of neonatal respiratory 
problems. Those babies who were more acidotic developed more 
respiratory problems.
2 no effect on the concentration of amniotic fluid phospholipids.
3 no obvious relationship to fetal UA levels of cortisol NAD and 
AD.
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T a b le  9 .1
Condition at Birth and Clinical Outcome 
RDS
Gestation RDS No RDS Significance *
Number 32 14
v< 29 weeks BW (kg) 1.06 (.3) 1.17 (.4) NS
UApH 7.23 (.1) 7.2 (.1) NS
Number 21 33
30-33 weeks BW (kg) 1.38 (.4) 1.72 (.4) NS
UApH 7.22 (.1) 7.28 (.08) p <.02
Number 5 64
34-35 weeks BW (kg) 2.3 (.2) 2.1 (.4) NS .
UApH 7.17 (.1) 7.25 (.09) NS
* Tests of Significance UApH Mann Whitney
BW Student's *T1 Test
T ab le  9 .2
Condition at Birth and Clinical Outcome 
Ventilation Requirements
Gestation Ventilation No Ventilation Significance *
Number 32 14
x< 29 weeks BW (kg) 1.06 (.3) 1.17 (.4)
UApH 7.23 (.1) 7.2 (.1)
NS
NS
Number 24 30
30-33 weeks BW (kg) 1.7 (.5) 1.8 (.5) NS
UApH 7.23 (.09) 7.28 (.08) p <.008
Number 8 61
34-35 weeks BW (kg) 2.17 (.3) 2.5 (.4) NS
UApH 7.11 (.1) 7.26 (.07) p <.01
* Tests of Significance UApH Mann Whitney
BW ' Student's 'T' Test
T ab le  9 .3
Condition at Birth and Clinical Outcome 
Survival
Gestation Died Survived Significance *
v.< 29 weeks
Number 
BW (kg) 
UApH
21
0.9 (.3)
7.2 (.1)
25
1.25 (.25) 
7.22 (.1)
NS
NS
30-33 weeks
Number 
BW (kg) 
UApH
7
1.6 (.6) 
7.15 (.1)
67
1.7 (.5)
7.27 (.07)
NS
p <.05
34-35 weeks
Number 
BW (kg) 
UApH
1.94 (.2) 
7.02 (.1)
66
2.16 (.4) 
7.26 (.08)
* Tests of Significance BW. - Student's 'T' Test
UApH - Mann Whitney
T a b le  9 .4
Condition at Birth and Amniotic Fluid Phospholipids 
L/S Ratio and PG
Gestation <2 No PG >2 + PG Significance
Number
29 weeks BW (kg) I N S U F F I C I E N T  D A T A  
UApH
Number 17 18
30-33 weeks BW (kg) 1.5 (.4) 1.8 (.4) NS
UApH 7.24 (.09) 7.28 (.08) NS
Number 7 39
34-35 weeks BW (kg) 2.14 (.3) 2.13 (.4)
UApH 7.21 (.1) 7.25 (.08)
NS
NS
T a b le  9 .5
Condition at Birth and Amniotic Fluid Phospholipids
L/S Ratio
Gestation < 2 2 Significance
Number
<<29 weeks BW (kg) I N S U F F I C I E N T  D A T A  
UApH
Number 44 23
30-33 weeks BW (kg) 1.65 (.4) 1.75 (.5) NS
UApH 7.26 (.08) 7.26 (.1) NS
Number 24 42
34-35 weeks BW (kg) 2.17 (.5) 2.13 (.4)
UApH 7.24 (.08) 7.26 (.09)
NS
NS
T ab le  9 .6
Condition at Birth and Amniotic Fluid Phospholipids
PG
Gestation Absent Present Significance
Number 36 10
^ 2 9  weeks BW (kg) 1.04 (.4) 1.32 (.3) p <.01
UApH 7.21 (.1) 7.22 (.1) NS
Number 29 45
30-33 weeks BW (kg) 1.7 (.5) 1.7 (.4) NS
UApH 7.25 (.1) 7.27 (.07) NS
Number 13 56
34-35 weeks BW (kg) 2.19 (.4) 2.15 (.4)
UApH 7.20 (.1) 7.26 (.07)
NS
NS
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Obstetric Complications
10.1 Introduction
Clinical experience over many years has suggested that certain 
obstetric complications are associated with a lower incidence of RDS, 
whilst others are associated with a higher incidence than expected 
(Chapter 3).
Premature rupture of the membranes - PROM (Chiswick 1973, Yoon 
and Harper 1973, Lee et al 1976, Sell 1977, Worthington 1977),
intrauterine growth retardation - IUGR (Procaindy et al 1980),
hypertension (Chiswick and Burnard 1973, Lee at al 1976) and
antepartum haemorrhage (Gluck et al 1972) have all been associated 
with an 'acceleration' of fetal lung maturity whilst neonates of 
diabetic mothers (Gluck and Kulovich 1973) are thought to be at 
greater risk of developing RDS.
Exactly how such obstetric stress influences fetal lung maturity 
is unknown. However, elevated cord blood and amniotic fluid cortisol 
levels have been found in pregnancies complicated by PROM (Murphy
A
1974 , Bauer et al 1974, Cohen et al 1976), pregnancy induced
hypertension (Goldkrand 1978) and IUGR (Sybulski 1977). Similarly,
elevated cord catecholamine levels have been noted in pregnancies 
complicated by preclampsia (Tunbridge & Donnai 1981, Sammour et al 
1980), by IUGR (Divers et al 1981) and by PROM (Blouquit et al 1979).
In this chapter the effect of various obstetric complications on 
clinical and biochemical lung maturity and on the levels of fetal 
cortisol and catecholamines was studied.
The evidence in the literature that premature rupture of the
membranes (PROM) causes an 'acceleration' of fetal lung maturity 
(especially biochemical lung maturity) is more convincing than for 
other other obstetric complications (Chapter 3). Therefore, the first
138
part of this chapter considers only PROM. In the second part of the 
chapter other complications, namely intrauterine growth retardation 
(IUGR), proteinuric hypertension, vaginal bleeding, abnormal antenatal 
cardiotocograph and spontaneous onset of labour and vaginal delivery 
were considered together.
10.2 Results
10.2.1 Premature rupture of membranes(PROM)
The first section of this chapter considers the effect of PROM on 
clinical outcome, amniotic fluid phospholipids and cord blood 
biochemical parameters.
Two groups of babies who laboured spontaneously, prior to 36 
weeks, were studied. In one group the membranes had been ruptured for 
less than 24 hours prior to delivery and this group was compared with 
a group whose membranes had ruptured > 24 hours prior to delivery. 
Because of the relatively small numbers involved, only 2 gestational 
age groups were considered, ie 24-29 weeks and 30-35 weeks. Although 
a higher percentage of babies were delivered by caesarean section in 
the group whose membranes had ruptured for < 24 hours, this was not 
statistically significant (Chi square) (Tables 10.1 and 10.2).
a) PROM and clinical outcome
There were no significant differences in mean birthweight or 
gestational age for those whose membranes had ruptured < 24 hours 
compared with > 24 hours, in either gestational age group (Tables
10.3 and 10.4).
Duration of rupture of membranes seemed to have no influence on 
clinical outcome - the occurrence of RDS, requirement for ventilation 
or mortality (Tables 10.3 and 10.4).
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b) PROM and amniotic fluid phospholipids
There was no significant difference in amniotic fluid 
phospholipids between those babies whose membranes had ruptured < 24 
hours compared to those with ruptured membranes > 24 hours in either 
gestational age group (Tables 10.5 and 10.6).
c) PROM and umbilical arterial cortisol
PROM ( > 2 4  hours) seemed to have no significant influence on
UAC levels (Table 10.7).
d) PROM and umbilical arterial catecholamines
PROM ( > 24 hours had no influence on mean UA NAD or AD levels
(Table 10.8).
e) PROM and umbilical arterial pH
PROM ( >24 hours) had no effect on condition of infant at birth
as reflected by the mean UA pH (Table 10.9).
10.2.2 Obstetric complications (other than PROM)
In this section the influence of 5 obstetric complications on 
clinical outcome, amniotic fluid phospholipids, umbilical arterial 
cortisol and catecholamines was studied. The 5 obstetric 
complications considered were, proteinuric hypertension - (a blood 
pressure of at least 140/90 accompanied by significant proteinuria 
>0.5 g/litre in a 24 hour hour collection), vaginal bleeding, 
intrauterine growth retardation - (birth weight < 5th centile for 
gestational age), an abnormal antenatal cardiotacograph - (no 
acceleration in a 20 minute tracing and/or the presence of 
decelerations), and a group of babies who had uncomplicated 
sponteneous onset of labour and vaginal delivery.
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Unfortunately it is not possible to obtain a control group of 
'normal' babies delivered prior to term, as the delivery of a preterm 
baby, either electively or spontaneously is not a normal event. Those 
babies undergoing spontaneous onset of labour and vaginal delivery are 
probably as close to a 'normal' group as can be obtained.
Some pregnancies were complicated by more than one problem (eg 
proteinuric hypertension and IUGR) and it was often impossible to 
assign one major complication to a particular case.
The babies were divided into the following gestational age 
groups, as previously outlined, ,<: 29 weeks, 30-33 weeks, 34-33 
weeks. In order to increase numbers in each group and thus allow more 
meaningful statistical analysis, a third group 30-35 weeks was also 
included.
Tables 10.10 to 10.13 show the number of babies for each 
obstetric complication, by gestational age and method of delivery.
Table 10.14 shows the mean birthweight for each complication in 
each gestational age group studied. It can be seen that the mean 
birthweight in the IUGR group was consistently significantly lower 
than that in the preterm labour or vaginal bleeding groups, but
similar to the proteinuric hypertension and abnormal CTG groups.
a) Obstetric complications and clinical outcome
The 5 complications assessed seemed to have little obvious effect 
on whether respiratory problems developed. In each gestational age 
group, the highest percentage of babies who died was in the group with 
abnormal CTGs (Tables 10.15 - 10.18).
b) Obstetric complications and amniotic fluid phospholipids
None of the 5 obstetric complications appeared to influence the
amniotic fluid phospholipids in any particular way (Tables 10.19 -
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10.22). Although an abnormal CTG was associated with a lower 
percentage of babies with amniotic fluid PG (Table 10.22).
c) Obstetric complications and umbilical arterial cortisol
None of the 5 obstetric complications appeared to affect the cord
blood cortisol in any consistently significant way. However after 33
weeks, the preterm labour group and the IUGR group had significantly 
raised mean UAC concentration compared to the proteinuric hypertension 
group (Table 10.23).
d) Obstetric complications and umbilical arterial catecholamines
None of the 5 obstetric complications appeared to affect the cord
blood catecholamines in any consistently significant way (Tables 10.24 
and 10.25).
e) Obstetric complications and condition of infant at birth
The mean UA pH was consistently depressed in babies delivered in 
response to an abnormal CTG (Table 10.26).
10.3 Discussion
It is believed that certain obstetric complications, eg pre 
eclampsia, IUGR, PROM, appear to protect the neonate from developing 
RDS and it has been suggested that they may do so by 'stressing' the 
fetus. However, in none of the obstetric complications investigated 
were the levels of so-called stress hormones NAD AD and cortisol 
consistently different from the others, particularly the 'control' 
group of spontaneously preterm labouring and vaginally delivered 
babies.
Of the obstetric complications considered only in pregnancies 
where there was an abnormal antenatal CTG was there a suggestion of a
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different clinical outcome. The higher percentage of babies dying or 
requiring ventilation were found in this group (Table 10.15 to 10.18). 
These babies were also in a poor condition at birth as reflected by 
the mean UA pH which was significantly lower in the abnormal CTG group 
compared with the other groups (except IUGR group), (Table 10.26). 
This difference in UA pH however was not reflected in the levels of 
the'other stress products measured, namely cortisol, noradrenaline and 
adrenaline which have been implicated in influencing neonatal 
respiratory function.
There was no evidence to suggest any difference in amniotic fluid 
phsopholipids between those babies undergoing the physiological stress 
of spontaneous preterm labour and vaginal delivery and the 
pathological stress of IUGR, proteinuric hypertension or vaginal 
bleeding. However, those babies who were severely stressed in the 
abnormal CTG group had the lowest occurrence of AFPG (Table 10.22).
No support could be found from this chapter for the idea of 
acceleration of fetal lung maturity (either clinical or biochemical 
lung maturity). However, this is not really surprising, considering 
the hypothesis of acceleration of fetal lung maturity as a result of 
obstetric complications implies that we know the normal timing of 
events in lung development in the human. How is it possible to derive 
a normal timetable for fetal lung maturation using prematurely born 
infants who, by definition are not normal, whether because of the time 
of their birth or underlying maternal pathology. The fact that more 
than one obstetric complication can, and often does occur in some 
pregnancies, makes the situation even more confusing and open to 
misinterpretation.
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It would seem therefore that the gestational age and the 
condition of the infant at birth are more important factors 
determining neonatal respiratory performance than obstetric 
complications which themselves led to premature delivery.
10.4 Conclusions
1 None of the obstetric complications studied, (proteinuric
hypertension, IUGR, vaginal bleeding, spontaneous preterm labour 
and vaginal delivery, PROM) appeared to cause an acceleration in 
either clinical or biochemical lung maturity.
2 None of the obstetric complications studied consistently effected
the levels of fetal stress hormones NAD, AD and cortisol in any 
particular way.
3 The gestational age and the condition of the infant at birth
would seem to be at least as important as any obstetric 
complications which may lead to preterm delivery.
4 The presence of an abnormal CTG seemed positively deleterious to 
the neonates, who required significantly more ventilatory 
support.
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Table 10.1
Membranes Ruptured < 24 hours 
Number of cases by gestational age and method of delivery
Gestation (weeks) Vaginal C/S All
25 3 0 3
26 2 1 3
27 2 0 2
28 3 2 5
29 8 2 10
30 5 1 6
31 3 2 5
32 4 4 8
33 5 7 12
34 12 8 20
35 7 4 11
ALL 54 (64%) 3? (300 85
Table 10.2
Membranes Ruptured 24 hours
Number of cases by gestational age and method of delivery
Gestation (weeks) Vaginal C/S All
24 1 0 1
28 2 1 3
29 2 1 3
30 1 0 1
31 1 0 1
32 4 0 4
33 2 0 2
34 3 2 5
35 2 0 2
ALL 18 (82%) 4 (18%) 22
Table 10.3
PROM and Clinical Outcome 
24-29 weeks' gestation
Membranes Ruptured 
< 24 hours > 24 hours
(n = 23) (n = 7)
Birthweight (kg) 
(Mean SD)
1.16 (0.3) 1.15 (0.5) NS
Gestation (weeks) 27.7 (1.5) 27.9 (1.7) NS
(Mean SD)
RDS (14/23) 61% (4/7) 57% NS
Ventilation (16/23) 70% (4/7) 575 NS
Died (7/23) 30% (3/7) 71! NS
Table 10.4
PROM and Clinical Outcome 
30-35 weeks' gestation
Membranes Ruptured
< 24 hours > 24 hours
(n = 62) (n = 15)
Birthweight (kg) 2.03 (0.4) 1.98 (0.5) NS
(Mean SD)
Gestation (weeks) 33.1 (1.5) 33.0 (1.5) NS
(Mean SD)
RDS 10/62 (16%) 3/15 (20?^ ) NS
Ventilation 14/62 (23?i5) 3/15 (20?<0 NS
Died 3/62 (5?^ ) 0/15 (0?«5) NS
Table 10.5
PROM and Amniotic Fluid Phospholipids 
Mean (SD)
24-29 weeks gestation
Membranes Ruptured 
< 24 hours > 24 hours
(n = 23) (n = 7)
L/S Ratio 1.2 (0.4) 2.2 (1) NS
PG/S Ratio 0.7 (0.4) INSUFFICIENT DATA
AFPG * (7/23) 305 (1/7) 145 NS
' Lecithin concentration 13.2 (2.2) INSUFFICIENT DATA
1 PG concentration 5.2 (1.5) INSUFFICIENT DATA
* PG present in amniotic fluid 
’ (ymolA)
Table 10.6
PROM and Amniotic Fluid Phospholipids 
Mean (SD)
30-35 weeks' gestation
L/S Ratio
Membranes Ruptured
<24 hours 
(n = 62)
2 . 1 9  ( 0 . 9 )
>24 hours 
(n = 15)
2 . 8  ( 1 . 9 ) NS
PG/S Ratio 1 .0 9  ( . 7 )  0 .9 5  ( . 6 )  NS
AFPG * ( 4 6 / 6 2 )  74?o ( 1 0 /1 5 )  67?o NS
'Lecithin concentration 2 6 . 4  (15 )  34 .2  (2 6 )  NS
PG concentration 5 . 4  ( 2 ) 6 . 3  ( 3 )  NS
* PG present.in amniotic fluid 
(pmol/S,)
Table 10.7
PROM and Umbilical Arterial Cortisol (nmol/i)
Mean (SD)
Membranes Ruptured 
<24 hours >24 hours
24-29 weeks 192 (108) 318 (203) NS
----------- (n = 23) (n = 7)
30-33 weeks 307 (183) 403 (172) NS
(n = 62) (n = 15)
t
Table 10.8
PROM and Umbilical Arterial Catecholamines (nmol/&)
Membranes Ruptured 
< 24 hours > 24 hours
UA NAD 12.3 (13) 19.3 (9.2) NS
24-29 weeks (n = 23) (n = 7)
UA AD 1.11 (0.9) 2.5 (2.6) NS
UA NAD 17.2 (42) 17.9 (17) NS
30-35 weeks (n = 62) (n = 15
UA AD 2.0 (1.7) 3.3 (3.1) NS
Table 10.9
24-29 weeks
30-35 weeks
PROM and Condition of Baby at Birth (UApH)
Membranes Ruptured 
< 24 hours > 24 hours
UApH 7.22 (.1) 7.26 (.06) NS
(n = 23) (n = 7)
UApH 7.27 (.08) 7.28 (.07) NS
(n = 62) (n = 15)
Table 10.10
Proteinuric Hypertension 
Gestation (weeks)
Delivery 29 30-33 34-33
Vaginal - - 2
Elective C/S 7 14 ^
Emergency C/S - - 2
7 14 13
Table 10.11
Vaginal Bleeding 
Gestation (weeks)
Delivery c  29 30-33 34-33
Vaginal 9 8 1
Elective C/S 1 2  1
Emergency C/S 4 8 4
14 18 6
Table 10.12
Abnormal Antenatal Cardiotocograph 
Gestation (weeks)
Delivery ^29 30-33 34-33
Vaginal 1 2 2
Elective C/S 4 8 4
Emergency C/S 1 - 2
6 10 8
Table 10.13
IUGR
Gestation (weeks)
Delivery <29 30-33 34-33
Vaginal 3 1 1
Elective C/S 3 7 10
Emergency C/S - 2 3
6 10 16
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CHAPTER 11
Fetal Cortisol
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Fetal Cortisol
11.1 Introduction
As discussed in Chapter 2, a number of animal studies (Liggins 
1969, De Lemos et al 1970, Kotas and Avery 1971), have tended to 
confirm the hypothesis of corticosteroid induction of enzymes involved 
in surfactant synthesis. Subsequently a trial of antepartum 
betamethasone treatment to human mothers threatening preterm labour 
apparently reduced the incidence of RDS (Howie and Liggins 1977). 
There is also some evidence in humans to suggest an endogenous 
deficiency antenatally in babies who subsequently developed RDS (Naeye 
et al 1971, Murphy 1974B, Sybulski and Maughan 1976).
Therefore it might be reasonable to propose that the suspected 
effect of stress on fetal lung maturity may be mediated via endogenous 
fetal cortisol production and that clinical and biochemical immaturity 
of the fetal lung would be less frequent when cortisol levels were 
highest.
This chapter will investigate the influence of fetal cortisol on 
clinical outcome (RDS, requirement for ventilation and survival), and 
the relationship between endogenous fetal•cortisol and the amniotic 
fluid phospholipids.
11.2 Results
11.2.1 Fetal cortisol and clinical outcome
The babies were again divided into gestational age groups:
29 weeks, 30-33 weeks, 34-33 weeks, as described in Chapter 3.
a) RDS
There was no significant difference in mean birthweight (Table 
11.1) or in percentage of babies delivered by Caesarean section 
between those babies with and without RDS (Table 11.2),
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Based on experimental and clinical evidence it might be expected 
that RDS would be less frequent when cortisol levels were highest. 
However there was no significant difference in mean UAC level in those 
babies with and without RDS before 34 weeks. In the 34-35 week group 
the babies with RDS had significantly lower UAC levels (Table 11.3).
b) Ventilation requirements
There was no statistically significant difference in mean 
birthweight, percentage of infants delivered by Caesarean section or 
mean UAC level in the babies who required neonatal artificial 
ventilation to those babies with minimal or no respiratory problems 
(Tables 11.4, 11.5 and 11.6).
c) Survival
There was no significant difference in mean birthweight between 
those infants who died or survived in each gestational age group 
(Table 11.7).
The mean UAC level was significantly lower in those babies who 
died in the 30-33 week group (Table 11.9). However the numbers are
small and a high percentage were delivered by Caesarean section 
compared to the survival group (Table 11.8).
11.2.2 Effect of fetal cortisol on amniotic fluid phospholipids
a) Correlation between fetal cortisol and amniotic fluid
phospholipids
The correlations between UAC and the amniotic fluid phospholipids 
- L/S ratio, PG/S ratio, lecithin concentration and PG concentration, 
are shown in Table 11.10 for all cases in study, in Table 11.11 for 
the Term group[ (36-41 weeks) alone and Table 11.12 for the preterm
group alone (24-35 weeks). In each table allowance is also made for
method of delivery.
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O v e r a l l  (T a b le  1 1 .1 0 )  th e  c o r r e l a t i o n s  were v e ry  poo r b u t
surprisingly statistically significant between UAC and the L/S, PG/S 
ratios and lecithin concentration, when all gestations were 
considered. After correction for gestational age (Tables 11.11 and 
11.12) only a few weak correlations remained in the preterm group (24- 
35 weeks) (Figures 11.1, 11.2 and 11.3).
b) • UAC levels in babies with mature and immature amniotic fluid
phospholipids
A similar percentage of babies were delivered by Caesarean 
section in the mature and immature phospholipid groups (Table 11.13).
There was no significant difference in mean birthweight between 
groups except when PG alone was considered. In this case those babies 
with PG present had a significantly higher mean birthweight compared 
to those with PG absent (Table 11.14), in the ^29 week group.
In the 3 situations investigated, phospholipid profile (L/S ratio
and PG ), L/S ratio alone and PG alone, there were no significant 
differences in mean UAC between those babies with mature and those 
with immature amniotic fluid phospholipids, at any gestational age 
group studied (Table 11.15).
Discussion
The beneficial effects of labour on lung function have often been 
attributed to increased surfactant synthesis secondary to the cortisol 
surge associated with labour (Fedrick and Butler 1972, Cabero et al 
1976). However this would seem an unlikely theory as it has been 
shown that exogenous steroids have no effect in preventing RDS unless 
given at least 24 hours before delivery (Liggins and Howie 1972, 
Dluholucky et al 1976).
Prior to 34 weeks there was no difference in mean UAC between 
those babies with and without RDS. However those babies developing
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RDS in the 34-35 week group had a significantly lower mean UAC lwevel. 
This may reflect the small numbers involved (only 5 cases of RDS),
however it is interesting that the main UAC surge occurs around 34
weeks (Figure 6.5) and it may be that those babies who develop RDS 
around this gestational age do not demonstrate this UAC surge.
The surge in UAC at around 34 weeks may result in a steroid 
induction of the enzymes involved in surfactant synthesis. However, 
no direct link was found between fetal cortisol levels and biochemical 
lung maturity as assessed by measurement of the amniotic fluid 
phospholipids (Tables 11.13, 11.14 and 11.15).
The finding of very weak but surprisingly statistically 
significant correlations between UAC and L/S, PG/S ratios and lecithin 
concentration (Table 11.10) suggested that endogenous fetal cortisol 
might influence surfactant levels. However as Chapter 6 has 
demonstrated there is a marked rise in both amniotic fluid
phospholipids and UAC with gestation. When the term group of babies
only were considered (Table 11.11) the correlations between UAC and 
the amniotic fluid phospholipids were no longer present, suggesting 
the correlations were not due to a direct effect of UAC on amniotic 
fluid phospholipids but rather to the compounding effect of 
gestational age. In the preterm group (24-35 weeks) some weak but 
significant correlations between UAC and amniotic fluid phospholipids 
remained (Table 11.2). These weak correlations were almost certainly 
due again to a gestational age effect as shown in Figures 11.4, 11.5
and 11.6. Therefore although both UAC and the amniotic fluid 
phospholipids increase with gestational age this does not mean that 
one necessarily influences the other.
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Fetal cortisol, however, may act in a different way by 'priming' 
the fetal adrenal medulla resulting in increased conversion of NAD to 
AD, which is the catecholamine most implicated in influencing fetal
lung maturity. This aspect will be considered in detail in Chapter 12.
d) Conclusions
1 UAC level did not relate to survival, requirement for ventilation 
or to the development of RDS before 34 weeks.
2 A significantly lower mean UAC level was found in babies 
developing RDS in the '34-35 week age group, suggesting a 
deficiency in the fetal cortisol surge in those babies, which is 
known to occur at this time.
3 No relationship was found between UAC levels and biochemical lung 
maturity as reflected by the amniotic fluid phospholipids.
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Table 11.1
Comparison of Birthweights in Babies 
With and Without RDS
Gestation (weeks) RDS No RDS
>< 29 1.06 (.3) 1.17 (.4) NS
(n = 32) (n = 14)
30-33 1.38 (.4) 1.77 (.4) NS
(n = 21) (n = 33)
34-35  2 .3  ( . 2 )  2 .1  ( . 4 )  NS
(n  = 5 )  (n  = 14)
Table 11.2
Percentage Delivered by Caesarean Section 
in Babies With and Without RDS
Gestation (weeks) RDS No RDS
29 31% 50%
(n = 32) (n = 14)
30-33 61% 53%
(n = 21) (n = 33)
34-35  40% 58%
(n  = 5 )  (n  = 64)
Table 11.3
The Effect of Fetal Cortisol on Occurrence of RDS 
UAC (nmol/&)
Gestation (weeks) RDS No RDS
^ 29 193 (94) 280 (189) NS
(n = 32) (n = 14)
30-33 217 (102) 227 (155) NS
(n = 21) (n = 53)
34-35  185 (9 0 )  368 (1 6 8 )  p < .0 2
(n  = 5 )  (n  = 64)
Table 11.4
Birthweight and Ventilation Requirements 
Birthweight (kg) Mean (5D)
Gestation (weeks) Ventilation No Ventilation
,<29 1.06 (.3) 1.17 (.4) NS
(n = 32) (n = 14)
30-33 1.7 (.3) 1.8 (.5) NS
(n = 24) (n = 30)
34-35 2.17 (.3) 2.15 (.4) NS
(n =8) (n = 61)
Table 11.5
Ventilation Requirements and 
Percentage of Babies Delivered by Caesarean Section
Gestation (weeks) Ventilation No Ventilation
^  29 31 % 50%
(n = 32) (n = 14)
30-33 70% 30%
(n = 24) (n = 50)
34-35 63% 56%
(n = 8) (n = 61)
Table 11.6
The Effect of Fetal Cortisol on Ventilation Requirements 
UAC (nmol/&) Mean (SD)
Gestation (weeks) Ventilation No Ventilation
<  29 193 (94) 280 (189) NS
(n = 32) (n = 14)
30-33 198 (101) 238 (156) NS
(n = 24) (n = 50)
34-35 300 (192) 361 (168) NS
(n = 8) (n = 61)
Table 11.7
Died or Survived
A Comparison of Birthweights (kg) Mean (5D)
Gestation (weeks) Died Survived
,< 29 0.9 (.3) 1.23 (.25) NS
(n = 21) (n = 25)
30-33 1.6 (.6) 1.7 (.5) NS
(n =7) (n = 67)
34-35 1.94 (.2) 2.16 (.4) NS
(n =3) (n = 66)
Table 11.8
Died or Survived
Percentage Delivered by Caesarean Section
Gestation (weeks) Died Survived
,< 29 38% 36% NS
(n = 21) (n = 23)
30-33 86% 53% NS
(n = 7) (n = 67)
34-35 67% 55%
(n =3) (n = 66) NS
Table 11.9
Effect of Fetal Cortisol on Survival 
UAC (nmol/&) Mean (SD)
Gestation (weeks) Died Survived
^  29 224 (108) 204 (104)
(n = 21) (n = 25)
30-33 155 (35) 229 (143)
(n =7) (n = 67)
34-35 540 (42) 347 (170)
(n =3) (n = 66)
NS
p< .01
NS
f
T a b le  11 .10
C o r r e la t i o n  between F e t a l  C o r t i s o l  and A m n io t ic  F l u i d  P h o s p h o l ip id s
All Gestations
Lecithin PG
UAC L/S Ratio PG/S Ratio Concentration Concentration
All Cases 0.4* 0.4* 0.4* 0.2
All Vaginal 0.43* 0.4* 0.4* 0.3
Elective C/S 0.24 0.28 0.3 0.01
Labour + C/S 0.43** 0.4° 0.3 0.1
*  p <.001 * *  p <.01 ° p <.02
Table 11.11
C o r r e l a t i o n  between F e t a l  C o r t i s o l  and A m n io t ic  F l u i d  P h o s p h o l ip id s
Term Group 36-41 weeks' gestation
UAC L/S Ratio PG/S Ratio Lecithin PG
Concentration Concentration
All Cases 0.18 0.3 0.1 0.1
Vaginal 0.2 0.3 0.1 0.2
Elective C/S 0.1 0.4 -0.3 -0.2
Emergency C/S 0.4 0.2 0.1 -0.04
No significant correlations
Table 11.12
Correlation between Fetal Cortisol and Amniotic Fluid Phospholipids 
Preterm Group 24-35 weeks' gestation
Lecithin PG
UAC L/5 Ratio PG/S Ratio Concentration Concentration
All Cases 0.2 -0.06 0.4* 0.02
Vaginal 0.4* -0.1 0.4* 0.1
Elective C/S -0.07 -0.2 0.09 -0.07
Emergency C/S 0.2 0.2 0.3 0.07
*  p <.01
0
*D
•H
CL
•H
>— 1
c O
o X
•H CL
X 0
O O
CD X
CO CL
c •o
CO •H
CD D
U r-H
CO L.
CO
0 O
CO •H
C_) X
O
>> •H
-O C
E
TD <
0
u 0
0 L<
> D
•H -L»
i— 1 0
0 IE
O
•u
0 c
0 0
•H
XI 0
0 Li
CD D
4-)
<4- 0
O E
E
0 l-H
cn
ro X
X X
c •H
0 3 :
o
Ll 0
0 0
CL •H
X
0
CD
C
•H
IA
X
0
4J
C o LA VO
0 r— LA
0 o°
0 O  II O  II <0- II
Li LA vo LA
CL C c C
V^ / S./
0  CD
C  CL
O
r-H
<
CD
CL 4-) /-N N
c VO ON IA
0 IA CM *—
0 s?
X IA II CM II ON II
< IA LA VO
C C C
CD S./ s_✓ Sw*
CL
0  CSl IA CM
c  a \ CMo  A
r—i 1 r- II rA n
C  CO VO LA
\ c C
O  X V_/ '— /
•H
X
0
QC
/—\
CO CM vfr
\ CM
_J V £>?
1 ON II CM II
CO lA VO
N c c
X
CD
Q_
+
0 CO ON
i— 1 CM 7^— IA
■H A\ oS S?i4_ a \ 1 A- II ON II
O VO
Li CO C C
Q_ \ v_^ '_/
X
"D
•H
CL
■H
i— l
O  CD
X  CL
CL
0  O
O  Z s
X ✓— ^
Q_ CM r— A-
oS oS
V 1 lA II a*» ii
VO l a :
CO C c
\ v_f ___
X
_
0
_Y
0
0
3
C
o ON IA LA
•H CM IA fA
X 1 1
0 v / OX / IA IA
0
0
CD
Bi
rt
hw
ei
gh
t 
(k
g)
 
- 
Me
an
 
(S
D)
 
in 
Ba
bi
es
 
wi
th
 
Im
ma
tu
re
 
an
d 
Ma
tu
re
 
Am
ni
ot
ic
 
Fl
ui
d 
Ph
os
ph
ol
ip
id
s
0
-u *
c /-"M /"S X—N /—N
0 IA O <r la <f NO
0 • r— • LA
0 __' —^ / V./
(-1 II n II
CL (A LA
rA c c r- C
0 CJ •v— « ^
C  Q_ —^ —^ CM
O
r-H
<
*
CD -■— „
Q_ -L> ,-"N X—----
C . vO LA ON <t IA
0 r— IA • CM • r—
0 s_X S_X
_Q II II II
<=C <r ON
O  C l"> c r- C
CD • V_X • N_' • '-X
CL r_ r— CM
_
lA  ^
CM • fA • CM
8 A\ 1 v-' CM v_x <f
O LA II IA II
i—1 CO r^ r—
<  \ • c • C
_l —^  '— ' CM ^
O
•H
4J
CO /—v X—s
QC LA A
CM
CO v-x CM
\  V 1
— I LA II r- ii
CO MD —^
\ • c • c
— I CM ^
CD
CL
+ X—X X—N
<fr CO <J- ON
0 CM • r— • IA
i— 1 . 1 N._X __/
• H  A\ II II
C- IA
O  CO 8 n r- C
p  \ • v_' • '—x
0___ 1 CM
TJ
•H
CL
•H
rH CD
O  CL
SZ
CL O
0  z /-- --o <r r>» IA x-n
-C CM • r- • r-
Q_ 1 '— * '—x
V II II
CO LA C r- C
\ • V_X • V-X
CM
_
0
ss
0
0
2
co ON IA LA
•H CM IA fA
4-> 1 1
0 v/ O-p IA IA
0
0
CD
O
V
Q.
UA
C 
Le
ve
ls
 
(n
mo
l/
g,
) 
in 
Ba
bi
es
 
wi
th
 
Im
ma
tu
re
 
an
d 
Ma
tu
re
 
Am
ni
ot
ic
 
Fl
ui
d 
Ph
os
ph
ol
ip
id
s
la
0iH
.a
ca
Q
CO
C_)
<
CO
0
CD
-P
c ✓-X /— X
0 /-V /-v I"" Ox '-X
CO Os O r- LA 'T- SO
0 Os r~ lA
U '— / __' X_/
Q_ II II II
CO O O
0  CJ CO c o  c SO C
C  Q_ t—  v_y CM x-' IA x^
O
i— 1
<
CO
Q_ -P ✓-X /-X
C o  '-x CM -"-x LA ^ ~x
0 fA SO SO OS IA
0 v- fA Tr- CM <:—  —^
JO V_/ x_s x_/
< II II II
CO SO CM
CO r- C LA C IA C
Q_ C M -- CM x_x rA x—'
_
CM '-x rx ^ -x
0  CM r- IA so CM
c <C r- CM <fr
O  a \ 1— __
1-1 c II II
<t to Q Os LA
O  C LA C
O  _1 I— CM '— fA -x^
•H Z
-P UJ
CO t— I
QC C_) /— X
t— 1 h- ^ -x lA ^ ~x
CO CM Li­ CM <f CO <f
\ la. xt r- CM
_J V 10 v_/ x_/
to II II
CO 2 CO CO
\ t— 1 O  C xf c
_ f CM x-' IA
CD
Q-
+ -^X -^X
CO CO ^ x
0  CM CO so os
i-H <c r—  r— r- IA
•H A\ 1— X_/ V — ->
Cp < II II
o  to Q lA IA
O  C SO C
0----- 1 1— CM ^ IA x-^
z
TD Ld
•H HH
CL CJ
•H (—)
-— I CO u .
O  Q_ la-
JZ IO
CL O to
0  Z Z /— X *--X
O ►—I CM ''-x IA
-C CM lA ^ ~x
Q_ r- *— rx
V x._s X.--'
II II
to CM l^ x
CM C IA C
CM x^ fA —
0
0
0
S
—
c
o OS IA LA
•H CM IA IA
-P 1 1
0 v / CO
4J IA fA
No 
si
gn
if
ic
an
t 
di
ff
er
en
ce
s
Figure 11.1
Relationship between Lecithin Concentration (ymol/&) and UAC (nmol/&)
Preterm Group (24-35 weeks) All Methods of Delivery
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Relationship between Lecithin Concentration (pmol/Jl) and UAC (nmol/ft)
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CHAPTER 12
Fetal Catecholamines
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Fetal Catecholamines
12.1 Introduction
Evidence is now accumulating that the catecholamines may have an 
important role to play in preparing the fetus for extrauterine 
existence, especially with regard to lung function (Olver 1981).
Infusion of AD into fetal lambs causes absorption of lung fluid 
(Lawson et al 1978) and a correlation between endogenous AD 
concentration and lung liquid absorption has also been noted in animal 
experiments (Brown et al 1981). In addition to aiding the absorption 
of fluid from the fetal lungs there is also evidence to suggest that 
catecholamines may cause an increase in surfactant release (Lawson et 
al 1978, Enhorning et al 1977, Dobbs and Mason 1979). Those effects 
have been blocked by propranolol in animal experiments Abdellatif and 
Hollingsworth 1979), implying that they are mediated via Beta 
receptors. This theory is supported by observations on rabbit and 
lamb fetuses infused with Beta sympathomimetic drugs (Wyazogrodski et 
al 1974, Corbet et al 1977, Bergman & Hedner 1978, Enhorning et al 
1977, Brown et al 1981, Walters and Olver 1978). In humans, treatment 
with Beta mimetic drugs in an attempt to suppress preterm labour and 
delivery, has been associated with a decreased incidence of RDS (Kero 
et al 1973, Boog et al 1973). Woodman et al (1978) noted a 
significant correlation between the ratio of amniotic fluid NAD/AD and 
L/S ratio and Artal et al (1979) found that mature amniotic fluid 
phospholipid profiles correlated significantly with rising metanephine 
levels. Therefore, stress in the form of the physiological stress of 
labour or the pathological stress of certain obstetric complications 
may act via endogenous fetal catecholamines to promote optimal lung 
function as discussed in Chapter 2.
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This chapter will investigate the influence of fetal 
catecholamines on clinical outcome (RDS, requirement for ventilation 
and survival), and the relationship between endogenous fetal 
catecholamines and the amniotic fluid phospholipids. In addition, 
where an attempt was made to suppress labour by use of intravenous 
Ritodrine the influence of this Beta sympathomimetic drug on clinical 
outcome and amniotic fluid phospholipids was also considered.
12.2 Results
12.2.1 Fetal catecholamines and clinical outcome
The babies were divided into gestational age groups ^ 29 weeks, 
30-33 weeks, 34-33 weeks as outlined in Chapter 5.
a) RDS
There was no significant difference in mean birthweight (Table 
11.1) or in the percentage of babies delivered by Caesarean section 
between those babies with and without RDS (Table 11.2).
NAD
The mean UA NAD concentration was significantly lower in those 
babies developing RDS ^  29 weeks (Table 12.1). However this was not 
found consistently in the other gestational age groups.
AD
There were no significant differences in mean UA AD concentration 
between the 'RDS' and 'no RDS1 groups (Table 12.1).
NAD/AD Ratio
There was some evidence in Chapter 6 to suggest that compared to 
the term baby, the preterm baby had lower NAD and AD levels and that 
the ratio of NAD/AD may be higher in the preterm. In particular 
Figure 6.24 identified a group of preterm babies with high NAD/AD
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ratios and low cortisol levels. These babies might be considered 
biochemically immature and at increased risk of developing RDS. 
Figure 12.1 shows the relationship between UA NAD/AD ratios, UAC 
levels and the occurrence of RDS. However, RDS did not occur 
predominantly in those babies with high NAD/AD ratios and low cortisol 
levels.
Rit'odrine Treatment
One hundred and thirty one babies laboured spontaneously. An 
attempt was made to suppress labour in 54. In the remainder no 
treatment was initiated as obstetric complications contraindicated 
their use or labour was so advanced as to make any attempt at 
suppression worthless.
There was no significant difference in mean birthweight or the 
percentage of babies delivered by Caesarean section in those babies 
treated and not treated with ritodrine (Table 12.2 and 12.3). There 
was no significant difference in incidence of RDS between the treated 
and non treated groups (Table 12.4).
b) Neonatal Ventilation Requirements
There was no difference in mean birthweight or percentage of 
babies delivered by Caesarean section between those babies who 
required and those who did not require mechanical ventilation (Table
11.4 and 11.5).
NAD
In the ^29 week group those babies who required mechanical 
ventilation had a significantly lower mean NAD concentration. After 
this gestation, however, no differences in NAD concentration were 
found between those babies requiring and not requiring artificial 
ventilation (Table 12.5).
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AD
There were no statistically significant differences in mean UA AD 
concentration between those babies who required ventilation and those 
who did not (Table 12.5).
Ritodrine Treatment
There was no significant difference in the requirement for 
neonatal mechanical ventilation between those babies who had and those 
who had not been given tocolytic therapy (Table 12.4).
c) Survival
There was no significant difference in mean birthweight or in 
percentage of babies delivered by Caesarean section between those
babies who died and those who survived (Tables 11.7 and 11.8)
NAD
There was no obvious relationship between fetal NAD levels and 
survival of the baby (Table 12.6).
AD
Similarly AD levels did not relate to the chance of the baby 
surviving (Table 12.6).
12.2.2 Effect of fetal catecholamines on amniotic fluid phospholipids
a) Correlation between fetal catecholamines and amniotic fluid 
phospholipids
There were no significant correlations between UA NAD or UA AD
and the amniotic fluid phospholipids for all cases in study (Tables
12.7 and 12.8) or after considering them as a term group (Tables 12.9 
and 12.10) and a preterm group (Tables 12.11 and 12.12).
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b) UA NAD and AD levels in babies with mature and immature amniotic
fluid phospolipids
The percentages of babies delivered by Caesarean section have 
already been shown in Tables 11.13 and the birthweights in each group
in Table 11.14, for those babies with mature and immature
phospholipids.
At each gestational age group studied, a mature lung phospholipid
profile (L/S ^ 2 + PG) was compared to an immature profile (L/S < 2.0
no PG) with respect to UA NAD and AD (Table 12.13 and 12.14).
In addition to the L/S ratio combined with PG, the L/S ratio
alone and PG alone (Tables 12.13 and 12.14) were also considered at 
each gestational age group.
There were no significant differences in UA NAD or UA AD levels
between those babies with mature and those with immature
phospholipids.
c) Beta sympathomimetic treatment and amniotic fluid phospholipids
There were no significant differences in mean L/S, PG/S ratios or 
mean lecithin or PG concentrations between the treated and non treated
groups at any gestational age (Tables 12.15 - 12.17).
Although the percentage of babies with amniotic fluid PG present
was higher in the treated groups in no case did this reach statistical
significance (Chi squared).
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Discussion
Despite the evidence available from many animal experiments 
showing the importance of catecholamines specially AD in the 
achievement of optimal lung function (Chapter 2), the mechanism 
linking fetal stress with lung maturity as outlined in Figure 2.2, 
could not be supported in the human from the results of this Chapter.
In contrast to corticosteroids, (Chapter 11) the catecholamines 
are quick acting and during labour may reach extremely high levels in 
some babies. These levels are extremely high even in comparison to 
adult patients with a phaechromocytoma and therefore one might have 
expected to find some evidence linking them with neonatal respiratory 
function as suggested by Olver (1981) and others.
However there was no direct link found between the levels of 
fetal catecholamines and the development of RDS, neonatal ventilation 
requirements or the biochemical maturity of the fetal lung making it 
very unlikely that a fetal catecholamine surge has a major influence 
on neonatal lung function in humans.
It has been suggested that fetal cortisol may act in a different
way by 'priming1 the fetal adrenal resulting in increased conversion
of NAD to AD, which is the catechoiamine most implicated in
influencing fetal lung maturity (Chapter 6). The glucocorticoids are
known to regulate the activity of phenylethanolamine-N-methyl
transferase (PMMT) (Wurtmann & Axelrod 1966). This enzyme is
necessary for the N-methylation of NAD, thus converting it to AD, and
is mainly located in the adrenal medulla. The adrenal medulla,
«
situated in close proximity to the cortex is exposed to increasing 
concentration of glucocorticoids as gestation . advances, thus 
encouraging the N-methylation of NAD resulting . in increasing 
concentrations of AD. A neonate with a low cortisol level and a high 
NAD/AD ratio could be considered biochemically immature and at
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increased risk of developing RDS. However Figure 12.1 has shown that 
the development of RDS was not confined to those babies with a 
combination of high NAD/AD ratios and low cortisol.
It has been suggested that fetal catecholamines have an important 
role to play in preparing the fetus for extrauterine existence, not 
just in promoting lung maturity but in glucose homeostatis, 
cardiovascular changes and via non shivering thermogenesis (Phillipe 
1983, Artal 1980).
However a recent paper by Falconer and Poyser (1986) could find 
little evidence to support sympathoadrenal mediated metabolic 
responses in the human fetus. Interestingly Jones et al (1985) noted 
that human fetal platlets showed an impaired alpha 2 adrenoreceptor 
function with absent aggregatory responses to adrenaline compared to 
adult platlets. The defect in adrenoreceptor function in the fetus 
was not thought to be due to changes in the number of fetal platlet 
alpha receptors nor to changes in receptor affinity for adrenaline, as 
fetal platlets failed to aggregate to adrenaline from deliveries with 
high and low cord blood catecholamines. The possibility remains 
therefore that despite several reviews suggesting an important role 
for the catecholamines (Phillipe 1983, Artal 1980), the human fetus 
may not be capable of responding to these very high catecholamine 
levels because of a deficiency in adrenoreceptor function. This would 
be in keeping with our findings which show a lack of efect of NAD nd 
AD on fetal lung maturity.
Treatment of the pregnant mother with intravenous ritodrine in an 
attempt to suppress preterm labour did not seem to influence he 
incidence of RDS or the requirement for ventilation, not were there 
any significant differences in the amniotic fluid phospholipids 
between the babies of treated and non-treated mothers. Although this 
was not a randomised controlled trial to test the possible benefit of
158
Beta mimetic treatment on functional lung maturity there was little to 
suggest that such drugs will be useful.
It does not appear that the fetal stress hormones, the
catecholamines, have a major role to play in influencing neonatal lung 
function.
12.4 Conclusions
1 The level of fetal catecholamines had no influence on incidence
of RDS or requirement for ventilation.
2 There was no obvious relationship between fetal catecholamine
levels and biochemical lung maturity as assessed by measurement 
of amniotic fluid phospholipids.
3 Treatment of the mother with the Beta sympathomimetic drug
ritodrine had no influence on clinical or biochemical lung
maturity. This was not however a controlled study.
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Table 12.2
Effect of Ritodrine Treatment 
Method of Delivery 
(24-35 weeks)
Treated Non Treated
(n = 54) (n = 77)
Vaginal Delivery 69% 62%
Caesarean Section 31% 38%
Table 12.3
Effect of Ritodrine Treatment 
Birthweight (kg) Mean (SD)
Gestation (weeks) Treated Non Treated
v< 29 1.14 (.2) 1.14 (.5)
(n = 22) (n = 15)
30-33 1.7 (0.4) 1.79 (0.3)
(n = 20) (n = 29)
34-35 2.15 (0.2) 2.3 (0.4)
(n = 12) (n = 33)
No significant differences
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Table 12.7
Correlation between UA NAD (nmol/&) and Amniotic Fluid Phospholipids
All Gestations
Lecithin PG
L/S PG/S Concentration Concentration
ii mol/Ji) (ymol/il)
All Cases 0.14 0.01 0.14 -0.02
Vaginal Delivery 0.12 0.04 0.1 -0.05
Elective
Caesarean Section 0.13 -0.08 0.1 -0.02
Labour +
Caesarean Section 0.08 -0.11 -0.07 -0.1
Table 12.8
Correlation between UA AD (nmol/il) and Amniotic Fluid Phospholipids
All Gestations
L/S
Lecithin PG
PG/S Concentration Concentration
(ymol/£) (ymol/£)
All Cases 0.12 0.07 0.17 0.03
Vaginal Delivery 0.12 0.09 0.16 -0.09
Elective
Caesarean Section 0.01 - 0.02 -0.06 - 0.02
Labour +
Caesarean Section 0.08 0.07 0.7 0.3
Table 12.9
Correlation between UA NAD (nmol/il) and Amniotic Fluid Phospholipids
Term Group (36-41 weeks)
L/S PG/S
Lecithin
Concentration
{ymol/£)
PG
Concentration 
(ymol/a)
All Cases - 0.01  - 0.1 0.02 - 0.1
Vaginal Delivery -0.03 0.01 0.02 -0.16
Elective
Caesarean Section 0.12 -0.34 -0.4 - 0.02
Labour +
Caesarean Section -0.1 -0.3 -0.4 -0.4
Table 12.10
Correlation between UA AD (nmol/ft) and Amniotic Fluid Phospholipids
Term Group (36-41 weeksD
L/S PG/S
Lecithin
Concentration
(y mol A )
PG
Concentration
(ymolA)
All Cases -0.06 -0.05 -0.03 -0.08
Vaginal Delivery -0.09 0.06 -0.04 -0.19
Elective
Caesarean Section 0.05 -0.34 -0.43 0.12
Labour +
Caesarean Section. -0.12 -0.2 -0.26 0.04
Table 12.11
Correlation between UA NAD (nmol/g,) and Amniotic Fluid Phospholipids
Preterm Group (24-35 weeks)
L/S PG/S
Lecithin PG
Concentration Concentration
(ymol/il) ( y m o l A )
All Cases 0.08 -0.04 0.03 - 0.1
Vaginal Delivery -0.01 -0.3 -0.06 -0.29
Elective
Caesarean Section -0.01 0.2 -0.13 -0.13
Labour +
Caesarean Section 0.3 0.1 0.1 0.15
Table 12.12
Correlation between UA AD (nmol/jQ and Amniotic Fluid Phospholipids
Preterm Group (24-35 weeks)
L/S PG/S
Lecithin
Concentration
(ymol/£)
PG
Concentration
(ymol/O
All Cases 0.07 0.1 0.08 -0.08
Vaginal Delivery 0.14 -0.15 0.11 -0.3
Elective
Caesarean Section -0.16 -o;33 -0.15 -0.14
Labour +
Caesarean Section 0.2 0.3 0.1 0.45
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Table 12.15
L/S Ratio
PG Present
PG/S Ratio
Lecithin
Concentration
(ymol/il)
PG
Concentration
(vimol/il)
Effect of Ritodrine Treatment 
Amniotic Fluid Phospholipids - Mean (SD) 
24-29 weeks
Treated Non Treated
(n = 22) , (n = 15)
1.27 (0.5) 1.42 (0.7)
(8/22) 365K (1/15) 7%
0.68 (0.3) INSUFFICIENT DATA
13.2 (2.5) 12.7 (0.8)
4.8 (1.5) INSUFFICIENT DATA
No significant differences
Table 12.16
Effect of Ritodrine Treatment 
Amniotic Fluid Phospholipids - Mean (SD)
L/S Ratio
PG Present
PG/S Ratio
Lecithin
Concentration
(ymol/£)
PG
Concentration
(]jmol/&)
30-33 weeks
Treated 
(n = 20)
2.3 (1.1)
(13/20) 75%
0.9 (0.6)
23.6 (8.8)
4.4 (2.5)
Non Treated 
(n = 29)
1.9 (1.2)
(17/19) 59%
0.8 (0.5)
21.2 (8.9)
5.4 (2.2)
No significant differences
Table 12.17
Effect of Ritodrine Treatment 
Amniotic Fluid Phospholipids - Mean (SD)
L/S Ratio
PG Present
PG/S Ratio
Lecithin
Concentration
(pmol/£)
PG
Concentration
(pmol/Jl)
34-35 weeks
Treated 
(n = 12)
3.18 (2)
(12/12) 100%
2.1 (2.5)
34.2 (21.4)
5.3 (0.6)
Non Treated 
(n = 33)
2.5 (1.4)
(24/33) 73%
0.9 (0.5)
32.2 (21.6)
6.1 (2)
No significant differences
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CHAPTER 13
A m n io t ic  F lu id  P h o s p h o lip id s  and C l in i c a l  Outcome
160
Amniotic Fluid Phospholipids and Clinical Outcome
13.1 Introduction
This chapter will consider the influence of amniotic fluid 
phospholipids on clinical outcome. Firstly, the clinical outcome 
(RDS, necessity for ventilation and survival) will be compared between 
those babies with and without a mature amniotic fluid phospholipid 
profile. A mature phospholipid profile is defined as an L/S ^2.0 +
PG. The effect of PG alone or an L/S ratio < 2.0 or ^ 2.0 will also 
be investigated. Secondly, the amniotic fluid phospholipids will be 
compared in those babies with or without a favourable outcome (RDS, 
requirement for ventilation and survival).
As before the preterm babies ( \ 35 weeks) were divided into the
following gestational age groups: ^ 29 weeks, 30-33 weeks, 34-35.
13.2 Results
13.2.1 Clinical outcome in babies with immature and mature amniotic 
fluid phospholipids
a) L/S Ratio + Presence or Absence of PG (The phospholipid profile)
(Only 2 babies had L/S ^ 2 in ^ 29 week group and therefore this 
group has been omitted from Table 13.1.)
When the L/S < 2 and no PG was present nearly 60?o of babies 
developed significant respiratory problems and almost one third died 
between 30-33 weeks (Table 13.1).
In contrast a mature amniotic fluid phospholipid profile (L/S ^2 
+ PG) was associated with an excellent outcome for the baby both with 
regard to morbidity and mortality.
b) Consideration of L/S ratio alone (Table 13.2)
When the L/S ratio ^ 2.0 the babies had statistically 
significantly less respiratory problems and although fewer babies died
161
when L/S ^2.0, this did not reach statistical significance.
c) Consideration of PG alone (Table 13.3)
The presence of PG in the amniotic fluid was associated with 
considerable advantage to the neonate, in terms of a significantly 
reduced incidence of respiratory problems and an increased chance of 
survival.
13.2.2 Amniotic fluid phospholipids in babies with unfavourable and 
favourable outcomes
a) RDS
The relationship between the amniotic fluid phospholipids and the 
occurrence of RDS is shown in Table 13.4 in each gestational age 
group.
When PG was absent a higher percentage of babies developed RDS 
(statistically significant at 34-35 weeks). In addition, at 34-35 
weeks those babies developing RDS had significantly lower mean L/S 
ratios and lecithin concentrations than those babies with no RDS.
b) Neonatal ventilation requirements
In the ^ 29 week age group the data were identical to Table 13.4. 
In the 34-35 week (Table 13.5) age group the mean L/S ratio and
lecithin concentration was significantly lower in those babies who
required ventilation.
Significantly fewer babies had PG present when ventilation was 
required (Table 13.5) in the 34-35 week group.
c) Survival (Table 13.6)
Fewer amniotic fluids contained PG amongst pregnancies in which
the babies died. This was statistically significant in each
gestational age group. Of the 31 babies who died only 6 % had PG 
present compared to almost 70?o in those babies who survived in the age
162
group 24-35 weeks.
In addition, those babies who died had a statistically 
significantly lower mean L/S ratio and mean lecithin concentration 
compared to those babies who survived in the 30-33 week gestational 
age group.
13.3 Discussion
The amniotic fluid L/S ratio has become the standard biochemical 
method of assessing fetal lung maturity (Gluck et al 1971). However 
it is rather an insensitive method as although a mature L.S ratio is 
unlikely before 34 weeks' gestation, the incidence of RDS may be as 
low as 12.9% at 32-33 weeks and 56% at 30-32 weeks (Howie and Liggins 
1977). In an attempt to improve the prediction of neonatal RDS, Gluck 
and his colleagues (Kulovich et al 1979) developed a more specific 
test, the lung profile which included as well as the L/S ratio, the 
percentages of other phospholipids, phosphatidylinositol and PG. 
While this profile gave a more complete evaluation of the fetal lung, 
it has been shown that only the L/S ratio and the presence or absence 
of PG are important indicators of the risk of RDS. The L/S ratio 
alone, PG alone and the phospholipid profile of L/S ratio + PG have 
been used in this chapter as a biochemical assessment of fetal lung 
maturity. The importance of these phospholipids in the development of 
respiratory problems and indeed the survival of the baby has been 
confirmed in this chapter. In a recent paper by Whittle et al (1986) 
the chance of survival is strikingly improved when PG is present 
regardless of gestational age. In addition there is less need for 
ventilatory support and the incidence of intraventriculai? haemorrhage 
and patent ductus arteriosis is much lower, for babies in whom PG is 
present.
The occurrence of RDS when amniotic fluid PG was present is
163
higher in this chapter compared to other published series (Whittle et 
al 1981). However, as outlined in Chapter 5, in order to avoid 
confusion over the diagnosis of RDS in cases where only mild 
respiratory problems (ie not requiring ventilatory support) were 
present the RDS group in this Chapter only contained those babies 
requiring artificial ventilation either by CPAP or IPPV.
It is this group in which serious problems of morbidity and 
mortality occur.
13.4 Conclusions
This Chapter demonstrates clearly the importance of the surface 
active phospholipids, especially PG, which make up lung surfactant not 
only in the development of RDS and requirement for ventilation but 
also for the eventual survival of the baby.
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CHAPTER 14
Final Discussion
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F in a l  D is c u s s io n
The aim s o f  t h i s  s tu d y  as o u t l in e d  in  C hap te r 4 w e re : -
1 To evaluate certain obstetric factors, considered to influence
fetal lung maturity.
2 To investigate what controls respiratory maturity in the human
. fetus.
3 To evaluate human fetal adrenal cortical and medullary activity
from mid-trimester until term.
14.1 The basis of the study
The basis of the study is outlined in Figure 2.2 and revolves 
round the concept of fetal stress in utero being the interlinking 
factor between the various obstetric factors and fetal lung maturity.
Fetal stress is not easily defined, but it relates to the fetal 
condition which may be found not only in the presence of certain 
obstetric complications (PROM, IUGR, hypertension, antepartum 
haemorrhage and acidosis) but also physiologically as a result of 
labour and particularly vaginal delivery.
It has been the clinical impression for many years that certain 
’stressful' pregnancy complications appear to be associated with a 
generally improved neonatal outcome. The reason for this is unclear 
but it has been proposed that a hostile intrauterine environment may, 
perhaps as a result of relative hypoxia, promote the release of 
hormones such as cortisol and catecholamines. These hormones may 
facilitate the maturational processes, particularly in the lung and so 
help to prepare the fetus for extrauterine life. The concept of fetal 
stress hormones, cortisol and catecholamines being the final common 
pathway in the modification of lung maturity is derived both from
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animal experiments and clinical experience. As discussed in Chapter 
2, Farrell and Zackman (1973) have shown that the enzymes involved in 
catalising the synthesis of the phospholipids can be influenced by 
corticosteroids. A number of animal studies have tended to confirm
the idea of steroid induction of the enzymes involved in surfactant
synthesis (Liggins 1969, De Lemos et al 1970, Kotas and Avery 1971, 
Wang et al 1971, Chiswick et al 1973, Motoyama et al 1971). These 
findings are supported by research demonstrating that fetal lungs of 
rabbits, lambs and humans all contain the specific glucocorticoid 
receptor (Ballard and Ballard 1972 and 1974).
Subsequently, studies in humans have found a reduction in the 
incidence of RDS following treatment of pregnant mothers with 
corticosteroids (Liggins and Howie 1972, Howie and Liggins 1977, 
Ballard and Ballard 1976, Block et al 1977, Schutte et al 1980,
Kennedy 1974, Caspi et al 1976, Morrison 1978). Unfortunately not all 
these studies were double blind or had adequate controls. A few small 
studies in humans have noted a rise in L/S ratio following
corticosteroid treatment (Spellacy et al 1973, Eklund et al 1976, 
Zuspan et al 1977, Diedrich et al 1978). In addition, there is some 
evidence to suggest a corticosteroid deficiency in RDS (Naeye et al 
1971, Murphy 1974 A and B, Sybulski and Maughan 1976).
Exogenous corticosteroid treatment antenatally seems to influence 
fetal lung maturity and it might be reasonable to propose as in Figure
2.2 that the effect of stress on fetal lung maturity is mediated via 
endogenous cortisol production by the fetus.
Although the production of surfactant may be controlled, at least 
partly, by adrenocortical hormones, it has been suggested that in 
addition to dehydrating the fetal lungs (Chapter 2) the catecholamines 
may cause an increase in surfactant release (Lawson et al 1978, 
Abdellatif and Hollingsworth 1979). These effects of catecholamines
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were blocked by propranolol, suggesting a Beta receptor response.
In the human, a number of workers have noted a reduced incidence 
of RDS in preterm babies whose mothers were treated with Beta mimetic 
drugs in an attempt to suppress labour (Kero et al 1973, Boog et al 
1973, Hastwell 1977).
Therefore available evidence in the literature would suggest that 
both cortisol and the catecholamines may be important modulators of 
surfactant synthesis and release. Situations of stress, either 
physiological or pathological, resulting in a rise in cortisol and the 
catecholamines should therefore be theoretically beneficial to the 
human fetus.
The literature regarding the adrenocortical and sympathoadrenal 
responses to the various physiological and pathological stress factors 
were reviewed extensively in Chapter 3. It is apparent that knowledge 
regarding these stress responses is more complete for the term than 
the preterm human fetus. This is especially true for the 
sympathoadrenal responses in the preterm human fetus. Two studies 
involving small numbers have shown conflicting evidence. Lagercrantz 
and Bistoletti (1973) found that preterm infants had lower cord 
catecholamine levels compared with the term fetus while Newnham et al
(1984) found significantly higher AD levels in 36 preterm compared to 
a group of term neonates.
During the course of this study the adrenocortical and 
sympathoadrenal responses of the human fetus were studied from 24 to 
41 weeks' gestation in a large number of babies at birth.
Information is even more sparse concerning the preterm babies' 
stress responses in the face of various obstetric complications 
(discussed in Chapter 3) and these were studied in detail in 
Chapter 10.
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1 4 .2  What d id  th e  s tu d y  d e m o n s tra te ?
Chapter 6 Influence of gestational age on clinical and biochemical 
lung maturity and fetal stress responses
Gestational age had a marked influence on clinical lung maturity 
- the incidence of RDS, and mortality increasing with decreasing 
gestational age below 34-35 weeks, and on biochemical lung maturity - 
the important surface active phospholipids lecithin and PG increasing 
with gestational age.
Gestational age also had a major influence on the fetal 
adrenocortical responses. UAC levels increased with gestational age, 
especially after 34 weeks, and seems to parallel the rise in amniotic 
fluid phospholipids and suggests that cortisol levels might have an 
influence on surfactant.
The proposed influence of exogenous corticosteroids on fetal lung 
maturity (Howie and Liggins 1977) raises the probability that 
corticosteroids transferred from the mother may add to fetal cortisol 
to influence fetal lung maturity. It is felt that most of the free 
cortisol in the fetal circulation originates from the fetal adrenal 
gland, the contributions of the maternal cortisol being of lesser 
importance (Chapter 2 p 43). However there was some evidence in this 
Chapter (p109) suggesting that fetal cortisol levels may be influenced 
by high maternal venous levels associated with vaginal delivery, 
especially in the preterm labour.
Cortisol may facilitate maturation of the fetus in another way by 
'priming' the fetal adrenal medulla, ie by increasing the conversion 
of NAD to AD, which is the catecholamine most associated with 
optimising neonatal lung function.
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This could not be substantiated in this study however as there 
was no obvious relationship between UAC levels and the UA NAD/AD ratio 
(p 103).
This may be far too crude a method of assessing this however as 
varying quantities of NAD are probably released from extraadrenal 
chromaffin tissue and from adrenergic nerve endings which would 
distort the NAD/AD ratio and may mask a possible relationship with 
fetal cortisol.
In contrast to cortisol, gestational age did not have such a 
marked effect on the fetal catecholamines. However, in those babies 
delivered vaginally, the preterm group (24-33 weeks) had significantly 
lower NAD and AD levels than the group of babies born in the term 
group (36-41 weeks). This is in contrast to the finding of higher AD 
levels in the preterm fetus by Newham and colleagues (1984). However 
this was a much smaller series of preterm babies (36) compared to the 
present study, the results of which tend to support the work of 
Lagercrantz and Bistoletti (1973) who found lower catecholamine levels 
in 16 preterm babies compared to a group at term.
The highest NAD/AD ratios were found in the preterm group of 
babies and there was some evidence to suggest that as AD increases the 
ratio of NAD/AD is greater in the preterm baby (Figures 6.20 and 
6.21), implying a poorer adrenaline response in the preterm fetus.
The evidence from this Chapter also suggests that, again in 
contrast to cortisol, the maternal and fetal sympathoadrenal systems 
function independently.
Chapter 7 Influence of labour and delivery
The route of delivery had little effect on incidence of RDS, on 
neonatal survival or on biochemical lung maturity as' reflected by the 
amniotic fluid phospholipids. In contrast to this however, the route
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of delivery had a marked influence on the fetal stress hormones. 
Those babies born vaginally had significantly raised mean UAC levels 
compared to those delivered by caesarean section. If the cortisol 
response to labour was of importance in determining fetal lung 
maturity, one might have expected that those babies delivered by 
elective caesarean section would have in increased incidence of 
respiratory problems. This however was not the case.
The route of delivery also had a marked influence on UA 
catecholamine levels in the term (36-41 weeks) group of babies, those 
born vaginally having significantly raised mean UA NAD and AD levels 
compared to those delivered by caesarean section.
In the preterm group of babies (24-33 weeks), the effect of route 
of delivery on UA catecholamines was not so clear cut and this is in 
agreement with Newnham et al (1984) who could also find no differnce 
between vaginal delivery and caesarean section.
In contrast to the babies delivered by elective caesarean section 
in the term troup, those in the preterm elective caesarean section 
group were a group under much more stress (as reflected by lower mean 
UApH) and this may explain the lack of difference in catecholamine 
levels between elective caesarean section and vaginally delivered 
babies in the preterm group.
Chapter 8 Multiple Pregnancy
There was no difference in the incidence of respiratory problems 
and very few differences in amniotic fluid phospholipids between 
singletons and twins.
There was no significant difference in UA catecholamine levels 
between singletons and twins and only after 34 weeks was there any 
difference in mean UAC levels. The mean UAC level was significantly 
raised in singletons compared to twins after 34 weeks' gestation.
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There was no difference in clinical or biochemical lung maturity 
between first and second born twins and no difference in mean UA 
catecholamine levels. However after 35 weeks the mean UAC level was 
significantly higher in first compared to second born twins.
An excellent correlation was found between twin I and twin II for 
UAC, NAD and AD but not pH.
Chapter 9 Condition of infant at birth
The condition of the baby at birth (as indicated by UApH) had a 
significant effect on occurrence of RDS, requirement for ventilation 
and for the ultimate survival of the infant.
Respiratory problems were more common in babies who were acidotic 
at birth. No obvious relationship could be demonstrated betgween UApH 
and the amniotic fluid phospholipids or between UA pH and UAC and the 
UA catecholamines.
Chapter 10 Obstetric complications
None of the obstetric complications studied, (proteinuric 
hypertension, IUGR, vaginal bleeding, spontaneous preterm labour and 
vaginal delivery, PROM) appeared to cause an acceleration of clinical 
or biochemical lung maturity, neither did they affect the levels of 
fetal stress hormones NAD, AD and cortisol, in any particular way.
Only in pregnancies where there was an abnormal antenatal CTG was 
there a suggestion of a different clinical outcome. The highest 
percentages of babies requiring ventilation or dying were found in 
this group (Tables 10.15 - 10.18). These babies were in a poor 
condition at birth, as reflected by mean UA pH which was significantly 
lower in the abnormal CTG group compared with the other obstetric 
complications (Table 10.26).
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C h a p te r 11 F e ta l c o r t i s o l  and lu n g  m a tu r i t y
1 UAC level did not relate to survival, requirement for ventilation 
or to the development of RDS before 34 weeks.
2 A significantly lower mean UAC level was found in babies 
developing RDS in the 34-33 week age group, suggesting a 
deficiency in the fetal cortisol surge in these babies, which is 
known to occur at this time.
3 No relationship was found between UAC levels and biochemical lung 
maturity as reflected by the amniotic fluid phospholipids.
Chapter 12 Fetal catecholamines and lung maturity
The level of fetal catecholamines had no apparent influence on 
incidence of neonatal respiratory problems nor on biochemical lung 
maturity as reflected by the amniotic fluid phospholipids.
Treatment of the pregnant mother with the Beta sympathomimetic 
drug ritodrine had no influence on clinical or biochemical lung 
maturity.
Chapter 13 AmniotLc fluid phospholipids and clinical outcome
This Chapter demonstrated clearly the importance of the lung 
surface active phospholipids, especially PG, not only in the 
development of lung maturity but also for the ultimate survival of the 
infant.
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1 4 .3  C o n c lu s io n s  drawn from  th e  s tu d y
1 It is generally believed that certain obstetric complications can 
protect the fetus from developing RDS, however from this study there 
is little evidence to support this (Table 8.15-8.18) and in addition 
none of the obstetric complications studied had any consistent 
influence on fetal cortisol or catecholamine levels.
2 Despite much indirect evidence in the literature (Chapters 2 
and 3) we were unable to confirm the proposed effect of stress on 
fetal lung maturity as oulined in Figure 2.2. In this Figure a 
mechanism was proposed whereby fetal stress in utero, either the 
physiological stress of labour or the more pathological stress of 
certain obstetric complications could act via the fetal adrenal gland 
and extra adrenal chromaffin tissue to cause a rise in fetal cortisol 
and catecholamine secretion.
3 The adrenocortical and sympathoadrenal responses have been 
extensively studied in the human fetus at birth from 24 to 41 weeks1 
gestation. Although there is a marked increase in UAC levels with 
gestation, especially from 34 weeks, the changes in sympatho-adrenal 
responses are not so clear cut. There was a tendency for the levels 
of both NAD and AD to rise with gestation and there is some evidence 
to suggest that the ratio of NAD/AD does decrease with increasing 
gestation, suggesting an increased AD response to stress in the term 
compared to the preterm group.
Interestingly neither the adrenocortical nor the sympatho-adrenal 
responses seemed to influence the clinical outcome for the baby.
4 It cannot be assumed that a fetus under chronic stress will 
necessarily have accelerated fetal lung maturity, a history of 
obstetric complications producing stress is often found in babies who
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die from RDS. Indeed from this study those babies who developed RDS, 
required ventilation or died were significantly more acidotic than 
those babies who had no respiratory difficulties.
The study therefore does not support the view that stress, either 
the physiological stress of labour or the pathological stress of 
certain obstetric ocmplications accelerates fetal lung maturity. In 
addition to this it does not appear that the stress products cortisol 
or catecholamines have a major role to play in influencing neonatal 
lung function. Gestational age and the condition of the baby at birth 
would seem to be of paramount importance.
14.4 The Relationship of the Study to Current Literature
For many years obstetricians have had the impression that certain 
pregnancy complications appear to be associated with an unusually low 
incidence of neonatal RDS. However it is doubtful if this can really 
be substantiated from a detailed review of the literature (Chapter 3). 
There is almost equal evidence to support or refute the claim that 
PROM, IUGR, hypertension in pregnancy or antepartum haemorrhage cause 
a reduction in the incidence of RDS and only in PROM does the evidence 
tend to support the idea of an acceleration in the normal timing of 
biochemical lung maturity as reflected by the amniotic fluid 
phospholipids.
Evidence to support a rise in the fetal stress hormones, 
purported to influence fetal lung maturity, is sparse. What studies 
there are tend to be either conflicting or based on small numbers.
The present study failed to find a link between any of the 
obstetric complications studied and an acceleration of clinical or 
biochemical lung maturity or a rise in fetal stress hormones peculiar 
to any one of them. These findings therefore would not be out of step 
with available literature.
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Large epidemiological studies have shown that a baby delivered 
after the experience of labour is less likely to develop RDS than one 
delivered by elective caesarean section (Fedrick and Butler 1972). 
However in the small group of babies studied in this thesis, labour 
seemed to confer little benefit and it would seem that in the 
individual baby the method of delivery would be much less important to 
the baby's morbidity and mortality than the gestational age and 
condition at time of birth.
The proposed mechanism linking stress and lung maturity outlined 
in Figure 2.2 was derived mainly from the results of animal 
experiments.
There is a large body of convincing evidence in animals linking 
corticosteroids with induction of the enzymes involved in surfactant 
synthesis and catecholamines with clearance of lung fluid and control 
of the release of surfactant (Chapter 2). No such relationships were 
found during the course of this study in the human. Indeed the 
evidence for the efficacy of exogenous corticosteroid treatment to the 
pregnant human mother in preterm labour to prevent neonatal RDS is 
conflicting and has never been fully accepted by all authorities. The 
results of experiments in animals may not be applicable to the human, 
eg there are certain important differences in the adrenal cortex 
between human and non-human. The human fetal adrenal contains a large 
internal zone, the fetal zone, which comprises about 80?^  of the mass 
of the fetal adrenal and regresses rapidly rapidly after birth.' Such 
a fetal zone is not present in the adrenals of sheep, rabbits and rats 
on whom most experimental work in this field has been performed.
Similarly there may be important differences in the sympatho­
adrenal responses between the human and non-human fetus. For example 
Padbury et al (1981) provided evidence suggesting that fetal 
catecholamines play a significant role in the sex difference of
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pulmonary maturity. They found significantly more adrenaline in the 
fetal adrenal gland of the female rabbit fetus and the ratio of 
adrenaline to total catecholamine content in the adrenal gland was 
greater in the female fetus. They also found a greater number of 
adrenergic receptors in the fetal lung of the female fetus. However, 
in humans, Padbury et al (1981) were unable to find any sex 
differences in plasma noradrenaline or adrenaline levels or in 
responsiveness.
It has been suggested the fetal catecholamines have an important 
role to play in preparing the fetus for extrauterine existence, not 
just in promoting lung maturity but in glucose homeostasis, 
cardiovascular changes and via non shivering thermogenesis (Phillips 
1983, Artal 1980). A recent paper by Falconer and Poyser (1986) 
could find little evidence to support sympathoadrenal mediated 
metabolic responses in the human fetus. Interestingly Jones et al
(1985) noted that human fetal platelets showed an impaired alpha 2 
adrenoreceptor function with absent aggregatory responses to 
adrenaline compared to adult platelets. The defect in adrenoreceptor 
function in the fetus was not thought to be due to changes in the 
number of fetal platelet alpha receptors nor to changes in receptor 
affinity for adrenaline, as fetal platelets failed to aggregate to 
adrenaline from deliveries with high and low cord blood 
catecholamines. The possibility remains therefore that despite 
several reviews suggesting an important role for the catedholanines 
(Phillipe 1983, Artal 1980), the human fetus may not be responding to 
these very high catecholamine levels because of a deficiency in 
adrenoreceptor function. This would be in keeping with the findings 
of this thesis showing a lack of effect of MAD and AD on fetal lung 
maturity.
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The study therefore does not support the view that stress, either 
the physiological stress of labour or the pathological stress of 
certain obstetric complications accelerates fetal lung maturity. In 
addition to this it does not appear that the stress products cortisol 
or catecholamines have a major role to play in influencing neonatal 
lung function. Gestational age and the condition of the baby at birth 
would seem to be of paramount importance.
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